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Chapter 1
National Drugs Strategy and
Structural Mechanisms
Rosalyn Moran and Brigid Pike
1.1   Introduction
In April 2001 the Irish Government approved the National Drugs Strategy for
2001-2008 (2001). The National Drugs Strategy Review Group, which was
responsible for developing this new Strategy, had begun its task by undertaking
an exhaustive review and consultation process. As a result of this process, the
Review Group concluded that the approach to the drugs issue taken to date by
the Irish Government provided a solid foundation from which all those trying to
tackle the drugs problem should work in the future. The Review Group
endorsed the existing approach and, in developing the new Strategy, expanded
and strengthened the pillars and principles underpinning this approach
(Department of Tourism, Sport and Recreation, 2001). 
In this chapter the strategic framework and main structural mechanisms for co-
ordinating and implementing the strategy are described under the following
headings:
1.2 National Drugs Strategy 1996-2000 
1.3 National Drugs Strategy 2001-2008
1.4 National Development Plan 2000-2006
1.5 National Co-Ordination and Implementation 
1.6 Regional/Local Co-ordination and Implementation
1.7 Evaluation of National Strategies
1 Particular thanks to Ms Kathleen Stack of the Department of Tourism, Sport and Recreation and Ms
Mary Jackson of the Department of Health and Children, who provided much background information
and informed commentary. The authors acknowledge their co-operation and enthusiasm.
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1.2   National Drugs Strategy 1996 - 2000 
Since 1996 the Irish Government's drugs strategy has been underpinned by the
findings, recommendations and policies established by the two reports of the
Ministerial Task Force on Measures to Reduce the Demand for Drugs (1996,
1997). The overall aim of the Irish Government's drugs strategy has been to
provide an effective, integrated response to the problems posed by drug misuse 
and to work in partnership with the communities most affected by the drugs
problem in tackling the issues raised.
Arising from this overall aim, the key objectives of Government policy have been
to:
! reduce the number of people turning to drugs in the first instance 
through comprehensive education and prevention programmes;
! provide appropriate treatment and aftercare for those who are 
dependent on drugs;
! have appropriate mechanisms at national and local level aimed at 
reducing the supply of illicit drugs; and
! ensure that an appropriate level of accurate and timely information is 
available to inform the response to the problem.
In line with these overall aims and objectives, four basic principles have
underpinned the Government's strategy:
! it is recognised that an effective strategy must encompass a range of 
responses, which not only address the consequences of drug misuse, 
but also attack its causes;
! the response to the drug problem must take account of the different 
levels of drug misuse, which are being experienced around the country.  
While illicit drug use is a nation-wide phenomenon (particularly the 
use of drugs such as cannabis and ecstasy), heroin abuse, in view of its 
public health implications and close association with crime, is currently 
seen as the most pressing aspect of the problem.  A more targeted 
response is required, therefore, in the areas experiencing the highest 
levels of heroin abuse;
! the need for all agencies, which have a role in responding to the drug 
problem, to work together so as to ensure that their individual 
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contributions form part of an overall coherent and integrated approach; 
and 
! the need to tap the depth of experience and knowledge which 
community groups and voluntary organisations can bring to a response 
to the drug problem. It is recognised that there is considerable 
knowledge and experience among communities in the areas 
experiencing the highest levels of use. These communities, therefore, 
must have an opportunity to participate in the design and delivery of 
the response to the problem in their areas  (Flood, 1999).
In line with the above strategy and policy directions, national policies and
strategies have undergone considerable changes over the past five or so years,
involving a more integrated, inter-agency response to the drugs problem, and
greater engagement of local communities in policy-making and implementation
(e.g. Integrated Services Process, Local Drug Task Forces, and Young People's
Facilities and Services Fund). More recently, greater regionalisation in the
implementation of initiatives in the drugs area has been taking place within the
framework of the new National Development Plan 2000-2006 (NDP, 2000) and
related social partnership arrangements, which, inter alia, prioritise social
inclusion as an objective of national development. 
At the micro level, a major objective of drug policy in Ireland has been to
maintain people in, and restore misusers to, a drug-free lifestyle. In practice, it is
acknowledged that this is not an option for a number of citizens in the short
term.  Accordingly, a pragmatic approach is taken and the importance of the
minimisation of risk, i.e. harm reduction, is stressed in treatment and in a
number of education and rehabilitation programmes. The emphasis on harm
reduction has grown with the concern relating to the public health implications
of the growth in AIDS/HIV and hepatitis B and C infections.    
1.3   National Drugs Strategy 2001-2008
1.3.1  National Drugs Strategy Review - The Process 
A comprehensive review of the National Drugs Strategy was initiated by the
Department of Tourism, Sport and Recreation in April 2000. A sub-group of the
Inter-Departmental Group on Drugs, which includes representatives of the state
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agencies and the National Drugs Strategy Team, oversaw the management of the
review. It was assisted by independent consultants. 
The objective of the review was to identify gaps or deficiencies in the existing
strategy, revise strategies and, if necessary, develop new arrangements through
which to deliver the strategies. The review was to identify the latest available
data on the extent and nature of drug misuse in Ireland as a whole, attempt to
identify any emerging trends and pinpoint the areas with the greatest levels of
drug misuse. To be as comprehensive as possible, the review was also required
to look at international trends, developments and best practice models
(Department of Tourism, Sport and Recreation, Internal Document).
The review involved extensive consultations through invited submissions (over
190 received), discussions with key players in the state, voluntary and
community sectors, and a series of eight public regional consultative fora
(attendance by approximately 600 people) held throughout the country during
June 2000. Over thirty agencies and organisations were invited to make detailed
presentations to further assist in the identification of any gaps or deficiencies in
the current strategy. These consultations were underpinned by extensive
research of international examples of best practice, and a review of various
relevant evaluation reports and other literature.
In early 2001 the Review Team published its findings (Department of Tourism,
Sport and Recreation, 2001) and the Government approved the National Drugs
Strategy 2001-2008 (2001).
1.3.2 Objectives, Aims and Key Performance Indicators 
The overall strategic objective of the National Drugs Strategy 2001-2008 is: 
to significantly reduce the harm caused to individuals and society by the misuse
of drugs through a concerted focus on supply reduction, prevention, treatment,
and research (Ireland's National Drugs Strategy, 2001-2008, 2001: 8). 
The new Strategy endorses the Irish Government's existing approach to tackling
the drugs issue. The four 'pillars' of the new Strategy - supply reduction,
prevention, treatment and research - focus on the same four issues as in the
Government's previous Drugs Strategy (see Section 1.2 above). 
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The new National Drugs Strategy, however, seeks to strengthen the strategy and
sharpen its focus, by:
! welcoming the Government's positioning of the National Drugs 
Strategy within the wider Social Inclusion policy and the strong 
commitment to areas of disadvantage in the NDP 2000 - 2006. The 
Review Team recognises that the best prospects for communities 
affected by the drugs problem, in the longer term, rest with a Social 
Inclusion strategy which delivers much improved living standards to 
areas of disadvantage throughout the country; and
! requiring all state agencies involved in delivering the National Drugs 
Strategy to specify annual targets in terms of outputs and desired 
outcomes for their respective programmes and initiatives.
With these broad considerations in mind, the Strategy has identified seven
overall aims:
! to reduce the availability of illicit drugs;
! to promote throughout society a greater awareness, understanding and 
clarity of the dangers of misuse; 
! to enable people with drug misuse problems to access treatment and 
other supports in order to re-integrate into society;
! to reduce the risk behaviour associated with drug misuse;
! to reduce the harm caused by drug misuse to individuals, families and 
communities; 
! to have valid, timely and comparable data on the extent and nature of 
drug misuse in Ireland; and
! to strengthen existing partnerships in and with communities and build 
new partnerships to tackle the problem of drug misuse.
To sharpen the focus, the National Drugs Strategy 2001-2008 (2001) specifies
objectives and key performance indicators (KPIs) for each of the four pillars -
supply reduction, prevention, treatment and research. These are briefly outlined
overleaf.
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Supply Reduction
The objectives in relation to supply reduction are:
! to significantly reduce the volume of illicit drugs available in Ireland, to 
arrest the dynamic of existing markets and to curtail new markets as 
they are identified; and
! to significantly reduce access to all drugs, particularly those drugs that 
cause most harm, amongst young people especially in those areas 
where misuse is most prevalent.
These objectives are underpinned by a quantitative KPI, which seeks to increase
the volume of opiates and all other drugs seized in Ireland by 25 per cent by 2004
and by 50 per cent by 2008. To support achievement of this KPI, the National
Drugs Strategy Review Team (Department of Tourism, Sport and  Recreation,
2001) considered that law enforcement resources should continue to be targeted
at disrupting the activities of organised crime groups. It welcomed the progress
made in legislating against drug-related crime and developments in the prisons
in relation to drug treatment services. Additional KPIs include increasing Garda
resources in LDTF areas, and strengthening coastal watch and international co-
operation, and enhance drugs policy co-ordination within the Gardaí. 
Prevention
The objectives in relation to prevention are:
! to create greater social awareness about the dangers and prevalence of 
drug misuse; and
! to equip young people and other vulnerable groups with the skills and 
supports necessary to make informed choices about their health, 
personal lives and social development.
The first KPI sets a quantitative target of bringing drug misuse by school-goers
below the EU average and, as a first step, reducing the level of substance misuse
reported to ESPAD2 by school-goers by 15 per cent by 2003 and by 25 per cent
by 2007. Specific initiatives include the development and launch of an ongoing
National Awareness Campaign highlighting the dangers of drugs; linking the
National Drugs Strategy with the National Alcohol Policy; strengthening the
links between the Department of Education and Science and the LDTFs and
providing educational supports in LDTF areas.
2 European Schools Survey Project on Alcohol and Other Drugs.
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Treatment 
The objectives in relation to treatment are:
! to encourage and enable those dependent on drugs to avail of treatment 
with the aim of reducing dependency and improving overall health
a n d
social well being, with the ultimate aim of leading a drug-free lifestyle; 
and
! to minimise the harm to those who continue to engage in drug-taking 
activities that put them at risk.
Four out of the seven KPIs relate to the quality of treatment services - immediate
access for drug misusers to professional assessment and counselling, followed
by appropriate treatment within one month; access for under-18s to treatment,
following the development of an appropriate protocol; increasing the number of
treatment places to 6,000 by the end of 2001, and to a minimum of 6,500 by the
end of 2002; and having a service charter in place for each health board by the
end of 2002. The Strategy also specifies that the recommendations of the Steering
Group on Prison-Based Treatment Services (Irish Prisons Service, 2000) should
be implemented as a priority, and that proposals should be implemented to end
heroin use in prison by 2008.
The Strategy also requires that, by the end of 2002, each health board should
have in place a range of treatment and rehabilitation options as part of a planned
progression for each drug misuser, and that the number of opportunities for
training and employment for stabilised drug misusers should be increased by 30
per cent by the end of 2004.
Research
The objectives in relation to research are:
! to have available valid, timely and comparable data on the extent of 
drug misuse amongst the Irish population and specifically amongst all 
marginalised groups; and
! to gain a greater understanding of the factors which contribute to Irish 
people, particularly young people, misusing drugs.
The KPIs set targets for the elimination of all major research gaps in drug
research by 2003, and the publication of an annual report on the nature and
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extent of the drug problem in Ireland, which will include a progress report on
achievement of  the objectives set out in the National Drugs Strategy.
Co-Ordination and Evaluation
Although not designated one of the 'pillars' of the National Drugs Strategy, KPIs
relating to the establishment of an efficient and effective framework for
implementing and evaluating the Strategy are identified. They include
establishing an effective regional framework to support the measures;
completing an independent evaluation of the effectiveness of the overall
framework; requiring each agency to prepare a critical implementation path for
each of the actions listed in the Strategy that are relevant to their remit; and
reviewing the membership, workload and supports required by the National
Drugs Strategy Team to carry out its terms of reference.
1.4  National Development Plan 2000-2006
The National Drugs Strategy Review Team (Department of Tourism, Sport and
Recreation, 2001) welcomed the Government's positioning its approach to the
drugs issue within the context of its Social Inclusion strategy, a plank of its
National Development Plan (NDP, 2000) for 2000-2006. Social Inclusion became
a major aspect of the NDP arising out of agreements between the Government
and the social partners, including the NAPS (National Anti-Poverty Strategy,
1998/99; 1999/2000) and the PPF (Programme for Prosperity and Fairness, 2000). 
Under the NDP, spending earmarked for social inclusion amounts to Ir£19,077.7
million /  24,223.7 million. The NDP involves greater devolution to the regional
and local levels, with the Border-Midland-West (BMW) and South-East (SE)
regions receiving allocations of Ir£112 million / 142.2 million and Ir£10 million
/ 12.7 million respectively, specifically to combat drug misuse.
The Government's Social Inclusion strategy involves a range of responses that
address the causes and consequences of drug misuse. The Government's
response can be characterised as supporting general initiatives to tackle social
exclusion, and specific initiatives within the Social Inclusion framework but
more specifically targeted at drug-related problems. The general initiatives are
targeted at issues seen as contributing to the drugs problem, e.g. unemployment,
social deprivation (Drug Misuse Research Division, 1999). Such programmes
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provide scope for agencies and communities affected by the drugs problem, to
avail of financial and other resources to tackle the broader problems associated
with drug misuse in their communities. 
The Government's specific response to tackling the drugs problem is focused
around two major initiatives - the Local Drug Task Forces (LDTFs) and the
Young People's Facilities and Services Fund (YPFSF). Both initiatives have been
largely focused on urban areas, where the drug problem is most acute. 
In the following sections the structural mechanisms to plan, co-ordinate,
implement and evaluate the National Drugs Strategy 2001-2008 (2001) are
described, together with many of the 100 individual actions identified in the
Strategy to address specific gaps in the existing drugs strategy, to strengthen
each of the four pillars which underpin it, and to ensure the objectives are met.
1.5 National Co-Ordination and Implementation
The National Drugs Strategy Review Team (Department of Tourism, Sport and
Recreation, 2001) endorsed the existing arrangement for co-ordinating and
implementing roles at national level, with the addition of an Oireachtas
Committee on Drugs (see Table 1.1). The roles and functions, as outlined in the
National Drugs Strategy 2001-2008 (2001), are described below under the
following headings:
1.5.1 Central Co-Ordination  
1.5.2 Key Government Departments and Agencies
1.5.3 Research and Information
1.5.1 Central Co-Ordination 
At national level, the policy and co-ordination tasks in relation to the drugs issue
overlap with the mechanisms to promote Social Inclusion in general in Ireland.
Foremost among these mechanisms is the Cabinet Committee on Social
Inclusion, which gives political direction to the Government's Social Inclusion
policies, including the National Drugs Strategy. Chaired by the Taoiseach, this
committee receives input on the drugs issue from the Department of Tourism,
Sport and Recreation, the Inter-Departmental Group on Drugs (IDG) and the
National Drugs Strategy Team (NDST).
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NATIONAL
LEVEL
Policy &
Implementation
(Key Government
Departments/
Agencies/
Programmes)
Co-Ordination
Implementation
Cabinet Committee on Social Inclusion
l Minister of State for Local Developmentat
DoTSR, with responsibility for National
Drugs Strategy.
l DoTSR
DoTSR
Department of
Education & Science
DMRD
(HRB)
Regional Drugs Task Forces Local Drugs Task Forces YPFSF Development Groups
Regional Health Boards Community and Voluntary Sectors
FAS
Dept. of Health & Children
Revenue Commissioners
Customs & Excise Service
Department of
Environment and
Local Government
DSCFA
l Community
Development
Programme
Oireachtas Committee on Drugs
IDG YPFSF
National Assessment
Committee
Dept. of Justice,
Equality & Law Reform
l An Garda Siochana
l Irish Prisons Service
l Probation & Welfare
Services
l Courts
NDST NACD
REGIONAL/
LOCAL
LEVEL
Direction
&
Co-Ordination
TABLE 1.1
Outline of Structural Mechanisms to Deliver National Drugs Strategy 2001 - 2008
KEY: Existing Structure New Structure proposed in National Drugs Srategy 2001 - 2008
The National Drugs Strategy 2001-2008 (2001) identifies the need for an
Oireachtas Committee on Drugs. The Strategy includes an action to establish a
dedicated drugs sub-committee of the existing Select Committee on Tourism,
Sport and Recreation. This Oireachtas committee would meet at least three times
a year.
In 1997 the Government appointed a Minister of State for Local Development
at the newly-created Department of Tourism, Sport and Recreation, with
special responsibility for Co-ordination of the National Drugs Strategy. Under
the National Drugs Strategy 2001-2008 (2001) the Minister of State chairs the IDG
and reports to the Cabinet Committee on Social Inclusion, bringing to its
attention any identified issues with a detrimental effect on the implementation
of policy. The Department of Tourism, Sport and Recreation has responsibility
for the overall co-ordination of national policy to tackle drug misuse, including
implementation of the National Drugs Strategy 2001-2008. The Department
works in partnership with government departments, state agencies and the
community and voluntary sectors, through the IDG and NDST. The
Department's co-ordinating responsibilities also include the establishment of an
evaluation framework for the National Drugs Strategy (see Section 1.7.2 below). 
The National Drugs Strategy Review Team (Department of Tourism, Sport and
Recreation, 2001) noted that, in other countries, responsibility for co-ordinating
drugs strategies usually resides either in the Department of the Prime Minister
or the Department of Health. While the advantages of both these options were
acknowledged (in terms of political authority, budget size and service-provision
experience), the Team recommended retaining the responsibility in Tourism,
Sport and Recreation. The Team considered that the Department of Tourism,
Sport and Recreation can be objective in relation to all the thematic areas covered
by the national policy. Moreover, given this Department's role in local
development and co-ordination of a number of different programmes relating to
Social Inclusion, and given the correlation between drug misuse and social
exclusion, it was considered that it was strategically well placed to take the lead
role in co-ordination. In other words, it can bring a holistic and integrated
approach to the drugs issue.
The Inter-Departmental Group on Drugs (IDG) plays a key role on overseeing
the implementation of the National Drugs Strategy. Strengthened under the
National Drugs Strategy 2001-2008 (2001) to comprise senior level
representatives from government departments, and the chair of the NDST, and
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to be chaired by the Minister of State at the Department of Tourism, Sport and
Recreation, the IDG, inter alia, will advise the Cabinet Committee on Social
Inclusion on critical matters of a public policy nature relating to the National
Drugs Strategy; ensure timely and effective input by relevant Departments and
agencies into emerging operational difficulties or conflicts; and approve the
plans and initiatives of the LDTFs and the proposed Regional Drugs Task Forces
- RDTFs, and monitor and evaluate the outcomes of their implementation, in
conjunction with the NDST. By the end of 2001, the IDG, in conjunction with the
NDST, is to develop formal links at local, regional and national levels with the
National Alcohol Policy, to ensure complementarities between the different
measures being undertaken.
The National Drugs Strategy Team (NDST) includes representatives from
relevant government departments and agencies, and also two non-government
representatives, one each from the community and the voluntary sectors,
making the NDTS a partnership between the statutory, community and
voluntary sectors. Members of the NDTS play a central role in overseeing the
implementation of the Government's National Drugs Strategy by ensuring, inter
alia, effective co-ordination between departments, agencies and the community
and voluntary sectors, in delivering LDTF and the proposed RDTF plans;
reviewing the need for LDTFs in disadvantaged urban areas (particularly having
regard to evidence of localised heroin misuse); identifying and considering
policy issues and ensuring that policy is informed by the work of and lessons
from the LDTFs; overseeing the establishment of the proposed RDTFs; drawing
up guidelines for the operation of, and evaluating the action plans of, LDTFs and
RDTFs. The NDTS has joint monthly meetings with the IDG, and they jointly
report to the Cabinet Committee on Social Inclusion every six months (National
Drugs Strategy, 2001).
The YPFSF National Assessment Committee was established under the Young
People's Facilities and Services Fund (see Section 1.6.3 below), to prepare
guidelines for the development of integrated plans in the target areas for the
Fund; to assess the plans and to make recommendations on funding to the
Cabinet Committee on Social Inclusion. The Committee oversees the
implementation of the Fund. Membership of the Committee comprises civil
servants, representatives of state agencies and representatives of the community
and voluntary sector, and the NDST.
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1.5.2 Key Government Departments and Agencies
A number of government departments and agencies play lead roles in
developing and implementing policy to tackle the drugs issue in Ireland. Their
roles and responsibilities, including new actions assigned under the National
Drugs Strategy 2001-2008 (2001), are outlined below. The departments are
represented on the IDG, described in Section 1.5.1 above
Department of Tourism, Sport and Recreation
The Department of Tourism, Sport and Recreation has responsibility for the
overall co-ordination of national policy to tackle drug misuse, including
implementation of the National Drugs Strategy 2001-2008. The Department
works in partnership with government departments, state agencies and the
community and voluntary sectors, through the IDG and NDST. The
Department's co-ordinating responsibilities also include the establishment of an
evaluation framework for the National Drugs Strategy (see Section 1.7.2 below).
The Department of Tourism, Sport and Recreation also has responsibility for
local development, and the implementation of the Integrated Services Process
(ISP) inter alia.  The aims of the ISP include the development of a more focused
and better co-ordinated response by the statutory authorities to the needs of
communities with the greatest levels of disadvantage. The ISP is aimed at
developing an integrated framework within which ongoing programmes can be
rationalised and enriched to do a better job of making services available to
communities (O'Brien & Moran, 1998).
In early 2001 the Government launched the RAPID (Revitalising Areas by
Planning, Investment and Development) Programme, under the aegis of the
Department of Tourism, Sport and Recreation. RAPID is a focused initiative by
the Government targeting the twenty-five most concentrated areas of
disadvantage in the country. The targeted areas will be prioritised for
investment and development in relation to health, education, housing, childcare
and community facilities including sports facilities, youth development,
employment, drug misuse and policing. The programme is based on ISP
principles, involving an implementation team (comprising state agency
personnel, the local Area Partnership and residents of the local community) and
a co-ordinator. Under the National Development Plan, up to Ir£15 billion / 19.5
billion has been earmarked for Social Inclusion measures, and the RAPID
programme will prioritise the twenty-five targeted areas and front-load a
significant share of this money to them over the next three years.
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The Department also has continuing responsibility for providing accessible,
positive alternatives to drug misuse through the YPFSF (see Section 1.6.3 below),
through arts and culture youth programmes, the schemes run by the Irish Sports
Council and the facilities provided under the Sports Capital Programme. The
National Drugs Strategy 2001-2008 (2001) states that LDTF areas should be
prioritised and specific efforts made to ensure that the groups who are most at
risk of drug misuse are actively engaged in recreational activities at local level.
Department of Health and Children
The Department of Health and Children plays key roles in relation to both
prevention and treatment of drug misuse. The National Health Promotion
Strategy (Department of Health and Children, 2000) outlines a number of
objectives relating to drug misuse. The principal aim of the strategy is to support
best-practice models for the promotion of the non-use of drugs and the
minimisation of the harm caused by drugs. The objectives are to: 
! ensure each health board has in place a comprehensive drugs education 
and prevention strategy;
! continue to support the implementation of existing drug-related health 
promotion programmes; 
! work in partnership with relevant government departments (e.g. 
Department of Education and Science) and other bodies to co-ordinate 
health promotion activities; and
! develop prevention and education programmes, with particular 
emphasis on schools and the youth sector and on interventions in areas 
where drug misuse is most prevalent. 
The National Drugs Strategy 2001-2008 (2001) has assigned the Department the
task of launching a National Awareness Campaign highlighting the dangers of
drugs, by the end of 2001. The campaign is to promote greater awareness of the
causes and consequences of drug misuse not only to individuals but also to their
families and to society in general. The Department works closely with the
Department of Education and Science in the design, implementation and
evaluation of educational programmes. New strategies and actions in this area
are discussed below under the entry for the Department of Education and
Science.
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In relation to drug treatment and rehabilitation, the Department of Health and
Children has overall policy responsibility. The Department's policy on the
treatment of drug and alcohol misuse stresses the need for community-based
interventions including family support and community medical and social
services. The Department funds the regional health boards, which provide drug
treatment services at regional and local levels (see Section 1.6.5 below).
Increasingly, this service provision involves more active liaison with local
government structures.
The National Drugs Strategy 2001-2008 (2001) identifies three actions for the
Department of Health and Children, designed to maintain the quality of
treatment and rehabilitation services - ensuring adequate training is provided
for health care and other professionals engaged in the management of drug
dependency; consulting all treatment and rehabilitation providers to ensure that
performance indicators accurately and consistently reflect the reality of the drug
problem locally; and overseeing the implementation of the recommendations of
the Benzodiazepine Working Group.
Department of Education and Science 
The Department of Education and Science plays a role in relation to prevention,
operating mainly through the formal education system. Its initiatives to combat
drug use, such as 'Walk Tall' for primary level and 'On My Own Two Feet' for
secondary level, and more recently the Social, Personal and Health Education
(SPHE) programme, are linked to its overall package of measures to combat
educational disadvantage. The National Drugs Strategy 2001-2008 (2001)
stipulates that the Department is to ensure that every second-level school is to
have an active programme to counter early school-leaving, with particular focus
on areas with high levels of drug misuse.
The Department of Education and Science liaises closely with the Department of
Health and Children. Both departments are tasked jointly by the National Drugs
Strategy 2001-2008 (2001) with providing school-based education and preventive
programmes in all schools by September 2003, and ensuring that evaluation is an
ongoing element of the 'Walk Tall' and 'On My Own Two Feet' programmes,
from 2002 onwards. Moreover, all programmes are to be informed by ongoing
research into the factors contributing to drug misuse by particular groups.
Parents of at-risk children are to be specifically targeted in school programmes -
providing them with access to factual preventative materials, which will
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encourage them to discuss the issues of coping with drugs and drug misuse with
their children. Schools are also to be assisted, through the provision of
guidelines, developed by the departments of Education and Health, in co-
operation with the health boards, on the formation of a school drug policy.
In the non-formal education sector, the Department of Education and Science
works closely with FÁS on joint-funded initiatives such as Youthreach, and in
the running of workshops aimed at increasing drug awareness in areas where
acute drug problems are apparent. In relation to LDTFs, the role of the
Department of Education is to be strengthened under the National Drugs
Strategy 2001-2008 (2001). The Department is to publish and implement a policy
statement on education supports in LDTFs, including an audit of current
supports, by the end of 2001, and to nominate a departmental official to serve on
each LDTF.
FÁS
FÁS, the state training agency, operates specific drug-related programmes,
including the Special Drugs Community Employment Programme, on which
1,000 places have been assigned for recovering drug misusers. Trained staff are
available to work with stabilised drug misusers, to help them access
employment or further training. Similarly, advocates, located in severely
disadvantaged areas, provide a mentoring service to young people experiencing
drug problems.
Acknowledging that the FÁS Community Employment Programme has been an
important element of the existing approach to rehabilitation, the National Drugs
Strategy 2001-2008 (2001) sets a target for increasing the number of training and
employment opportunities for drug misusers by 30 per cent by the end of 2004.
The Strategy also identifies the need to examine the potential to involve
recovering drug misusers in Social Economy projects, and in other forms of
vocational training.
Department of Environment and Local Government
The Department of the Environment and Local Government is responsible for
policy and programmes in relation to the environment and for a wide range of
services, provided mainly through the local government system. It is also
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responsible for the local government system, construction industry matters and
franchise and electoral systems.
The Department is involved in a broad range of initiatives which are drug-
related, e.g. the National Anti-Poverty Strategy (NAPS), and is represented on
relevant co-ordination structures. The Department also has a major role in
relation to housing, homelessness and estate management.
The National Drugs Strategy 2001-2008 (2001) identifies two actions for the
Department, both relating to the issue of homelessness and drug misuse - to
commission an external evaluation of the impact of enforcement activity under
the Housing Act 1997 on homelessness, and to monitor and evaluate
homelessness initiatives in relation to drug issues.
Department of Social, Community and Family Affairs
The Department of Social, Community and Family Affairs' schemes and
programmes of support for community development focus on investment in
capacity building, so that socially-excluded groups and local communities can be
active participants in identifying and meeting their own development needs,
working alongside the other social partners.
While the main focus of the Department's programmes is not on drug prevention
strategies, rehabilitation etc., local projects working in disadvantaged areas may
provide support, in a community development context, to those affected by drug
abuse. The Department is represented on the IDG and is to be represented on the
proposed Regional Drug Task Forces. Section 1.6.6 below gives an overview  of
the Dublin Citywide Drugs Crisis Campaign, funded by the Department of
Social, Community and Family Affairs, which provides technical assistance and
expertise to local communities to develop their capacity to respond to the drugs
crisis in their area.
Department of Justice, Equality and Law Reform 
The Department of Justice, Equality and Law Reform has overall responsibility
for policy and legislation relating to the reduction of the supply of drugs, inter
alia. In recent years Ireland has put in place one of the strongest legislative
frameworks in Europe for countering drugs. Key pieces of legislation include the
Criminal Justice Act 1994, the Criminal Justice (Drug Trafficking) Acts 1996 and
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1999, the Criminal Assets Bureau Act 1996, and the Proceeds of Crime Act 1996
(Moran, O'Brien, Dillon & Farrell, with Mayock, 2001). 
The National Drugs Strategy 2001-2008 (2001) tasks the Department with
overseeing the establishment of a framework to monitor the number of
successful prosecutions, arrests and the nature of the sentences passed;
establishing, after consultation, best-practice guidelines and approaches for
community involvement in supply control activities with the law enforcement
agencies; reviewing the ongoing effectiveness of crime legislation in tackling
drug-related activity; and working with regional health boards in considering
how best to integrate child-care facilities in treatment and rehabilitation centres
and in residential treatment  settings.
The Department also has administrative responsibility for An Garda Síochána,
the Irish Prisons Service, the Welfare and Probation Service and the Courts,
which, between them, have roles and responsibilities in relation to supply
reduction, prevention, treatment and rehabilitation.
An Garda Síochána has responsibility for the State security services and all
traffic and criminal law enforcement functions, including those laws related to
drug offences. Special units have been integrated into the organisational
structure of An Garda Síochána in an effort to address the drugs issue. In each of
the country's twenty-seven Garda Divisions, there is a specialised Drug Unit,
which has responsibility for the enforcement of drugs legislation. There may also
be a Drug Unit in a District where drugs present particular problems (Moran et
al., 2001).  
The Garda National Drugs Unit (GNDU) was established in 1995 with specific
responsibility for drug law enforcement. The primary focus of the GNDU is to
target major drug traffickers, as well as monitoring, controlling and evaluating
all drug intelligence and policies within the force.  As part of its focus on the
national and international aspects of drug trafficking, the GNDU maintains close
liaison with police forces from other jurisdictions, through various police
networks and operational exchange programmes (An Garda Síochána, 1999).  In
1996 the Criminal Assets Bureau was set up as an inter-agency response,
including An Garda Síochána, the Office of the Revenue Commissioners and the
Department of Social, Community and Family Affairs, to target the proceeds of
crime, especially drug trafficking. At a community level Community Policing
Fora have been established on a pilot basis in several LDTF areas. The Garda
A Collection of Papers on Drug Issues in Ireland
18
have also been instrumental in implementing a number of operations addressing
supply reduction, including  Cleanstreet, Nightcap, Rectify, Tap and Dóchas.
Under the National Drugs Strategy 2001-2008 (2001) it is intended to extend, and
enhance the efficiency of, all the above initiatives - adding resources to existing
drug units, and establishing drug units in areas where they don't exist;
establishing a co-ordinating framework for drugs policy in each Garda District
to liaise with the community and act as a source of information for parents and
members of the public; increasing the level of Garda resources in LDTF areas,
building on the lessons learned from the Community Policing Fora, and
extending the Community Policing Forum model to all LDTF areas, if the
evaluation of the pilot is positive.
The Gardaí are also active in prevention, particularly in relation to young people
involved in, or at risk of becoming involved in, drugs and crime. Initiatives
include the Garda Youth Diversion Projects, generally managed by Foróige
and/or the City of Dublin Youth Service Board; the Drug Awareness
Programme for communities; Garda Schools Programmes; the Garda Mobile
Anti-Drugs Unit; and the Juvenile Diversion Project. Garda Juvenile Liaison
Officers are also assigned throughout the country. The National Drugs Strategy
2001-2008 (2001) identifies an opportunity for enhanced co-ordination, whereby
incidences of early use of alcohol or drugs by young people coming to Garda
attention are followed up by the Community Police and/or the health and social
services, so that problem-drug misuse may be diagnosed/halted early on.
The National Drugs Strategy Review Team (Department of Tourism, Sport and
Recreation, 2001) saw the Irish Prisons Service as playing a key role in relation
to supply reduction, treatment and rehabilitation. In relation to supply
reduction, the threat of imprisonment is seen as both a sanction against and
punishment for supply activity. The National Drugs Strategy 2001-2008 (2001)
endorses the recommendations of the first report of the Steering Group on
Prison-Based Drug Treatment Services (Irish Prisons Service, 2000), and
recommends that they be implemented as a priority, together with proposals to
end heroin use in prisons by 2008. The Strategy also seeks an expansion of
prison-based programmes with the aim of having treatment and rehabilitation
services available to those who need them, including programmes dealing
specifically with the reintegration of the drug-using offender into the
family/community. The Strategy also calls for an independent evaluation of the
overall effectiveness of the Prison Strategy by 2004.
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The Probation and Welfare Service co-ordinates a range of drug treatment
initiatives both within the prison setting and post-release, in conjunction with
rehabilitation agencies and the community.
Within the Courts system, a Drug Court has been established on a pilot basis in
north inner-city Dublin. These courts are intended to be treatment oriented,
where people with a drug problem, who are charged with non-violent offences,
are diverted to treatment programmes rather than prison. The success of the
initiative depends on the formulation and implementation of cohesive treatment
and rehabilitation programmes, which will help break the cycle of reoffending
and ultimately end all criminal activity. If the evaluation of the pilot study is
positive, this type of early intervention system is to be introduced in all LDTF
areas, accompanied by appropriate familiarisation for the judiciary on the role of
the Drug Court (National Drugs Strategy, 2001)
Office of the Revenue Commissioners
The Office of the Revenue Commissioners includes the Customs and Excise
Service. Customs have primary responsibility for the prevention, detection,
interception and seizure of controlled drugs, intended to be smuggled or
imported illegally into the State (Moran et al., 2001).
In 1992 a Customs National Drugs Team was established, with the principal role
of directing the work of Customs on the prevention of drugs smuggling and the
enforcement of legislative provisions regarding the import and export of
controlled drugs and other substances. The Team's units are strategically located
around the coast of Ireland in an effort to prevent drug trafficking (Office of the
Revenue Commissioners, 1993). 
In 1996 a Memorandum of Understanding was agreed between Customs and
Excise and An Garda Síochána regarding drugs law enforcement. As a result, a
joint task force comprising Customs, Garda and the Naval Service was
established, and personnel are exchanged at national level, and liaise at local
level. Customs also liaise with the Garda National Drugs Unit and the Criminal
Assets Bureau. Customs have also entered into agreements with trade
associations and individual companies regarding detection of illegal drug
smuggling, and developed a Coastal Watch Programme, which enlists the help
of coastal communities and seagoing personnel in reporting suspicious
activities. At an international level, the customs services of all EU member states
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are linked electronically to facilitate quick and effective exchanges of
information. A Customs official has been assigned to the Irish Embassy in
London, and appointments are to be made to Europol in The Hague.
Under the National Drugs Strategy 2001-2008 (2001), these initiatives are to be
strengthened and consolidated. Close liaison and collaboration, both nationally
and in conjunction with enforcement and intelligence agencies in Europe, are to
be developed; coastal watch and other port-of-entry measures to restrict
importation of illicit drugs are to be strengthened; and a Customs official is to be
assigned to the Europol National Unit. The Customs and Excise Service is also to
develop benchmarks, in conjunction with the Gardaí, against which seizures of
heroin and other drugs can be evaluated under the EU Action Plan on Drugs
(Commission of the European Communities, 1999), in order to establish progress
on a yearly basis.
1.5.3  Research and Information
An Interim Advisory Committee on Drugs was established by the Cabinet
Committee on Social Inclusion in recognition of the importance of having
authoritative information and research findings available as a guide to policy.
The Committee was chaired by the then Minister of State with special
responsibility for National Drugs Strategy, Chris Flood, TD, and later Eoin Ryan,
TD. The Committee  reported in February 2000 and, inter alia, made a number of
recommendations regarding the structure and composition for a National
Advisory Committee on Drugs, and recommendations for a three-year
programme of research and evaluation on the extent, nature, causes and effects
of drug misuse in Ireland. 
National Advisory Committee on Drugs
The National Advisory Committee on Drugs (NACD) was established in July
2000. The Committee was established on a non-statutory basis for three years
and has responsibility for research and information on drug misuse in Ireland
and for a three-year prioritised work programme of research and evaluation. 
The functions of the Committee are as follows:
! to advise the Cabinet Committee on Social Inclusion and through it, the 
Government, in relation to the prevalence, prevention, treatment and 
consequences of problem drug use in Ireland, based on the
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analysis and interpretation of research findings and information 
available to it;
! to review current information sets and research capacity in relation to 
the prevalence, prevention, treatment and consequences of problem 
drug use in Ireland and to make recommendations, as appropriate, on 
how deficits should be addressed, including how to maximise the use 
of information available from the community and voluntary sectors;
! to oversee the delivery of a three-year prioritised programme of 
research and evaluation, as recommended by the Interim Advisory 
Committee, to meet the gaps and priority needs identified by:
- using the capacity of relevant agencies engaged in information 
gathering and research, both statutory and non-statutory, to deliver 
on elements of the programme;
- liaising with these agencies with a view to maximising the resources 
allocated to delivering the programme and avoiding duplication;
- co-ordinating and advising on research projects in the light of the 
prioritised programme; and
- commissioning research projects, which cannot be met through 
existing capacity;
! to commission additional research at the request of the Government 
into drug issues of relevance to policy;
! to work closely with the Drug Misuse Research Division of the Health 
Research Board on the establishment of a national information 
/research database (in relation to the prevalence, prevention, treatment 
and consequences of problem drug use) which is easily accessible; and
! to advise relevant agencies with a remit to promote greater public 
awareness of the issues arising in relation to problem drug use and to 
promote and encourage debate through the dissemination of its 
research findings.
The first meeting of the Committee took place in late September 2000. It has
formulated a three-year work programme under six general headings, as
itemised below:
Inventory of Research and Information
! compile a comprehensive inventory of existing research and 
information sets relating to the prevalence, prevention, 
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treatment/rehabilitation and consequences of problem drug use
in Ireland;
Improved Co-ordination of Research and Data Collection
! open communication channels with key agencies to ensure that
the NACD is kept informed of any new research being
undertaken or new data being collected;
! establish a research network which will ensure better co-
ordination and integration of research projects among relevant
agencies and maximise resources in the context of the NACD's
programme of research;
Prevalence
! determine the size and nature of the drug problem in Ireland; 
! determine the extent and nature of opiate use, poly-drug use
and patterns of problem drug use (experimental, occasional,
regular non-medical use) particularly among young people
under 25;
! identify emerging trends and geographical spread;
! determine the extent and nature of problem use of prescription
drugs;
! determine the prevalence of problem drug users not in contact
with treatment services;
Prevention
! examine the effectiveness in terms of impact and outcomes of
existing prevention models and programmes, with particular
regard to evaluation instruments developed at European level;
! undertake comparative studies of different models with
particular reference to those in operation in Task Force areas;
! determine transferability of models among different target
groups;
Treatment/ Rehabilitation 
! examine the effectiveness in terms of impact and outcomes of
existing treatment and rehabilitation models and programmes;
! undertake longitudinal studies of the effectiveness of existing
treatment and rehabilitation models;
! examine the context in which relapse occurs;
! examine the impact of the treatment setting;
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Consequences
! examine the cost to society of the drug problem in terms of:
- drug-related deaths;
- impact of drugs on the family and communities;
- relationship between drugs and crime; and
- methods for tackling social nuisance related to drug misuse.
The National Drugs Strategy 2001-2008 (2001) has specified that the NACD
should examine its three-year research programme to establish whether it can:
! carry out studies on drug misuse among at-risk groups;
! commission outcome studies to establish the current impact of 
methadone treatment on both individual health and on offending 
behaviour; and
! conduct research into the effectiveness of new mechanisms to minimise 
the sharing of equipment.
Drug Misuse Research Division 
The Drug Misuse Research Division (DMRD) is a division of the Health Research
Board (HRB), a statutory body based in Dublin, and is involved in national and
international research and information activities in relation to drugs and their
misuse. The DMRD is funded by national and EU sources and contract research.
International collaborators include the EMCDDA and Council of Europe
Pompidou Group. 
The DMRD maintains and develops the national epidemiological database on
treated drug misuse in Ireland - the National Drug Treatment Recording System
(NDTRS). The NDTRS provides comprehensive data on the numbers and
characteristics of those treated for drug misuse in Ireland. 
Current and recently completed research studies include research into trends in
drug misuse; knowledge, attitudes and beliefs regarding drugs and drug users;
drug service provision; crèche availability and use in drug treatment contexts;
drug use, impaired driving and traffic accidents; drug use by prisoners and drug
use in rural areas.
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The DMRD is involved in information and dissemination activities at national
and European levels. It publishes research studies on an ongoing basis. These
publications are made available to all public and relevant specialist libraries in
Ireland. The DMRD also publishes DrugNet Ireland twice yearly. 
National Documentation Centre
On foot of the report of the Interim Advisory Committee on Drugs, the Drug
Misuse Research Division was nominated to establish a National Documentation
Centre. The Government designated the Health Research Board as a central
point to which all information on drug use in Ireland should be channelled.
(Press release : Minister of State, Eoin Ryan establishes NAC on Drugs, July
2000). The National Documentation Centre will include a drop-in access point
and library facility focusing on grey literature in the drugs area, development of
an electronic library and, in collaboration with the EMCDDA, a virtual library,
which will provide access to a pan-European information network on drugs. In
the long term it is planned that this resource will be entirely electronically based.
Related added-value activities envisaged include regular publication of a
Register of Research on Drug Misuse in Ireland and Annotated Bibliographies
on Drug Misuse in Ireland. An information and dissemination function will be
an integral part of the Documentation Centre. 
1.6   Regional/Local Co-Ordination and Implementation
The National Drugs Strategy Review team (Department of Tourism, Sport and
recreation, 2001) welcomed the embedding of the Government's approach to the
drugs issue within the context of its Social Inclusion strategy. Consequently, it
endorsed the existing regional and local structure of roles and responsibilities,
which are funded through the NDP. To strengthen co-ordination at regional
level, the National Drugs Strategy 2001-2008 (2001) has proposed the
establishment of Regional Drug Task Forces (see Table 1.1).
1.6.1 Regional Drug Task Forces 
All regional health boards currently have co-ordination structures in place
(Regional Drug Co-ordination Committees) and have appointed Drugs Co-
ordinators. The National Drugs Strategy 2001-2008 (2001) calls for the
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establishment of a Regional Drugs Task Force in each health board area
(including the three health board areas in the ERHA), incorporating and
expanding the work of the Regional Co-Ordination Committees (Department of
Tourism, Sport and Recreation, 2001). The NDST will oversee this development.
The membership and working arrangements adopted by the LDTFs will apply
to the RDTFs. 
The National Drugs Strategy 2001-2008 (2001) proposes that the RDTFs will
include representation from the local authority, VEC, health board, departments
of Education and Science and of Social, Community and Family Affairs, An
Garda Síochána, Customs and Excise, Probation and Welfare Services, FÁS, area-
based partnership, and the voluntary and community sectors. 
The roles of the RDTFs will be, inter alia, to ensure the development of a co-
ordinated and integrated response to tackling the drugs problem in their region;
to create and maintain an up-to-date database on the nature and extent of drug
misuse and to provide information on drug-related services and resources; to
identify gaps in service provision; to prepare a development plan to respond to
regional drugs issues for assessment by the NDST and approval by the IDG; to
provide information and regular reports to the NDST and to develop regionally
relevant policy proposals, in consultation with the NDST. 
1.6.2 Local Drugs Task Forces
The Local Drugs Task Forces (LDTFs) were established in 1997 with a three-fold
purpose - to ensure effective co-ordination of drug programmes and services at
local level; to involve communities in the development and delivery of locally-
based strategies to reduce the demand for drugs; and to focus actions on tackling
the problem in the communities where it is at its most severe. It was hoped that
the establishment of the LDTFs would also help offset the feelings of
marginalisation and abandonment being felt by these communities. The LDTFs
provide a strategic locally-based response by the statutory, community and
voluntary sectors to the drug problem in the areas worse effected.
Fourteen LDTFs3 have been established, in areas experiencing the highest levels
of drug misuse and, in particular, where heroin misuse is most prevalent. The
LDTFs were mandated to prepare and oversee the implementation of action
plans, co-ordinating all relevant drug programmes in their areas and addressing
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3 The LDTF areas are Ballyfermot, Ballymun, Blanchardstown, the Canal Communities, Clondalkin,
Dublin North Inner City, Dublin South Inner City, Dublin 12, Dun Laoghaire/Rathdown, Finglas-Cabra,
North Cork City, North East Dublin and Tallaght. Bray has recently been designated a LDTF area.
any gaps in service. Over 200 separate measures, mainly community-based
initiatives, were initially funded to complement and add value to existing
services and programmes under the themes of education, prevention, treatment,
aftercare, rehabilitation and reducing supply (Department of Tourism, Sport and
Recreation, 1999).
The LDTFs comprise representatives from statutory bodies such as the health
boards, Garda Síochána, local authorities, FÁS (training agency), the vocational
education committees, Probation and Welfare Services, departments of
Education and Science and Social, Community and Family Affairs (under
discussion at the moment) as well as from voluntary and community groups. It
is expected that representatives at a senior level from these agencies be
nominated to the LDTFs, i.e. people who are in a position to influence policy. In
addition, organisations are required to view staff participation in LDTF activities
as core duties and to allocate the time necessary for meaningful participation.
The formal composition of the LDTFs allows for broad representation and, in
addition, allows for representation of vocational groups/agencies through the
sub-committees and working groups of the LDTFs. Drug users can achieve
representation through the use of drug-user fora. Some of these latter groups are
campaigning for more direct involvement. LDTFs are required to ensure that
appropriate procedures are in place to assist them with the regular review of
representation (Department of Tourism, Sport and Recreation, 1999:16). At this
stage of the development of LDTFs, formal and informal activists are calling for
greater networking and sharing of experiences between LDTFs.
When the LDTFs were being established, an independent chairperson was
nominated to each LDTF by the Area Partnership in whose area the LDTF
operated. The Area Partnerships were set up in thirty-eight disadvantaged areas
around the country (including all the LDTF areas) under the Operational
Programme for Local Urban and Rural Development 1994-1999, to address the
issue of long-term unemployment, particularly in the context of social inclusion.
Subsequent chairperson vacancies have been filled through nomination by the
Area Partnership, in consultation with the LDTF and the NDST. 
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A range of supports have been put in place to assist the LDTFs in their work.
Each LDTF has a full-time co-ordinator funded by the relevant health board.
Each LDTF has been requested to identify its training needs. 
Phase 1 of LDTF Operation - January 1997 to October 1998 
The LDTFs prepared action plans for their areas and Ir£10 million / 12.7 million
were set aside to finance the plans. This money funded over 200 separate
projects, mostly community based and designed to complement and add value
to the drug programmes and services already being provided or planned by the
state agencies. Although projects were initially funded on a one-year basis, they
subsequently received interim funding, pending their formal evaluation and a
decision in relation to their 'mainstreaming'.
An evaluation of the LDTFs was concluded in October 1998, which focused on
the processes and structures associated with the initiative. The evaluation found
that the LDTFs had 'achieved a considerable degree of success in the short term
since they were established and that their very existence had provided a strong
focus for tackling drug issues in the target areas, often reducing the feeling of
isolation felt by local communities and preventing a potentially critical situation
from developing further' (PA Consulting Group, 1998). 
Subsequently, the NDTS undertook a detailed review of the operation of the
LDTFs, taking account of the findings and recommendations of the independent
evaluator. In July 1999, the Cabinet Committee on Social Inclusion agreed
arrangements for the continued operation of the LDTFs, based on the
recommendations brought forward by the NDST, on foot of this review. 
Phase 2 of LDTF Operation - October 1998 to October 2000
The proposed new arrangements for the LDTFs included the continuation of the
LDTFs for at least a further two years, new terms of reference and the addition
of elected public representatives and representatives from the departments of
Education and Science and Social, Community and Family Affairs (under
discussion at moment) to the membership of the LDTFs.  They also included the
putting in place of an evaluation framework, which would allow the LDTF
initiative to be measured in terms of outcomes and impacts (see Section 1.7.3
below). 
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In July 1999 the Cabinet Committee on Social Inclusion approved the following
terms of reference, revised membership of the LDTFs and designation of LDTF
areas for the next phase of the scheme:
New Terms of Reference for LDTFs 
LDTF are to:
! oversee and monitor the implementation of projects already approved 
under their existing action plans;
! ensure the evaluation of current projects, with a view to their 
mainstreaming by the relevant statutory agencies;
! in accordance with agreed guidelines, prepare updated action plans 
which:
- update the area profile and take into account changes in the drug 
problem since preparation of the original plan; and 
- ensure that emerging strategic issues are identified and propose 
policies (actions) to address such issues;
! oversee the implementation of the local drugs strategy, in consultation 
with appropriate voluntary and statutory agencies and community/ 
resident groups;
! ensure appropriate representation by the voluntary and community 
sectors on the LDTF;
! identify any barriers to the efficient working of the LDTF;
! develop networking arrangements for the exchange of information and 
experience with other LDTFs and the dissemination of best practice;
! identify the training needs of LDTF members and take the necessary 
steps to ensure those needs are met through appropriate courses, 
training programmes etc.;
! take account of and contribute to other initiatives aimed at tackling 
social disadvantage under the aegis of the Cabinet Committee on Social 
Inclusion, including the Integrated Services Process, the Young
P e o p l e s '
Facilities and Services Fund, the Local Development Programme, the 
Community Development Programme, etc.; and
! provide such information, reports and proposals to the NDST, as may 
be requested from time to time.
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Each LDTF was asked to prepare updated action plans, following specified
guidelines that stress the need for a more strategic approach. The updated action
plans are to be structured in three parts - review of progress in implementing the
existing action plans; development of a revised strategy; and development and
prioritisation of specific proposals to give effect to the revised strategy. The
guidelines provided were very detailed and further guidance in the form of
information sessions was made available to LDTFs, particularly with reference
to compiling and disseminating examples of best practice under the various
themes to be addressed in the plans. 
Membership of the Local Drug Task Force 
Membership is to be as follows:
! expanded to include representatives from the Department of Education 
and Science and Department of Social, Community and Family Affairs, 
and it is recommended that locally-elected public representatives be 
given the option of becoming members; and 
Designation of Local Drug Task Force Areas 
It was recommended that the focus should be on those areas, where the drug
problem is most acute.  The criteria to be used in determining such areas should
include:
! drug-treatment data from the Health Services;
! Garda crime statistics; 
! data relating to school attendance/drop out; and 
! other relevant data on the levels of social and economic disadvantage 
in the area. 
Using these criteria it was recommended that Bray be added to the list of
designated LDTF areas.
In agreeing these arrangements, the Cabinet Committee on Social Inclusion also
allocated a further Ir£15 million / 19.05 million to the initiative over the period
2000-2001. This funding was to enable the LDTFs to update their plans, as well
as address issues that needed to be tackled on a cross-Task Force basis. As
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indicated above, the NDTS has issued detailed guidelines to assist the LDTFs in
updating their plans.
Under the revised Drugs Strategy in the National Development Plan, the
allocations to combat drug abuse specifically through the LDTFs4 will be Ir£122
million / 155 million over the seven-year period of the Plan. The allocation
4 Department of Tourism, Sport and Recreation vote.
under the Regional Programmes will be Ir£112 million / 142.2 million, for the
SE (South-East) Region and Ir£10 million / 12.7 million for the BMW (Border,
Midlands and West) Region (Department of Tourism, Sport and Recreation,
Internal Document).
Achievements of the LDTFs
The LDTFs are an innovative response to a serious drug problem, which
manifested itself most acutely in a number of deprived communities. Amongst
the achievements of the initiative has been the active and constructive
community response in areas where resources were few, and the establishment
of a broad range of initiatives in the areas of treatment, rehabilitation, education,
prevention etc., which address local needs. 
Mainstreaming of LDTF projects has been instituted in order to ensure the
continuity of projects that are meeting their aims and objectives. The NDST has
prepared a set of protocols to govern the mainstreaming of such projects.
Fundamental to mainstreaming in this context is the transfer of budgetary
responsibility from government departments to agencies/project promoters for
specific pieces of work. The exchange is to be consolidated as a formal
contract/agreement witnessed by the LDTF.  Standards acceptable for
Exchequer accounting purposes will apply.  These protocols will provide a
platform on which project promoters and statutory agencies can enter into an
arrangement for the continuous operation of projects on a mutually acceptable
basis. 
One hundred and forty LDTF projects were evaluated April-June 2000, and 122
were subsequently mainstreamed involving a number of government
departments. PR Consultancy coordinated a composite report on the evaluation.
Mainstreaming will ensure ongoing funding. The process copperfastens the role
played by community and voluntary organisations in responding to drug
misuse at a local level.
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Documentation provided by the Department of Tourism, Sport and Recreation
indicates the following as amongst the achievements of the LDTFs:
! Eight hundred stabilised drug users are participating in specially-
designed Community Employment projects developed by the LDTFs, 
in conjunction with FÁS, the national training agency. These projects, 
supplemented with treatment and counselling, will assist drug users to 
improve their employment potential (Department of Tourism, Sport 
and Recreation, Internal Document). 
! The LDTFs have contributed to creating greater awareness about the 
issues around drug misuse. Nearly 350 schools have undergone drug 
awareness programmes in LDTF areas, with around 6,000 school-
children participating in these programmes. In addition, 350 teachers 
have received training. Over 300 youth groups have run drug-
prevention initiatives; training programmes have also been delivered
t o
1,300 community workers, 1,200 parents and 1,300 young people 
outside the school setting. These programmes are aimed not only at 
creating greater awareness of the dangers of drug misuse among young 
people, but also at educating communities about the needs of drug 
users, so that they are in a better position to respond to these needs
(Department of Tourism, Sport and Recreation. Personal Communication).
Evaluation of the LDTFs  will be ongoing.
1.6.3  Young People's Facilities and Services Fund 
An innovative and interesting feature of policy in the drugs area in Ireland has
been a focus on the potential of sport and recreation to engage young people
constructively and thereby discourage or divert them from involvement in drugs
and unhealthy life choices. 
Under an initiative separate from but complementary to the LDTF initiative, the
Government set up the Young People's Facilities and Services Fund (YPFSF). The
aim was to develop youth facilities, including sport and recreational facilities,
and services in disadvantaged areas where a significant drug problem exists or
has the potential to develop. The three-year Fund aims to attract young people
in those areas, who are at risk of becoming involved in problem drug use, into
more healthy and productive pursuits. The target group for this Fund is youth
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aged 10 to 21 years who traditionally have found themselves outside the scope
of mainstream youth activities because of their family background, their
involvement in crime or drug misuse or their lack of education. 
The primary focus of the YPFSF is the LDTF areas, and the six Urban Areas of
Galway, Limerick, South Cork City, Waterford, Bray and Carlow, where serious
drug problems exist or have the potential to develop.
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Development Groups in the thirteen LDTF areas, and six additional Urban
Areas, were established to develop plans and strategies for the YPFSF and to
oversee their implementation in conjunction with the relevant VEC and local
authority. In the LDTF areas, the Development Groups comprise one
representative each from the LDTF, the VEC and the relevant local authority. In
the targeted Urban Areas, the local VEC has responsibility for the development
and delivery of the strategies, in conjunction with relevant state agencies and the
community and  voluntary sectors.
To ensure complementarity with the LDTFs plans for the area, the LDTFs
nominate a representative, who generally acts as chairperson to the
Development Groups. The YPFSF plans and implementation process reports are
passed to the LDTFs for their information and views, before submission to the
National Assessment Committee (see Section 1.5.1 above), which evaluates them
and recommends funding to support their implementation. The Development
Groups are responsible for overseeing the effective implementation of the plans.  
YPFSF outside the LDTF Areas 
Recognising that the issue of problem drug use is not confined to the Urban
Areas, YPFSF funding has been allocated to a number of nation-wide initiatives
to inform and raise awareness of the dangers of problem drug use, particularly
through peer education. Up to Ir£7.2 million / 9.14 million has been allocated
under the YPFSF for the Springboard Initiative, which will see the establishment
of fourteen family support projects aimed at children at risk in disadvantaged
areas around the country. 
YPFSF Budget6
The YPFSF was established in 1998 with Ir£30 million /  38.1 million  allocated
over three years. This has since been increased to Ir£37.4 million7 /  47.5
million. Of this amount, Ir£27.4 million /  34.8 million has been approved for
support of over 295 projects in the LDTF areas. The remaining Ir£10 million /
12.7 million (approximately) has been allocated as follows: 
6 Acknowledgements to  K. Stack of the Department of Tourism, Sport and Recreation, and S. Falvey of
the Department of Education and Science, for supplying budgetary information.
7 This funding is separate to LDTF funding, and is in Department of Education and Science vote.
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! Ir£7.2 million / 9.14 million over three years (1998-2000) has been 
allocated to the Springboard Initiative, which is administered by the 
Department of Health and Children. Springboard funds fifteen family 
support projects. The projects work intensively with mainly 7-12 year 
olds (who are at risk of going into care or getting into trouble) and their 
families.
! Ir£2.3 million / 2.9 million was allocated to other urban areas outside 
the LDTF areas for prevention work, e.g. Waterford, Galway, South 
Cork City, Limerick, Bray and Carlow.
! Ir£0.5 million / 635,000 goes to voluntary organisations who have the 
capacity to deliver drug prevention programmes at national or regional 
level. This was a new initiative in 1999.
In terms of the new structures set up under the National Development Plan, the
breakdown of this money is as follows: 
! South and Eastern Region: Ir£29.756 million / 37.782 million
! Border Midlands and Western Region: Ir£0.450 million / 0.571 million
! Department of Health and Children: Ir£7.200 million / 9.142 million
! Total: Ir£  37.406 million / 47.496 million
The type of projects and initiatives approved as part of the plans and strategies
submitted to date include:
! capital projects such as building, renovating or fitting out community 
centres, youth facilities and sports clubs so as to provide suitable 
accommodation for programmes and services geared for the most 'at 
risk' young people in an area.  Access for the target group is an essential 
condition of funding for capital projects;
! a number of purpose-built youth centres, which will provide a focal 
point for youth activities in an area, particularly areas such as Tallaght, 
Ballymun, Clondalkin and Blanchardstown, where there is a dearth of 
dedicated youth facilities;
! the appointment of youth and outreach workers to work on the ground 
with the target group, offering developmental activities and 
educational programmes for young people who have traditionally 
found themselves outside the scope of mainstream youth work owing 
to family background, involvement with crime or drug misuse or lack 
of education;
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! the appointment of sports workers to encourage greater involvement 
of the target group in sports and recreational activities;
! a wide variety of community-based prevention/education 
programmes, including Early School Leaving Programmes, Sports and 
Recreational Activities, Family Support Programmes, Art, Drama and 
Music Programmes, Counselling and Transport Services;
! targeted interventions for particular groups such as youth work 
projects for young travellers;
! the appointment of national drugs education and training officers for 
youth organisations catering for the target group who will deliver 
programmes throughout the organisation; and
! a provision to meet the training needs arising from the Fund, 
particularly in the area of drugs training for youth workers.
Innovative measures, which can serve as a model for such projects, have been
applied to the draw-down of funds under the YPFSF. These measures ensure
that the most deprived groups will have access to funded facilities and services
and will prevent 'creaming' or the admission of only the 'more desirable clients',
which can be a feature of some programmes. The measures include, inter alia:
! clear focus on target group; 
! mandatory access for the target group; 
! proof of the operation of strategies to attract the target group into the 
facility/programme; and
! integration with existing or proposed initiatives in the area. 
Access for the target groups will be enforced where possible through the
involvement of the local authorities and/or the VECs in the management
structure. If this is not possible, then it will be necessary for projects to provide
a satisfactory access programme showing how the target group will be reached
and quantifying the extent of access.
Main Achievements of YPFSF 
A speech by Minister of State for Local Development, and with special
responsibility for the National Drugs Strategy, Mr Eoin Ryan, TD, at European
Cities Against Drugs, Millennium Mayor's Conference, held in Cork, on 28 April
2000, overviewed achievements under the YPFSF. He stated, 'Through the
Young People's Facilities and Services Fund, we are supporting the building or
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refurbishment of nearly fifty youth facilities, twenty sports clubs and nearly
twenty community centres in disadvantaged areas. Almost eighty youth and
outreach workers are being appointed to work with young people, offering them
the type of developmental activities and educational programmes which were
previously outside their reach, due to their family circumstances or their
involvement with drugs or crime. The Fund is also supporting a wide variety of
programmes, including early school leaving projects, family support
programmes, art, drama and music, counselling and transport services.'
1.6.4 County/City Development Boards
Preliminary arrangements have been made to advance the objective of regional
devolution, as outlined, for example, in the NDP (2000). Accordingly, the LDTFs
and area-based partnership companies are to work with the newly-appointed
Directors of Community and Enterprise and the County/City Development
Boards (CDBs) when drawing up their integrated local action plans.
Arrangements for co-ordination of planning and delivery of services are also to
be agreed with the CDBs. It is likely that the YPFSF will adopt similar procedures
when their next funding is due, i.e. 2002.
The recently-established County and City Development Boards (CDBs), whose
primary function will be to draw up a comprehensive Strategy for Economic,
Social and Cultural Development, by January 2002, have a key role in co-
ordinating local delivery of Social Inclusion measures. The CDBs will operate on
the partnership principle, with the Regional Assemblies and under the local
government umbrella, with membership drawn from local development
organisations, social partners, local representation of State agencies and local
government itself (NDP, 2000). A Director of Community and Enterprise has
been appointed by each CDB. All the relevant programmes and projects, and
their delivery mechanisms, covered by the NDP, will be expected to accord with
this framework. 
1.6.5  Regional Health Boards
Responsibility for the provision of treatment and rehabilitation services for drug
misusers throughout the country rests with the ten regional health boards. Each
health board provides services in response to emerging trends in their own
region, targeting specific segments of the local population and tailoring their
services to the needs of their particular target groups. 
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With Government strategy beginning to address the drug problem on a nation-
wide basis, in particular the use of recreational drugs, such as cannabis and
ecstasy, particularly among young people, regional drugs co-ordinators have
been appointed to assist the regional health boards in developing appropriate
programmes and services, mostly in relation to drug awareness, education and
prevention. The health boards have also set up regional co-ordinating
committees in their areas, which work in partnership with other relevant
agencies in developing a co-ordinated response to the drug problem, having
regard to the needs of their particular regions. Under the National Drugs
Strategy 2001-2008, Regional Drugs Task Forces are to be established in each of
the health board areas, incorporating and expanding on the work of the regional
co-ordinating committees (see Section 1.6.1 above).
The boards also provide support and training for community groups involved in
drug-related prevention or rehabilitation activities.
Over 20 per cent of the actions identified in the National Drugs Strategy 2001-
2008 (2001) are to be implemented by the regional health boards. The actions
relate to the improved range and management of treatment and rehabilitation
services.
In relation to range, health boards are to introduce a range of treatment and
rehabilitation options as part of a planned programme of progression for each
drug misuser by the end of 2002. These options are to be appropriate to the drug
users' needs and circumstances and assist in their re-integration back into
society. In addition, health boards are to explore the scope for provision of
alternative and non-medical treatment types; oversee the development of
comprehensive residential treatment models including detoxification,
intervention, pre-treatment counselling, motivational work, therapeutic
treatment and rehabilitation for misusers who wish to become drug-free;
consider developing drop-in centres, respite facilities and half-way houses to
help prevent relapse; and consider the feasibility of new suitably-trained peer-
support groups to act as a rehabilitative support.
For drug misusers who are continuing to misuse, health boards are to review the
existing network of needle-exchange facilities to ensure access for all injecting
drug misusers to sterile injecting equipment. Moreover, they are to continue to
develop good-practice outreach models, including models to outreach drug
misusers who are not in contact with mainstream treatment or support agencies. 
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Standards for timeliness, volume and quality of service provision are all
specified in the National Drugs Strategy 2001-2008. Drug misusers are to have
immediate access to professional assessment and counselling by health board
services, followed by commencement of treatment not later than one month after
assessment. The number of treatment places for opiate addiction is to be
increased to at least 6,500 by the end of 2002. In parallel, health boards are to
consider how to increase the level of general practitioner and pharmacy
involvement in primary treatment programmes, as a means of alleviating the
pressure on the secondary treatment services. Health boards are to pursue the
setting up of a Pilot Community Pharmacy Needle and Syringe Exchange
programme in the ERHA area.
The quality of services to the drug misuser is to be enhanced. Well-publicised,
short, easily-read guides to the drug treatment services available are to be
distributed widely, with a view to enhancing access. Service-use charters specific
to treatment and rehabilitation facilities will help ensure a greater balance in the
relationship between the service provider and the service user. Moreover,
treatment plans will be based on a 'continuum of care' model and a 'key worker'
approach, which will provide a seamless transition between each different phase
of treatment and after-care. To meet the needs of clients with parental
responsibilities, health boards are to consider how best to integrate childcare
facilities with treatment and rehabilitation centres and in residential treatment
settings. Special consideration is given to the needs of young people, with the
requirement to develop a protocol for the treatment of under 18 year olds
presenting with serious drug problems; the provision of easy access to
counselling services for young people seeking assistance with drug-related
problems; and using means such as family therapy and community integration
phases, to encourage family involvement in the treatment of young people.
Ensuring the long-term sustainability of the above actions, health boards are
required to have in place by the end of 2002, a clearly co-ordinated and well
publicised plan for the provision of a comprehensive and locally accessible range
of treatments for drug users, particularly young people. This is to be
implemented by the end of 2004. In conjunction with the production of this plan,
health boards must develop a management plan in consultation with local
communities to consider the location and establishment of treatment and
rehabilitation facilities. Health boards are to report to the NACD on the efficacy
of different forms of treatment and detox facilities and residential-drug free
regimes on an ongoing basis, and all treatment providers are encouraged to co-
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operate in returning information on problem drug use to the National Drug
Treatment Reporting System (NDTRS), managed by the Drug Misuse Research
Division of the Health Research Board.
1.6.6 Community and Voluntary Sectors
The National Drugs Strategy Review Team 2001-2008 (2001) acknowledged the
community and voluntary sectors as 'key actors' in the areas of drug supply
reduction, prevention and treatment. 
Through the LDTFs (see Section 1.6.2 above), local communities and voluntary
organisations have participated in the planning, design and delivery of services
The action plans of the LDTFs focus on developing community-based initiatives
to link in with and add value to the programmes and services already being
planned by the statutory agencies in the LDTF areas.  Representatives of the two
sectors are to sit on the proposed RDTFs as well. The National Drugs Strategy
Review Team identified a need to strengthen and improve the level of
community representation on task forces in order to ensure their effective
engagement. However, the Review Team also warned that greater 'integration'
might lead to greater 'formalisation', thereby alienating community groups
themselves from their constituencies. The Strategy, therefore, recommends that
the NDST consider funding, on a pilot basis, training initiatives to strengthen
effective community representation and participation on Task Forces. The
Strategy also recommends that the NDST examine the feasibility of introducing
a standards and accreditation framework for all individuals, groups and
agencies engaged in drug work.
The National Drugs Strategy 2001-2008 (2001)  has identified a new community-
based initiative in the area of prevention. RDTFs are to consider developing
community-based initiatives to raise awareness. The goal of these initiatives
would be to develop best-practice models, which send a clear and consistent
message and which are capable of being mainstreamed. In the communities
where drug misuse is most prevalent and where there is considerable
knowledge about all aspects of the drugs issue, schools could tap into and use
this knowledge as a beneficial aspect of their programmes.
The community and voluntary sectors participate in the development of drugs
policy and drugs initiatives through a number of structures and consultative
processes besides the LDTFs, as specified in the National Drugs Strategy 2001-
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2008 (2001). Both sectors are represented on the NDST. They are to be
increasingly involved in prison drug policy via the ongoing development of the
Local Prison Liaison Groups and the formal meetings between the sectors and
the Steering Group on Prison-Based Treatment Services. The Department of
Justice, Equality and Law Reform is to consult with both the community sector
and the Gardaí in establishing best-practice guidelines and approaches for
community involvement in supply control activities, such as the Coastal Watch
Programme. From 2002, regional health boards will be required to consult with
local communities in developing a management plan for considering the
location and establishment of treatment and rehabilitation facilities in local
areas.
Structures exist to support community and voluntary groups working in the
drugs area. The Department of Social, Community and Family Affairs funds the
Dublin Citywide Drugs Crisis Campaign, a specialist support agency to its
Community Development Support Programmes. The role of this support agency
is to provide technical assistance and expertise to local communities to develop
their capacity to respond to the drugs crisis in their areas and work alongside
statutory and other agencies in tackling the problem at local level. As well as
supporting local communities to develop skills to tackle the drug crisis, the
agency also seeks to involve local communities in developing policies and
making decisions on how resources are spent. The development of effective
partnership relationships is key to this process.
The Voluntary Drug Treatment Network provides a framework for voluntary
drug groups working in the area of treatment to meet, share issues of concern
and develop more comprehensive responses to the prevention and treatment of
problem drug use. The Network is an umbrella group that aims to challenge
drug misuse and related issues in a creative, caring and motivational way. It is
represented on the National AIDS Strategy Committee, NDST and NACD.
However, the Network does not have a national remit to represent all voluntary
drug treatment organisations in Ireland. It is mainly for Dublin-based
organisations, which deal with drug misuse, but some of its members have a
national focus in terms of treatment and training. 
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1.7  Evaluation of National Strategies 
1.7.1  Social Inclusion and Evaluation of Drugs Initiatives
The policy frameworks underlying actions in the drugs area - the National
Development Plan (NDP), National Anti-Poverty Strategy (NAPS) and
Programme for Prosperity and Fairness (PPF) - are underpinned by a culture of
evaluation and accountability. Thus, targets, review, evaluation, benchmarking
and indicators are core concepts and, increasingly, resources are being set aside
to develop the research capacity which can deliver good quality monitoring and
evaluation (see Inter-Departmental Policy Committee, 1999- 2000). Poverty- and
equality-proofing are also to become an integral aspect of national and regional
programme development. The more general Social Inclusion initiatives in the
drugs area, such as the LDTF and YPFSF, will be evaluated within this
framework. 
This culture of evaluation, however, is not as developed or formalised within
drug treatment environments. Thus, few evaluations of treatment programmes
have been conducted to date. However, the three-year research programme of
the National Advisory Committee on Drugs (NACD) includes a number of
evaluation studies in the drugs area, and regional health boards are increasingly
adopting evidence-based approaches in their work and developing research and
evaluation capabilities.
The implementation of Exchange of Drug Demand Reduction Action - EDDRA
in Ireland by the Drug Misuse Research Division has also helped promote a
culture of evaluation in the demand reduction context. Actors in the drugs area
are aware that inclusion of projects in the EDDRA database requires such
projects to have built-in evaluation. In addition, EDDRA training was made
available to all regional drug co-ordinators by the DMRD, in collaboration with
the EMCDDA. This training covered, inter alia, the planning and implementation
of project evaluation and was evaluated highly by participants.
1.7.2  National Drugs Strategy 2001-2008 
The National Drugs Strategy 2001-2008 includes a requirement for an evaluation
framework. The strategy specifies:
! overall strategic objective;
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! overall strategic aims;
! objectives under the four pillars of the strategy; and 
! key performance indicators (KPIs) for the objectives.
The IDG, in conjunction with the NDST, is to establish an evaluation framework
for the Strategy, focusing on the KPIs. Annual reports and mid-term evaluations,
in 2004, will facilitate progress towards the key strategic goals. The cost-
effectiveness of the various elements of each pillar of the new Strategy is to be
established for the mid-term evaluation, to enable priorities to be reviewed and
strategic objectives refocused if necessary.
Furthermore, evaluation is to be an integral stage in the implementation of the
initiatives and programmes within each of the four pillars of the strategy. For
example, the Irish Prisons Service is to commission an independent evaluation
of the overall effectiveness of the Prison Strategy, to be carried out by mid 2004;
the departments of Education and Science and Health and Children are to
evaluate on an ongoing basis school-based education and preventative
programmes; the Department of the Environment and Local Government is to
commission an external evaluation of enforcement activity under the Housing
Acts on homelessness, and also monitor and evaluate homelessness initiatives in
relation to drugs issues. Agencies involved in service delivery, moreover, are to
collect relevant data that will assist in evaluating programmes, e.g. recording
and monitoring outputs, assembling best-practice guidelines, researching and
establishing benchmarks.
1.7.3  Local Drugs Task Forces 
The culture of evaluation outlined above ensures that evaluation is seen as an
integral part of the planning exercises of the LDTFs. The Phase-2 updated plans
were required to specify the proposed inputs and expected measurable outputs,
outcomes and impacts in relation to each proposal and how it integrated into the
overall drugs strategy. Thus, in addition to the evaluation of the overall process
to measure its success or otherwise, evaluation of individual projects takes place
with a view to mainstreaming those which are operating effectively (Department
of Tourism, Sport and Recreation, 1999: 45).
In the handbook Local Drugs Task Forces - A Local Response to the Drug Problem
(Department of Tourism, Sport and Recreation, 1999), the National Drugs
Strategy Team names three mechanisms to facilitate the evaluation process:
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! a steering group (comprising the National Drugs Strategy Team and
t h e
LDTFs) was set up to oversee and monitor the process;
! a specially-appointed evaluation co-ordinator devised terms of 
reference for the conduct of the evaluation, along with appropriate 
performance indicators and these were approved by the steering
g r o u p ;
and
! a panel of evaluators was formed. LDTFs were free to nominate
p e r s o n s
or companies to this panel, provided they met the criteria outlined 
above. LDTFs could then make their selection of evaluators from the 
approved panel. In the event of there being excessive demand for the 
services of particular evaluators, the steering group determined their 
assignment.
The handbook also states that the evaluation process must be objective and
transparent, and must be carried out by individuals with a recognised and
proven track record, in accordance with agreed criteria.
Evaluation Criteria for LDTF Projects 
Over 200 projects were approved for funding on foot of the initial LDTF plans.
There was a wide variation in range, type and size of projects. From a financial
viewpoint, projects were divided into three types: those costing over Ir£50,000 /
63,487 per annum; those costing between Ir£10,000 / 12,700 and Ir£50,000 /
63,487 per annum; and those costing less than Ir£10,000 / 12,700  per annum.
The majority of projects were set up with a view to being ongoing, but some
were once-off.
Acknowledging the wide variety of projects (including the fact that they address
the drug problem under different themes, e.g. education/prevention, treatment,
rehabilitation, and community policing/estate management), it was
acknowledged that it would be difficult to devise one evaluation framework that
would suit all projects. It was recommended to develop a process that could be
applied in a flexible manner, depending on the type of project. It was envisaged
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that more rigorous evaluations would take place with the more expensive
projects.
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Guidelines as to how the evaluations were to be carried out, along with the
ground rules, were considered necessary and were developed by the steering
group, in consultation with the evaluation co-ordinator, LDTFs and project
promoters as the process developed.
As reported above, 140 LDTF projects were evaluated in April-June 2000, and
122 of these were mainstreamed. PR Consultancy co-ordinated a composite
report on the evaluation. 
1.7.4 Young People's Facilities and Services Fund 
An overall evaluation of the YPFSF is to be undertaken in 2001. The evaluation
will be based on good practice as established by preceding evaluation
mechanisms, e.g. mechanisms for the LDTF and the mainstreaming of youth
service projects.
1.8 Conclusions
Ireland's National Drugs Strategy 2001-2008 has been developed in the context
of various international and EU agreements, for example the Political
Declaration on the Guiding Principles of Drugs Demand Reduction (UN Special
Session on Drugs, held in New York, 1998),8 the UN Conventions on Narcotic
Drugs and Psychotropic Substances,9 the EU Action Plan on Drugs 2000 - 2004
(Commission of the European Communities, 1999), and the EU Drugs Strategy
2000 - 2004 (CORDROGUE 64, 1999). Development of the strategy has also
involved extensive consultation, including public fora in a number of centres
throughout the country. 
The main changes and new directions in Irish drugs policy, strategies,
implementation and evaluation can be summarised as follows:
8 At a UN Special Session on Drugs, held in New York in 1998, a Political Declaration on the Guiding
Principles of Drug Demand Reduction was adopted. It put an onus on every member state to have in place
a comprehensive drugs policy and an outline of how targets are to be achieved over the period 2000 to
2008.
9 Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol Amending the Single
Convention on Narcotic Drugs, 1961; the Convention on Psychotropic Substances, 1971; and the UN
Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. The
conventions may be accessed through the website - www.incb.org/e/conv/
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! publication of a major review of the National Drugs Strategy;
! adoption of the promotion of Social Inclusion as one of the priorities of 
the National Development Plan 2000-2006, and the situation of the 
drugs issue within this context;
! adoption of National Drugs Strategy for 2001-2008 (2001);
! greater devolution of power to regional structures, with which existing 
structures in the drugs area will co-operate;
! continued adoption of an integrated, inter-agency response to the 
drugs problem involving local communities;
! continued involvement of local communities in the development and 
implementation of drugs policy;
! increasing role of voluntary and community sectors; 
! continued development of a culture of evaluation and increased 
resources of knowledge infrastructure to support same; and
! development of drug-related research and information capability.
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Chapter 2
Drug-Related Infectious Diseases
Lucy Dillon and Mary O'Brien
2.1 Introduction
As in other European countries, the advent of HIV/AIDS and the connection
made between its spread and injecting drug use, can be seen to have played a
key role in influencing the development of drug-related policy and services in
Ireland (Butler, 1991; O'Gorman, 1998). Prior to the early 1990s, abstinence was
seen as the most acceptable goal for Irish drug-treatment programmes.
However, the early 1990s saw a move toward greater use of harm-reduction
strategies and the expansion of substitution and needle exchange programmes in
Irish drug-treatment services. The 1991 Government Strategy to Prevent Drug
Misuse confirmed both the shift in treatment philosophy from one based solely
on abstinence to one that included a harm-reduction strategy, and the central
role the advent of HIV had played in this policy shift: 
Insofar as HIV infection is concerned, of the 1,049 cases identified, 582 (or 57%)
are drug misuse related. … It is clear from the foregoing that the prevention of
transmission of HIV virus in this country must include strategies developed to
deal with the drug misuse problem. …These strategies must be community
based, client orientated and, given the serious nature of the problem, of
necessity, innovative. They must include emphasis on outreach programmes
involving counselling, methadone maintenance and needle exchange. Advice
on risk reduction services generally must form an essential part of any such
strategies to minimise the spread of the disease [HIV/AIDS]; (Government
Strategy to Prevent Drug Misuse, 1991: 7).
Furthermore, while the two reports produced by the Ministerial Task Force to
Reduce the Demand for Drugs  (1996, 1997) continued to reiterate the ultimate
aim of all treatment programmes as abstinence, harm-minimisation strategies,
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specifically aimed at preventing the spread of HIV (i.e. substitution and needle
exchange programmes), became a central feature of drug-treatment services. The
second report of the Task Force argued that it had developed 'a strong
philosophy of harm reduction and treatment of the consequences of drug abuse
- stabilisation, methadone maintenance, detoxification, rehabilitation and re-
integration' (Ministerial Task Force to Reduce the Demand for Drugs, 1997: 7). 
While HIV/AIDS may be seen as the drug-related infectious disease that was at
the centre of drug policy development in Ireland, other diseases, in particular
hepatitis C, are attracting an increasing amount of attention from those working
in the area. The following sections of this chapter will address three key issues
on drug-related infectious diseases in the Irish context:
2.2 Prevalence of HIV, HBV and HCV among Drug Users
2.3 Determinants of Drug-Related Infectious Diseases
2.4 Consequences of Drug-Related Infectious Diseases
2.5 New Developments and Uptake of Prevention/Harm Reduction and 
Care
2.2 Prevalence of HIV, HBV and HCV among Drug Users
Epidemiological analysis of drug-related infectious diseases in Ireland is
somewhat restricted by a lack of data. The gap in information is particularly
acute in relation to hepatitis B and C. The following sections will examine the
data that are available in relation to each of the relevant drug-related infectious
diseases: HIV, hepatitis B and hepatitis C. 
2.2.1  HIV
The majority of data collected on drug-related infectious diseases are related to
HIV. There are two main sources of data that will be discussed below: first, the
routine data on HIV-positive tests reported by the Department of Health and
Children; and second, special studies that have estimated the prevalence of HIV
among particular cohorts of drug users.
1985** 221 (60.9) 39 (10.7) 0 103 (28.4) 363 (100.0)
1986 112 (66.3) 11 (6.5) 21 (12.5) 25 (14.8) 169 (100.0)
1987 72 (49.7) 21 (14.5) 26 (17.9) 26 (17.9) 145 (100.0)
1988 58 (50.4) 17 (14.8) 20 (17.4) 20 (17.4) 115 (100.0)
1989 57 (49.1) 33 (28.5) 0 26 (22.4) 116 (100.0)
1990 50 (45.1) 25 (22.5) 24 (21.6) 12 (10.8) 111 (100.0)
1991 34 (36.9) 27 (29.4) 25 (27.2) 6 (6.5) 92 (100.0)
1992 82 (40.8) 58 (28.9) 50 (24.9) 11 (5.5) 201 (100.1)
1993 52 (38.0) 48 (35.0) 21 (15.3) 16 (11.7) 137 (100.0)
1994 20 (23.5) 31 (36.5) 22 (25.9) 12 (14.1) 85 (100.0)
1995 19 (20.9) 33 (36.3) 30 (33.0) 9 (9.9) 91 (100.1)
1996 20 (18.9) 41 (38.7) 27 (25.5) 18 (17.0) 106 (100.1)
1997 21 (17.7) 37 (31.1) 40 (33.6) 21 (17.7) 119 (100.1)
1998 26 (19.1) 37 (27.2) 47 (34.6) 26 (19.1) 136 (100.0)
1999 69 (33.0) 40 (19.1) 59 (28.2) 41 (19.6) 209 (99.9)
Total 913 (41.6) 498 (22.7) 412 (18.8) 372 (17.0) 2,195 (100.1)
Source: Department of Health and Children.
* IDUs = Intravenous drug users.
** Cumulative figure for 1982–5.
TABLE 2.1
Ireland 1985–1999. HIV-Positive C s s by Risk Category.
Numbers and Percentages.
Year IDUs*
n          %
Homosexual
Sex
n          (%)
Heterosexual
Sex / 
Risk Unspecified
n          (%)
Other
n          (%)
TOTAL
n      (%)
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Routine Data on HIV Testing
In Ireland, at the time of writing, the Department of Health and Children, in
collaboration with the Virus Reference Laboratory, based in University College,
Dublin, produces statistics on HIV-positive tests, which are published every six
months. The figures relating to HIV tests are broken down according to risk
category. There are a number of risk categories identified in relation to HIV
infection, including injecting drug use, homosexual sex and haemophiliac
contact. Therefore, it is possible to get a breakdown of the number of positive
HIV cases attributable to injecting drug use in a given year. However, there are
a number of limitations to this data source that should be noted: 
! it is limited to the tested population. Nothing can be inferred for those 
drug users who have not been tested;
! it is not possible to identify non-injecting drug users within the data set;
! no socio-demographic data are collected on those who are tested;
! there is only a limited geographical breakdown available;
! a gender breakdown has only been made available since 1997; and
! both risk behaviours (e.g. injecting drug use) and test locations (e.g. 
prison) are used as categories. This makes the data somewhat unclear. 
For example, it is not known through what risk activity those tested in 
the prison setting became infected with HIV. 
Despite these limitations, this data source provides the best information with
which to examine the epidemiological profile of HIV in Ireland over the past
decade and a half. 
The cumulative figures for the positive cases of HIV from the start of data
collection in 1982 up until 1985, show that just over 60 per cent (n=221) of all
positive cases (n=363) were attributed to injecting drug use (see Table 2.1).  Since
1985, injecting drug use has continued to be one of the main risk categories,
accounting for 41.6 per cent of the cumulative number of positive cases up until
31 December 1999 (see Table 2.1). Two possible explanations have been given by
O'Gorman (1999) for the high proportion of intravenous drug users in the known
HIV-positive population. She argues that the culture of injecting drug use that
existed among drug users in Ireland during the 1980s, at a time when both
information on safe injecting practices and access to clean injecting equipment
were limited,1 resulted in the rapid transmission of HIV among the injecting 
1 The first needle exchange programme in Dublin was established in 1989.
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population. Secondly, she argues, the injecting drug-using population may be
more likely to have been tested for HIV through their contact with drug-
treatment services than those individuals who may be at risk of infection
through other routes, e.g. heterosexual sex (O'Gorman, 1999: 6).
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The proportion of positive cases attributed to the intravenous drug user category
generally decreased from 1992 through to 1998. In 1994, for the first time,
intravenous drug use accounted for fewer new positive cases than the
'homosexual sex' or 'heterosexual sex/risk unspecified' categories (see Table 2.1).
In fact, the proportion of positive HIV tests attributed to intravenous drug use
fell from 49.1 per cent in 1989, to a low of 17.7 per cent in 1997 (see Table 2.1). It
is suggested that the reduction, both proportionately and in absolute numbers,
over this period may be attributed, at least in part, to the expansion of services
aimed at reducing the spread of HIV among injecting drug users, i.e. substitution
and needle exchange programmes. In an analysis of the trends up until 1998 the
National AIDS Strategy Committee comments that:
Epidemiological surveillance of HIV would indicate that in recent years the
overall incidence of HIV among intravenous drug users is reducing. While we
must be wary of drawing major conclusions from short term changes in
infection patterns service providers are optimistic that this trend is as a result of
the intervention through a combination of substitution therapy with methadone
and needle exchange service (National AIDS Strategy Committee, 2000: 63).
Despite the apparent reduction in the proportion of the total number of positive
cases attributed to injecting drug use, figures from 1999 show a substantial
increase in the number of positive cases attributed to injecting drug use. Between
1998 and 1999 the total number of new cases of HIV increased from 136 to 209.
Furthermore, the number of new positive cases attributed to injecting drug use
increased from 26 of the total new cases (n=136) in 1998, to 69 of the new cases
(n=209) in 1999. Therefore, proportionately, injecting drug use as a risk category
increased from accounting for 19.1 per cent of new HIV-positive cases within this
data source in 1998, to 33 per cent in 1999. This is the highest annual proportion
of new positive cases attributed to injecting drug use since 1993. 
Anecdotal evidence suggests a couple of explanations for the increase in the
number of positive cases attributable to injecting drug use during 1999. Firstly,
leading on from the Protocol for the Prescribing of Methadone, issued by the
Department of Health (1993), guidelines were developed for general
practitioners prescribing methadone within the general-practice setting and for
pharmacists in their dispensing of methadone. Following the completion and
evaluation of a pilot programme, the Report of the Methadone Treatment
Services Review Group made a number of recommendations on tightening
control on both the prescribing and dispensing of methadone, in accordance
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Year Malen %
Female
n %
Total
n %
1997 18 (85.7) 3 (14.3) 21 (100)
1998 16 (61.5) 10 (38.5) 26 (100)
1999 35 (50.7) 34 (49.3) 69 (100)
TABLE 2.2
Ireland 1997–1999. HIV Sero-Positive Intravenous Drug Users by Gender.
Numbers and Percentages.
with the 1993 protocol (Department of Health, 1997). Consequently, the Misuse
of Drugs (Supervision of Prescription and Supply of Methadone) Regulations
were drawn up in 1998. The regulations aim to create a more controlled
environment for the prescribing and dispensing of methadone. Within this
context, all those who were receiving methadone in Ireland were integrated into
a structured programme. Furthermore, drug users were integrated into a
structured programme-setting, where there is an active policy of carrying out
virology (blood test) in relation to HIV and hepatitis. It is suggested that this may
have resulted in an increase in the number of injecting drug users being tested
for HIV and, in turn, an increase in the number of positive cases being attributed
to injecting drug use during 1999. Secondly, it has been suggested anecdotally
that perceptions may be beginning to change among the drug-using population
in relation to HIV. It is argued that the availability of new treatment, i.e. Highly
Active Anti-Retroviral Treatment (HAART), and the visibility of individuals in
the community for whom treatment has been effective, has encouraged people
to come forward for testing so that they can avail of treatment if necessary. 
HIV among Prisoners
As mentioned above, within the Department of Health and Children's reporting
system on HIV-positive tests, those who are tested in prison are categorised
according to the testing location, i.e. prison. Although the proportion of positive
cases from the testing location category of prison which are attributable to
injecting drug use is not known, anecdotal evidence suggests that most of those
being tested have a history of injecting drug use. Since 1989, a total of thirty-nine
new positive cases have been attributed to 'prisoners', thirteen of whom tested
positive in 1999. The use of both risk categories and testing locations in the
Department of Health and Children's reporting system does not allow for any
conclusions to be drawn as to the significance of these figures in relation to the
injecting drug-using population. It is important that the risk category of these
cases be clarified.
HIV and Gender
Gender is the only socio-demographic data collected from those who are tested
for HIV by the Department of Health and Children. Gender has been reported
since 1997. An examination of the figures by gender suggests a possible change
in the profile of those who are testing positive for HIV in Ireland (see Table 2.2).
In 1997, females only accounted for three of the twenty-one new positive cases
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attributed to injecting drug use. In 1998 this had increased to ten of the twenty-
six  positive cases among injecting drug users, and in 1999 it had increased
further to account for thirty-four of the sixty-nine positive cases. Speaking in
percentage terms, women have increased from representing 14.3 per cent of the
positive tests among injecting drug users in 1997, to 38 per cent in 1998, to 49 per
cent in 1999. Owing to the lack of information on gender prior to 1997, it is not
possible to explore trends over a more extended period of time. Anecdotal
evidence suggests that these figures may reflect a real increase in the number of
female,   injecting drug-users who are becoming infected with HIV. However, it
is also suggested that these women may be becoming infected through their
sexual behaviour rather than their injecting drug use. Once identified as an
injecting drug user, however, their infection will tend to be attributed to their
injecting drug-using behaviour. Anecdotal evidence also suggests that a
growing number of women may be attending for testing in order to be able to
minimise the risk of infection to their baby were they to become pregnant.
Source: Department of Health and Children.
Special Studies on HIV Prevalence
A number of special studies have been carried out, which have explored the
prevalence of HIV among cohorts of drug users in a range of study locations. The
studies include drug users located in: the community, drug-treatment centres,
needle exchange programmes and prisons. A summary of the research findings
on the prevalence of HIV infection among particular cohorts of drug users is
presented in Table 2.3 below. 
One of the first studies of drug use in Dublin began in 1985, when O'Kelly &
Bury (1996) identified a cohort of known intravenous drug users in an inner city
area. The prevalence of HIV infection among this group was monitored over the
next decade. In 1991, 57.3 per cent of the total cohort (n=82) were known to be
HIV positive; by 1994, 64.6 per cent of the cohort had tested positive for HIV. In
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Author Study Sample Self Report/ Serum/ Sample % Infected 
Period Source Test Saliva Size of Those 
Teste Tested
Long et al., 1999 Committal Test Saliva IDUs 4 IDUs
(2000) Prisoners (n=173) 5.8%
n=593
Allwright et al., 1998 Irish Prisoners Test Saliva IDUs IDUs
(1999) n= 1,178 (n=509) 3.5%
Smyth et al., 1992- Drug Test Serum IDUs IDUs 
(1998) 1997 Treatment Centre (n=600) 1.2%
n=735
Dorman et. al., 1992 Drug Treatment Test Serum and IDUs IDUs
(1997) Centre & saliva (n=180) 8.4%
Non-Treatment 
n=185
O’Kelly et. al., 1984- IDUs in Test Serum IDUs IDUs
(1996) 1995 community (n=66) 65%
n=82
Johnson et al., 1991 Needle Exchange Test Saliva IDUs IDUs
(1994) (n=81) 14.8%
total, eighteen of those who had tested positive by 1994 had died. O'Kelly & Bury
(1996) argue that the high prevalence rate of HIV among this cohort reflects the
context in which their intravenous drug use developed. They argue that 'the
uncontrolled use of injected drugs and the sharing of scarce equipment were
commonplace at the time; the true impact of these practices is now clear in terms
of the spread of HIV infection among the young people who lived there' (O'Kelly
& Bury, 1996: 114). Another study, carried out in Dublin with a cohort who had
begun injecting during the same period, found similar rates of HIV prevalence.
Williams, Mullan, O'Connor & Kinsella (1990) found that, of a cohort of sixty-
nine individuals on a methadone maintenance programme, 70 per cent were
HIV positive.
These high prevalence rates of HIV were not found in the Dublin-based studies
subsequent to those of O'Kelly & Bury (1996) and Williams et al. (1990). Johnson
et al. (1994) found that in 1991, 14.8 per cent of a sample recruited from a needle
exchange programme were HIV positive. The Dorman, Keenan, Schuttler, Merry
& O'Connor (1997) study, carried out in 1992 in the context of a World Health
Organisation multi-national research initiative, found that 8.4 per cent of a
sample of 180 injecting drug users, recruited from both in and out of treatment,
were HIV positive. In contrast, the Smyth, Keenan & O'Connor (1998) study of a
drug-treatment sample, tested between 1992 and 1997, found a prevalence rate
for HIV of only 1.2 per cent. This is low in contrast to an estimated 8 per cent
prevalence rate (based on laboratory reports) among injectors attending Eastern
Health Board methadone clinics in 1997 (Barry, cited in Allwright, Barry,
Bradley, Long & Thornton, 1999: 2).
More recently, two studies have been carried, reporting on HIV prevalence
among the Irish prison population (Allwright et al., 1999; Long et al., 2000).
Included in the data are the prevalence rates for those prisoners who have a
history of injecting drug use. It was found that 5.8 per cent of committal
prisoners2 (Long et al., 2000) and 3.5 per cent of general prisoners3 (Allwright
et al., 1999) with a history of injecting drug use were HIV positive. Among those
prisoners who reported no history of injecting drug use, the infection rates were
0.5 per cent among the committal population (Long et al., 2000) and 0.9 per cent
within the general prison population (Allwright et al., 1999). In an environment
where injecting drug use is on-going, and in the absence of any provision for
clean injecting equipment, the risk for the spread of infection within this
population is high. 
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TABLE 2.4
Ireland 1998-2000. Summa y of R search Findi gs on the Prevalence of Hepatitis
B Infection among Particular Cohorts of Drug Users.
Numbers and Percentages.
Author
Long et al., (2000) 1999
Committal Prisoners
n=593
Test Saliva
IDUs
(n=173)
IDUs
17.9%
Allwright et al., (1999) 1998
Irish Prison Population
n=1,178
Test Saliva
IDUs
(n=509)
IDUs
18.5%
Smyth et al., (1998)
1992-
1997
Drug Treatment Centre
n=735
Test Serum
IDUs
(n=729)
IDUs
1%
Study
Period
Sample Source
Self
Report
Test
Serum/S
aliva
Sample
Size
Tested
%Infec
ted of
Those
Tested
IDUs = Intravenous drug users.
In summary, injecting drug use continues to be one of the main risk categories to
which HIV-positive cases are attributed each year. Despite the rate of new HIV-
positive cases attributed to injecting drug use plateauing in the early and mid-
1990s, recent figures suggest that there is an upward trend in the number of new
HIV-positive cases among Irish drug users. The information available on those
testing positive for HIV remains limited. Analysis of the figures highlights the
need for more information, in particular of a socio-demographic and behavioural
nature, to facilitate comprehensive epidemiological analysis of the trends.
Table 2.3. Ireland 1994-1999. Summary of Research Findings on the
Prevalence of HIV Infection among Particular Cohorts of Drug Users.
2 'Committal prisoners are prisoners who have been admitted to the prison within the preceding 48 hours,
accused or guilty of a new crime, excluding those on temporary release or transferred from another prison. The
committal population includes individuals entering on remand, following sentence, committed as a result of a
bench warrant and non-nationals without valid documentation' (Long et al., 2000: 2).
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3 All those incarcerated irrespective of their committal status.
4 IDUs: Injecting drug users
2.2.2  Hepatitis B
There is very little information in Ireland on the prevalence and incidence of
hepatitis B among both the general population and the injecting drug-using
population. While data are collected on the number of positive tests carried out
for hepatitis B by the Virus Reference Laboratory, no behavioural data are
collected and, therefore, those infected through drug use cannot be identified.
Information on prevalence rates is thus confined to a small number of special
studies that have been carried out in the field. 
The Smyth et al. (1998) study of drug users located in a treatment setting found
that only 1 per cent were infected with hepatitis B. However, more recent
research carried out in the prison setting found significantly higher prevalence
rates among injecting drug users. Allwright et al. (1999) and Long et al. (2000)
found 18.5 per cent and 17.9 per cent prevalence rates for hepatitis B,
respectively. While these figures suggest that hepatitis B may be prevalent
among the injecting drug-user population, the lack of data prohibits any in-
depth epidemiological analysis of the situation in Ireland.
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TABLE 2.5
Ireland 1995-2000 Summary of Research Findings on the Prevalence of
Hepatitis C Infection among Particula  C horts of Drug Users.
Numbers and Percentages.
Author
Long et al., (2000) 1999
Committal Prisoners
n=593
Test Serum
IDUs
(n=173)
Non
IDUs
(n=420)
IDUs
71.7%
Non
IDUs
1.4%
Allwright et al., (1999) 1998
Irish Prison Population
n=1,178
Test Serum
IDUs
(n=509)
Non
IDUs
(n=669)
IDUs
81.3%
Non
IDUs
3.7%
Smyth et al., (1998)
1993-
1996
Drug Treatment Centre
n=353
Test Serum IDUs(n=353)
IDUs
52.1%
Smyth et al., (1999b) 1997
Drug Treatment Centre
n=84
Self-
report
n/a IDUs(n=84)
IDUs
89%
Smyth et al., (1998)
1992-
1997
Drug Treatment Centre
n=735
Test Serum IDUs(n=733)
IDUs
61.8%
Smyth et al., (1995)
1992-
1993
Drug Treatment Centre
n=272
Test Serum IDUs(n=272)
IDUs
84%
Test-
ing
Period
Sample Source
Self
Report
Test
Serum/
Saliva
Sample
Size
Tested
%Infec-
ted of
Those
Tested
IDUs = Intravenous drug users.
2.2.3  Hepatitis C
In Ireland, there is no routine data collection in the area of hepatitis C. However,
there have been a number of special studies carried out among samples of drug
users in a variety of study settings (see Table 2.5). 
The first study of hepatitis C infection among injecting drug-users was carried
out between August 1992 and August 1993 by Smyth, Keenan, Dorman &
O'Connor  (1995). The study sample was identified through a treatment centre,
where all new attenders and re-attenders who presented during the study period
and who reported a history of injecting drug use were encouraged to take part.
In total, 272 injecting drug-users took part and a prevalence rate of 84 per cent
for infection with hepatitis C was found. Among those injectors who had been
injecting for between six months and two years inclusive, the prevalence rate
was 70 per cent. Among those with an injecting history of longer than two years,
the prevalence rate was 95 per cent. Furthermore, there was a significant gender
difference in relation to infection: of the 194 males, 156  (80%) tested positive,
whereas 73 of the 78 females (94%) were positive. 
Further studies were carried out by Smyth et al. (1998) and Smyth, Keenan &
O'Connor (1999a), which examined the prevalence of hepatitis C infection
among in-treatment populations. Consecutive new attenders at a treatment
service, who attended between July 1993 and December 1996, were approached
to take part in the study. In all, a sample of 353 injecting drug-users who
reported an injecting history of less than twenty-five months were recruited.
Overall, a prevalence rate of 52.1 per cent was recorded in this sample. In an
extension of this study cohort, Smyth et al. (1998) later found that of 733
consecutive new attenders between September 1992 and September 1997 at the
same treatment centre, 61.8 per cent were hepatitis C positive.
In two prison studies, which have been discussed in previous sections, the
prevalence of hepatitis C among prisoners was explored (Allwright et al., 1999;
Long et al., 2000). The prevalence of hepatitis C infection was found to be high
within this population. Allwright et al. (1999) found that among 509 prisoners
with a history of injecting drug use, 81.3 per cent tested positive for hepatitis C.
In contrast, only 3.7 per cent of those prisoners who did not report a history of
injecting drug use had tested positive for hepatitis C. A follow-up study of the
committal prisoner population (Long et al., 2000) found that, of 173 prisoners
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with a history of injecting drug use, 71.7 per cent were hepatitis C positive. Only
1.4 per cent of those prisoners who reported that they had no history of injecting
drug use tested positive for hepatitis C. 
While it is not possible from the available data to analyse infection trends over
time, it would appear from the studies available that hepatitis C infection has
been prevalent among Irish injecting drug-users over the past decade. Anecdotal
evidence suggests that the relative ease with which hepatitis C can be spread
through injecting drug use, and a lack of knowledge among users about hepatitis
C and the associated risks, have all contributed to its spread. In summary, the
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prevalence rate for hepatitis C infection has been found to be consistently high
within the drug-using population over the past decade.
2.2.4  Summary
The most comprehensive data available on drug-related infectious diseases in
Ireland are for HIV. While the number of new, positive tested cases for HIV,
which were attributable to injecting drug use, appeared to stabilise in the mid-
1990s, figures for 1999 show an increase in the number of cases. For both
hepatitis B and C, analysis is dependent solely on data from special studies.
Despite the absence of comprehensive data it appears from the evidence
available that hepatitis C continues to be highly prevalent among Irish injecting
drug users. Overall, it would appear from the data available that drug-related
infectious diseases continue to be a concern in relation to Irish injecting drug
users. Furthermore, this highlights the need for more comprehensive data
collection in the area of all drug-related infectious diseases in order to monitor
changes in the trends over time.
2. 3  Determinants of Drug-Related Infectious Diseases
This section addresses some of the determinants of drug-related infectious
diseases in the Irish context. It examines research that has looked at the risk
behaviours engaged in by Irish drug users, both in relation to their injecting drug
use and their sexual behaviour. Furthermore, it explores the data available on
both the health-related consequences and the wider social consequences of drug-
related infectious diseases.
2.3.1 Injecting Risk Behaviour
Once the link between the spread of HIV and injecting drug use was established
in the mid-1980s, the risk behaviours engaged in by the injecting drug-using
population became a focus of research. In the Irish context, studies on the
injecting risk behaviour of drug users have spanned the last decade. During this
period the provision of harm-reduction strategies has expanded from being
available through a small number of programmes to a small number of drug
users, to more widespread availability, to a significant number of programmes
catering for a significant number of drug users. This section first describes the
findings of research related to the risk behaviours of the general injecting
population, and then second describes the findings relating to three sub-groups
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of particular interest - young injectors, female injectors and injecting drug users
in prison. 
Injecting Drug Users in General 
Research carried out by Johnson et al. (1994) in 1991, among a sample of
attendees at a Dublin needle exchange, found that 52.6 per cent of respondents
reported that they had not shared equipment during the preceding twenty-eight
days, while over 34.2 per cent had shared with two or more other people. A
study carried out a year later, in 1992 (Dorman et al., 1997), among a sample
(n=185) of injecting drug users both in and out of treatment, found that 55.7 per
cent of the sample had shared and 61.6 per cent had lent injecting equipment in
the previous six months. 
Despite the expansion of harm-reduction strategies since the two studies
described above (Johnson et al., 1994; Dorman et al., 1997) were carried out, more
recent research has found that Irish drug users continue to engage in risky
injecting behaviour. In a study of those attending a needle exchange programme,
Cox & Lawless (2000) found that 59 per cent of the sample who had a history of
injecting drug use (n=1,323) reported sharing injecting equipment at some stage
in their injecting drug-using career. Furthermore, 29 per cent of these
respondents reported sharing recently (i.e. in the previous four weeks). Among
the 29 per cent who reported sharing recently, 17 per cent had lent their injecting
equipment, 50 per cent had borrowed it and 33 per cent had done both. Data
from the National Drug Treatment Reporting System (NDTRS), operated by the
Drug Misuse Research Division of the Health Research Board, offers further
evidence that Irish drug users continue to engage in injecting risk behaviours. In
1998, 575 out of first-treatment contacts (n=1,625) reported that they had ever
injected a drug, and 45.6 per cent of these reported that they had ever shared
injecting equipment. Furthermore, 352 of this sample reported that they were
currently injecting (i.e. within the last month), and 26 per cent (n=94) of these
reported that they were currently sharing injecting equipment (i.e. within the
last month).
Young Injectors 
In a study specifically aimed at exploring the risk behaviours engaged in by a
sample of young injectors (n=485), i.e. those under the age of 25, Cassin,
Geoghegan & Cox (1998) found a significant proportion regularly engaged in
injecting risk behaviours. Compared with a cohort of older injectors (n=285), i.e.
those over the age of 25, who were attending the same service, younger clients
were found to be significantly more likely to have reported both lending and
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borrowing used needles and syringes in the four weeks prior to first contact with
the syringe exchange programme. Furthermore, 64.3 per cent of the younger
cohort reported that they had shared injecting paraphernalia (i.e. spoons and
filters) in the four weeks prior to contacting the service, compared to only 43.8
per cent of the older cohort. 
Female Injectors 
Female drug users have been studied specifically in relation to their injecting risk
behaviours. Cox & Lawless (2000) found that among a cohort of needle-exchange
clients, women (n=304) were significantly more likely than men (n=1,000) to
report sharing injecting equipment with their sexual partner and to share
injecting paraphernalia with other injecting drug users. While 53 per cent of men
reported that they had shared injecting paraphernalia, 63 per cent of females
reported that they did so. The gender difference was more acute in relation to
sharing injecting equipment with a sexual partner: 13 per cent of men compared
to 37 per cent of women reported that they did so. However, this was directly
related to the fact that 68 per cent of women reported that they had a sexual
partner who was an injecting drug user, compared to just 24 per cent of men. Cox
& Lawless (2000) argue that the greater personal involvement of women with
other drug users has consequences in terms of health-related problems and risk
behaviour. The social opportunities created by living in close proximity with
other injecting drug users creates an environment in which risk behaviour
flourishes (Cox & Lawless, 2000). 
Injecting Drug Users in Prison 
To date, Irish prisoners do not have access to clean injecting equipment and only
a very limited number have access to a methadone maintenance programme in
the prison setting. This implies that, where injecting drug use occurs in the
prison, it may be particularly risky in relation to the spread of drug-related
infectious diseases. 
O'Mahony's (1997) study in a Dublin prison found that 42 per cent (n=45) of a
sample of 108 prisoners had used heroin while in prison serving their current
sentence. Of these forty-five, thirty-seven had engaged in intravenous use. One-
sixth of those reporting a history of drug use had tested positive for HIV, while
a quarter had never been tested. In addition, half these drug users said they had
tested positive for at least one form of hepatitis. O'Mahony described as
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'alarming' (O'Mahony, 1997: 107) the finding that, of those who reported having
tested positive for HIV, 60 per cent had engaged in needle sharing since being
notified of their positive status. An earlier study, based on data gathered
between 1987 and 1991, found that during this period, 168 known HIV-positive
prisoners had spent time in Mountjoy Prison in Dublin. A study of a sub-sample
of these HIV-positive individuals, selected on a random basis, found that 94 per
cent had engaged in drug use within the prison, suggesting a potential spread of
HIV to uninfected prisoners (Murphy, Gaffney, Carey, Dooley & Mulcahy, 1992). 
A more recent study of HIV and hepatitis B/C prevalence among prisoners
investigated the sharing of injecting equipment in the prison setting (Allwright
et al., 1999).  As may be expected in an environment where there is no formal
access to injecting equipment, it was found that injecting drug users were more
likely to share injecting equipment while in prison than when they were in the
community. Of injecting drug users, 58 per cent reported that they had shared
all injecting equipment (i.e. needles, syringes, filters, spoons) while in prison,
compared to 37 per cent who reported sharing in the month prior to being
incarcerated. Furthermore, of those injecting drug users who had shared
injecting equipment inside the prison, 89.1 per cent had tested positive for
hepatitis C. 
2.3.2  Sexual Risk Behaviour
In 1985 Irish family planning legislation was amended to allow for the sale of
condoms to people over the age of 18 without a prescription from a range of
named outlets. The sale of condoms was not deregulated in Ireland until 1993,
when the law was changed to make condoms available for sale through outlets
other than pharmacies. This change in the law was principally in response to
public health concerns in relation to HIV/AIDS, and the law referred to
condoms as infection preventers rather than as pregnancy preventers
(Prendiville & Smith,  1993). Condoms are sold from a wide range of sources,
including vending machines. Furthermore, condoms are distributed freely to
groups considered to be at high risk of infection, including injecting drug users.
Despite the wide availability of condoms, research carried out among drug users
suggests that they continue to engage in sexual risk behaviours which may
facilitate the spread of HIV and other infectious diseases. 
A study of first-time attenders at the Eastern Regional Health Authority needle
exchange programmes from 1990 to 1997 found that only 55 per cent of first-time
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attenders (n=5,152) reported using a condom during sexual encounters in the
previous year (Mullen & Barry, 1998). A study of drug-using women working in
prostitution (n=77) (O'Neill & O'Connor, 1999), 83 per cent of whom reported
injecting drugs in the previous month, found that while 92 per cent 'always' used
condoms with clients for vaginal sex, only 15 per cent 'always' used condoms
with their partners for vaginal sex. Furthermore, while none reported 'never'
using condoms with clients for vaginal sex, 52 per cent reported that they 'never'
used condoms with partners for vaginal sex. There were similar findings in
research carried out with a cohort of clients attending a syringe exchange
programme (n=1,309). It was found that 25 per cent of those who reported
having no regular sexual partner reported 'never' using condoms, whereas 41
per cent of clients who reported having a regular sexual partner (n=865) reported
'never' using condoms. It has been argued that the reluctance to use condoms
within long-term or steady sexual relationships can be particularly problematic;
this has been argued both in the context of the drug-using population (Cox &
Lawless, 2000) and the general population (Mahon, Conlon & Dillon, 1998). 
2.3.3  Summary
In summary, this section highlights the extent to which Irish drug users continue
to engage in behaviours conducive to the spread of drug-related infectious
diseases, both through their injecting drug use and their sexual activity. Despite
the expansion of harm-reduction strategies since the early 1990s, Irish drug-users
continue to engage in these risk behaviours. The findings of studies carried out
in the early 1990s in relation to risk behaviours may be explained by a lack of
appropriate service provision and a lack of knowledge among both service
providers and users of the risks involved in sharing. However, the more recent
study findings show that these patterns of risk behaviour continue to exist
despite the presence of appropriate services. Section 2.5 presents the research
findings on whether the introduction of harm-reduction strategies have had an
impact on drug users' risk behaviours.
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Intravenous Drug Use
Related* 142 61 43 21 22 27 25 27 34 17 10 1 12 8 16 7
Homo/Bisexual
Haemophiliacs/ 109 45 13 14 27 11 16 11 34 16 12 3 13 9 13 5
Heterosexuals
Others 52 27 12 9 18 6 13 8 11 1 8 2 14 4 11 5
Undetermined 5 3 0 0 0 0 1 0 0 0 2 1 2 0 1 0
Total 308 136 68 44 67 44 55 46 79 34 32 7 41 21 41 17
Risk Category 1982-1992
Cases Deaths
1993
Cases Deaths
1994
Cases Deaths
1995
Cases Deaths
1996
Cases Deaths
1997
Cases Deaths
1998
Cases Deaths
1999
Cases Deaths
TABLE 2.6
Ireland 1982-1999. AIDS Cases and Deaths by Risk Category.
Numbers
Source: Department of Health and Children / Virus Reference Laboratory.
*Includes categories ‘intravenous drug users’, ‘homo-bisexual/intravenous drug users’ and ‘babies born to intravenous drug users’.
D
rug-R
elated
 Infectious D
iseases
2.4  Consequences of Drug-Related Infectious Diseases
The consequences of drug-related infectious diseases have not received
significant attention in the Irish literature. This chapter explores the data
available on both the health-related consequences and the wider social
consequences of drug-related infectious diseases.
2.4.1  Health-Related Consequences
The most obvious consequences of HIV and hepatitis B and C infection are the
impact these diseases have on the individual's health. There are no data available
on the number of drug users who develop chronic hepatitis C infection or
require care for hepatitis B infection. The only data collected on the health
consequences of drug-related infectious diseases are those on AIDS-related cases
and deaths. Since recording began in 1982 and up until 31 December  1999, there
have been 691 AIDS cases reported in Ireland, and 349 AIDS-related deaths (see
Table 2.6). In 1999 there were 41 new AIDS-related cases recorded. Intravenous
drug users continue to represent one of the main risk categories recorded in this
data source. In 1999 intravenous drug users accounted for 39 per cent of new
AIDS cases, and 41 per cent of the year's AIDS-related deaths. 
Another area of concern is the extent to which HIV/AIDS is passed on from
mother to baby. From January 1986 to December 1999, a total of 172 HIV-positive
cases were attributed to the category 'children at risk', representing 7.84 per cent
of the total HIV-positive cases reported over the period (Department of Health
and Children). However, this category does not indicate the route of infection
and it is therefore not known to what extent HIV among these children is
attributable to maternal injecting drug use. However, the statistics collected on
AIDS cases and deaths indicate where a child's infection is attributable to
maternal drug use. In total, from 1982 to 1999 fourteen children born to drug
users were recorded as AIDS cases; this represents 2 per cent of the total 691
cases recorded up to 31 December 1999. Furthermore, there were eight AIDS-
related deaths among children of injecting drug users recorded in the same time
period, which accounts for 2.3 per cent of the total 349 deaths recorded up to 31
December 1999.
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In summary, little is known about the health-related consequences of drug-
related infectious diseases in Ireland. While there have been improvements in
treatment procedures, particularly in the area of HIV, coping with the impact of
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the high prevalence rate of hepatitis C infection will present a particular
challenge to service providers.
2.4.2  Social Consequences
The close link between social deprivation and problematic drug use in Ireland
has meant that those affected by drug-related infectious diseases are generally
from areas characterised by high levels of social deprivation. Individuals who
may be considered socially excluded may therefore suffer further exclusion as a
result of being affected by a drug-related infectious disease. In this context, it is
important that the wider social consequences of drug-related infectious diseases
be considered. However, little research has been carried out in this field, either
on individuals infected, their families or the community at large. 
As part of a wider study on heroin use in Dublin's inner city, McCarthy &
McCarthy (1997) surveyed twenty-six opiate users and eighteen families in
which there was a drug-using member. Among both groups, drug-related
infectious diseases were raised as an issue of concern. A number of respondents
reported that they had to cope with either their own or a family member's
infection and its effects. Particularly acute were the concerns expressed by
individuals in families where another member was HIV positive. Twenty-eight
of the respondents from the family cohort reported that they had a family
member who was HIV positive or living with AIDS. One mother reported that
four of her children had died from AIDS-related illnesses between 1989 and 1995
(McCarthy & McCarthy, 1997: 58). It was also found, however, that none of the
respondents who lived with a person who was infected with HIV had availed of
any formal support services for themselves in relation to HIV/AIDS issues.
O'Gorman (1999) carried out a qualitative study of the experiences of both
people directly infected by HIV and also those whose lives were affected by HIV,
i.e. the parents, partners, children and siblings of people who were HIV positive.
In total, members of nineteen families participated in the study - twenty-six
adults and seven children who had been diagnosed HIV positive, and a further
twenty-nine adults and fifty-four children who were affected by HIV/AIDS.
This study highlights the complex nature of the problems faced by both those
infected with and those affected by HIV/AIDS. The problems identified include
the trauma involved in being diagnosed; informing other family members (e.g.
partners, children), who may be at risk of infection; caring for a child who is HIV
positive, when the parent is also HIV positive; complying with treatment
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regimes; and coping with an AIDS-related death. O'Gorman (1999) argues that
in the absence of adequate public information campaigns, HIV and AIDS
continue to be widely viewed within Irish society with 'prejudice, fear and
ignorance' (O'Gorman, 1999: 55). Consequently, those infected with the disease
and their families have to live with the added strain of coping with the stigma
and secrecy that surrounds HIV. 
In summary, as in other European countries, the consequences of drug-related
diseases in Ireland are multi-faceted. While they encompass consequences on the
health and general well-being of the infected individual, they also impact on the
infected individual's family and wider community. The wider social
consequences of drug-related infectious diseases have been largely neglected in
the Irish context and are in need of further attention.
2.5  New Developments and Uptake of Prevention/Harm
Reduction and Care
As mentioned in previous sections, harm-reduction strategies play a key role in
the provision of services for drug users in Ireland. Both needle exchange
programmes and those based on substitution treatment were expanded in an
attempt to curb the spread of HIV among injecting drug users. More recently,
there has been an increased focus on the role these services play in preventing
the spread of other drug-related infectious diseases, i.e. hepatitis B and C. This
section gives an overview of the harm-reduction services available to Irish
injecting drug users, which aim to prevent the spread of drug-related infectious
diseases among this population. Furthermore, the section gives a brief overview
of those services that provide care for those already infected. The following areas
of service  provision will be addressed:
2.5.1 Harm Reduction Programmes 
2.5.2 Testing and Treatment
2.5.3 Hepatitis C Vaccination
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2.5.1  Harm Reduction Programmes
A number of harm-reduction strategies have been developed, which specifically
aim to prevent the spread of HIV and other drug-related infectious diseases
among injecting drug users in Ireland. However, the impact of these
programmes on infection rates among injecting drug users are unclear. Smyth et
al. (1999a) attempted to explore the impact of these programmes on the spread
of hepatitis C by carrying out tests for hepatitis C among a cohort of drug users.
The cohort included those who had begun their injecting drug use before and
after the expansion of harm-reduction programmes in Ireland. Smyth et al.
(1999a) argue that the findings suggest that those injecting drug users who began
their injecting drug use after the introduction of harm-reduction strategies,
demonstrated a reduced risk of hepatitis C infection. However, Smyth et al.
(1999a) emphasise that it was not possible to control for other factors that may
explain the decline in the hepatitis C infection rate, such as a possible reduction
in overall injecting frequency among more recent injectors. 
In this section three specific harm reduction services will be briefly overviewed,
and any research findings in relation to the impact they may have had on the
spread of drug-related infectious diseases presented. The services that will be
covered in this section are:
! Information and Education Programmes
! Needle Exchange Programmes 
! Substitution Programmes
Information and Education Programmes
Information on drug-related infectious diseases is made available to drug users
through a number of sources. Leaflets containing information on what these
diseases are and how they are spread are available to drug users from a number
of locations, including drug treatment centres, health centres, drop-in centres
and voluntary organisations. An information booklet dealing specifically with
hepatitis C has recently been produced, which is directly aimed at informing
drug users and their families about the disease (Keating, 2000). Furthermore,
there have been a limited number of education programmes aimed at informing
drug users directly about drug-related infectious diseases and the associated
risks. In 1996 the Health Promotion Unit of the Department of Health and
Children produced guidelines for effective HIV/AIDS education (Department of
Health, 1996). An example of an education programme aimed directly at drug
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users was established by the Probation and Welfare Service in Mountjoy Prison,
Dublin. This Drug Awareness Programme is a four-week programme consisting
of one session per week. The principal aim is to educate participants about their
drug use and the associated risks. It is aimed at all prisoners with a history of
drug use, including those who have ceased their drug use and those who are
continuing to use in the prison setting. Included in this programme is a session
on HIV and hepatitis. 
While education and dissemination of information about drug-related infectious
diseases and the associated risks have been an important component in Ireland's
prevention strategy, the effectiveness of information dissemination and the
impact of such information on risk behaviour is unclear. Prior to the
development of the Probation and Welfare Service's Drug Awareness
Programme in Mountjoy Prison, an award-winning booklet and video,
containing information for prisoners on HIV discrimination, infection and
prevention, were produced and were supposedly available to all prisoners.
However, a study carried out, based on focus-group interviews with prisoners
and former prisoners, found that HIV-positive individuals in the focus groups
had seen neither of these materials (O'Brien & Stevens, 1997). Furthermore, as
will be discussed in more detail below, Smyth et al. (1999b) found that even
where injecting drug users may be attending a treatment service and may have
regular contact with health professionals, this does not necessarily result in the
drug user developing a better understanding of hepatitis C and the related risk
behaviours. Bourke (1998) also found that, in a cohort (n=66) of young injecting
heroin users (aged 15 to 22 years) attending services, 'whilst most understood the
significance of sharing needles few were aware that sharing barrels, spoons and
filters put them at risk' (Bourke, 1998: 4).
It would appear from the evidence available that information is not always
passed on to injecting drug users in an effective manner. Despite the existence of
education and information materials as part of the prevention strategy in the
area of drug-related infectious diseases, it would appear that there is a need for
this information and education to be delivered in a more effective manner. 
Drug-Related Infectious Diseases
73
Needle Exchange Programmes
The first needle exchange programme in Ireland was established in 1989. Since
then the service has been expanded to include approximately twelve sites. All
the sites are located in the Eastern Regional Health Authority (ERHA) area,5
which includes Dublin City and surrounding areas. Three types of programmes
exist:
! The Merchant's Quay Project is a voluntary organisation, which, among 
other services, provides a needle exchange programme.
! A mobile clinic, which provides low-threshold services to drug users, 
including a needle exchange and a low dosage methadone programme. 
This clinic services four areas in Dublin City and the surrounding 
suburbs on a Monday to Friday basis.
! The remaining programmes are all in statutory services run by the 
ERHA. These are located in health centres and drug-treatment centres 
around the city. 
A one-for-one exchange of needles is aimed for by all needle exchange services.
However, there is flexibility in order to ensure the service is client-friendly. The
mean number of needles given out to injecting drug users at first attendance at
ERHA exchange programmes is 4.0 (Mullen & Barry, 1998). Overall, the ERHA
programmes estimate that approximately 60-70 per cent of needles are returned
to its exchange programmes. For 'first-time' clients at the Merchant's Quay
Project, the number of syringes and needles given is normally two barrels and
six needles (or six microfines) (Cox & Lawless, 2000). In 1998 a total of 16,509
syringes were dispensed by the Merchant's Quay Project through its exchange
programme (Cox & Lawless, 2000). 
While there has been an expansion in the number of needle exchange
programmes available to Irish drug users, a need for further expansion has been
identified. An external review of drug services in the Eastern Health Board
(EHB) area,  has described needle exchange provision in Dublin as 'patchy and
not very comprehensive' (Farrell, Gerarda & Marsden, 2000: 13). While it is
recognised that community resistance may impact on the expansion of these
services, it is argued that there needs to be a wider geographical distribution of
these services. Pharmacies have been suggested as a potential source for clean
injecting equipment for injecting drug users. 
5 Formerly the Eastern Health Board (EHB).
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While there are no restrictions on pharmacies in relation to selling injecting
equipment in Ireland, anecdotal evidence suggests that, in practice, this rarely
happens. Currently there is no central policy or programme under which
pharmacists provide needles to injecting drug users. The Pharmaceutical Society
of Ireland has stated that it supports 'the principle of needle and syringe
exchange. Its members are ready and willing to provide such a service as part of
a comprehensive national needle and syringe exchange network' (McDermott,
1999). 
In an evaluation of the Merchant's Quay Project's syringe exchange programme,
it was found that it had had a positive impact on reducing the incidence of
injecting risk behaviours among clients. Clients were questioned about their risk
behaviour when they first attended the service and then again after three
months. Within this period it was found that there was a 76 per cent reduction
in the numbers reporting lending injecting equipment and a 71 per cent
reduction in the numbers reporting borrowing injecting equipment (Cox &
Lawless, 2000: 69).
Substitution Programmes
Substitution programmes currently account for the majority of treatment
programmes available to injecting drug users in Ireland. At the end of August
2000 there were 4,813 clients receiving substitution treatment in Ireland. The
service is provided in a range of settings including addiction centres, satellite
clinics and from general practitioners in their own surgeries. It is assumed that
by providing a substitute opiate (i.e. methadone), and monitoring illicit drug use
through urinalysis, participation on a substitution programme will reduce the
illicit opiate intake of a client and, in turn, their injecting drug use. However, a
secondary function of substitution programmes in relation to preventing the
spread of drug-related infectious diseases is the dissemination of information to
clients about HIV and hepatitis and associated risk behaviour. 
Williams et al. (1990) carried out a study with sixty-nine clients of a methadone
maintenance treatment programme to investigate the extent of 'at-risk'
behaviour for HIV transmission among those known to be sero-positive, and to
measure the degree of positive change in their risk behaviour. It is important to
note that this study was carried out in 1988, prior to the introduction of needle
exchange programmes by the health board. Of those who were HIV positive
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(n=48), 63 per cent admitted that they had continued to share injecting
equipment since getting a positive test result. However, when comparing their
reported pre-test activities, the findings were deemed to be encouraging. Prior to
being tested, 98 per cent  reported that they had shared injecting equipment,
compared to 63 per cent after testing.
More recently, in 1997, Smyth et al. (1999b) carried out a study of knowledge
regarding hepatitis C among a sample of injecting drug users (n=84) in a
treatment setting in Dublin. Included in the sample were individuals who were
on a methadone maintenance programme and those who were on a short-term
detoxification programme. The researchers' basic hypothesis was that those
injecting drug users with increased contact with medical services would
demonstrate better understanding of hepatitis C and associated risk behaviours,
i.e. a 'dose-response' type effect. This hypothesis was not confirmed. Seventy-
three of the sample recognised the four main infection routes, i.e. injecting drug
use, sex, transfusion and vertical. However, only 44 per cent recognised activities
with no associated risk, i.e. injecting without sharing, smoking heroin, and
kissing. Smyth et al. (1999b) express concern about the finding that substantial
minorities believe that there is a risk of exposure even when not sharing injecting
paraphernalia. They argue that perceived personal vulnerability to infections
such as hepatitis C is likely to be a factor in leading individuals to avoid
practising unsafe injecting behaviour. Where this vulnerability is diminished by
false beliefs about already having been exposed to infection, when actually
engaging in 'safe' practices, then the preparedness to share injecting equipment
may well increase. 
In summary, while section 2.2 showed that a significant proportion of Irish
injecting drug users continue to engage in injecting risk behaviours, it would
appear from this section that harm-reduction strategies have had some positive
impact on injecting drug users' risk behaviours. While there is a need to improve
the delivery of some services, the findings suggest that infection rates would be
higher in the absence of the current harm reduction strategies.
2.5.2  Testing and Treatment 
Testing
Testing for hepatitis and HIV is offered to all those entering treatment and is
encouraged by low-threshold services such as needle exchange programmes. In
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these settings clients are given test results and may be offered referral to
treatment where appropriate. The actual proportion of injecting drug users who
have been tested for either hepatitis or HIV remains unknown. A study of HIV
and hepatitis B and C prevalence among the prison population (Allwright et al.,
1999) found that of 509 prisoners with a history of injecting drug use, 59.3 per
cent reported that they had been tested for hepatitis C, 49.6 per cent for hepatitis
B and 65 per cent for HIV. In the Cox & Lawless (2000) study of needle exchange
attenders, 49 per cent reported that they had been tested for HIV. It has also been
found that young injecting drug users (below the age of 25) are significantly less
likely to have been tested for either HIV or hepatitis than the older cohort
(Cassin et al., 1998). While the specific nature of these study populations needs
to be considered, these figures suggest that a significant proportion of drug users
have not been tested for the various drug-related infectious diseases.
Treatment
The provision of treatment for those infected with both HIV and hepatitis C is a
key aspect of drug-related infectious diseases. Treatment programmes for both
HIV and hepatitis C are available free of charge in Ireland. While it is not
essential for drug users to be referred by drug treatment clinics for HIV and
hepatitis C treatment, this is the route generally followed.
Highly Active Anti-Retroviral Treatment (HAART) is available free of charge to
drug users through referral to genito-urinary medicine (GUM) and infectious-
disease clinics in Ireland. There are four clinics that provide HAART, three based
in Dublin, the fourth in southern Ireland in Cork. The selection of patients for
HAART is based on internationally-recommended medical criteria, and the
motivation of the individual to undergo the treatment. A drug user generally has
to be stable on a substitution programme before he/she will be accepted on to a
HAART programme. This is due to problems of compliance with the treatment
regime and concerns about the risks of prescribing HAART to those who are
continuing to engage in illicit drug use.
Treatment for hepatitis C is also available to drug users where its provision is
deemed appropriate. Guidelines have been developed for selecting suitable
candidates for hepatitis C treatment. It is generally agreed among service
providers that a potential client should be 'drug stable' (i.e. free from street
opiates and injecting drug use) for a minimum of a year prior to starting
treatment and that they should not be drinking alcohol (Keating, 2000). As with
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HAART, it is argued that an individual needs to be drug stable in order to
maximise the chances of compliance with the treatment regime involved for
hepatitis C. Therefore, while a person with a history of injecting drug use may
access treatment for hepatitis C, an active injecting drug user may not. 
2.5.3  Hepatitis B Vaccination
Hepatitis B vaccination is available free of charge to all injecting drug users
through the drug services and, where the individual is entitled to free medical
care, through their general practitioner. However, anecdotal evidence suggests
there is a lack of knowledge among drug users about hepatitis B in general, and
about the availability of a vaccination. Furthermore, anecdotal evidence suggests
that not all service providers are offering drug users the hepatitis B vaccination.
While the total proportion of injecting drug users who are vaccinated against
hepatitis B is not known, special studies have found that a relatively low
proportion report having received a vaccination. A study of those clients
attending the Merchant's Quay Project found that only 19 per cent of clients
reported having been vaccinated for hepatitis B (Cox & Lawless, 2000).
Furthermore, a study of HIV and hepatitis B and C prevalence among committal
prisoners (Long et al., 2000) found that of 175 prisoners with a history of injecting
drug use, only 23 per cent (n=41) reported that they had been fully vaccinated
for hepatitis B. There is also a need to ensure that drug users who begin a course
of the hepatitis B vaccination complete the three injections. In their study of HIV
and hepatitis B and C prevalence among the prison population, Allwright et al.
(1999) found that while 300 respondents reported that they had been vaccinated
against hepatitis B, only 184 had completed the three doses. 
2.6  Conclusion
There appears to be on-going evidence that a significant proportion of Irish drug
users may be infected with at least one drug-related infectious disease. However,
analysis of the situation remains restricted in the absence of comprehensive
routine data collection in the field. It would also appear that while harm-
reduction programmes have played a role in containing the spread of drug-
related infectious diseases to some extent, a significant proportion of Irish
injecting drug users are continuing to engage in risky behaviours. It would
appear that there is a need for more comprehensive education and information
A Collection of Papers on Drug Issues in Ireland
78
dissemination strategies targeted at drug users, and in particular young
injectors. Furthermore, there is a need for a more effective delivery of testing
services and, in particular, hepatitis B vaccination to drug users.
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Chapter 3
Cocaine Use In Ireland: 
An Exploratory Study
Paula Mayock
3.1  Introduction 
In Ireland the heroin epidemic of the 1980s, coupled with the public health crisis
of HIV transmission through unsafe injecting practices, resulted in a
concentration of attention on 'high-risk' drug use categories, most notably heroin
and other intravenous drug use.  The major focus in the domains of drug policy,
treatment and research centred on the 'threats' posed by enduring patterns of
drug use, unsafe methods of drug administration and associated risk
behaviours.  Heroin, being a dominant drug of misuse among individuals
receiving treatment, certainly in the greater Dublin area (O'Brien, Moran,
Kelleher & Cahill, 2000), has attracted by far the greatest level of interest and
attention.  This situation is by no means unique to Ireland.  As Egginton & Parker
(2000) have remarked, 'so distinctive is the impact of this drug that heroin has its
own epidemiology' (Egginton & Parker, 2000: 7).  In practice, prevalence studies
and other empirical research focus on groups, such as opiate users or injectors,
who are of concern at a particular time (Frischer & Taylor, 1999).  Put differently,
attention to particular forms of drug use is very much a function of the drug-
political situation in any given jurisdiction (Cohen, 1996).
Despite heroin's prominence, publicity and official concern, the past decade has
witnessed increased recognition of the pervasiveness of drug use in society
generally. Drug use, traditionally associated with social and economic
disadvantage, is increasingly recognised as a widespread social phenomenon
and is clearly no longer confined to marginalised communities.  School surveys
point to a definite increase in the number of young people reporting lifetime use
of a range of illicit substances (Grube &  Morgan, 1986; Grube & Morgan, 1990;
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Hibell et al., 1997; Brinkley, Fitzgerald & Greene, 1999; Hibell et al., 2000).  Less
is known, in an Irish context, about drug use in the general population as few
household surveys, concentrating on adult rather than youth populations, have
been conducted.  However, a recent population survey, examining the lifestyle,
attitudes and nutritional status of people aged 18 to 55 years, revealed a lifetime
prevalence rate of 17 per cent for cannabis.  Last-year prevalence was estimated
at 2 per cent for amphetamines and ecstasy and 1 per cent for tranquillisers and
LSD (Friel, NicGabhainn & Kelleher, personal communication). Although
cannabis remains by far the most popular of the illicit drugs and the most likely
to be used repeatedly across time, available data suggest that other drugs,
including amphetamine, ecstasy and LSD, are increasingly likely to be used,
particularly by adolescents and young adults. It would appear that we are
increasingly living in a drug-conscious society.
In Ireland relatively little attention has focused on the use of individual drugs,
with the result that little is known about the extent and nature of specific forms
of drug involvement.  Attention to drug use, apart from heroin, has concentrated
almost exclusively on ecstasy.  Reviewing available data pertaining to ecstasy
use in Ireland, Bisset (1997) found evidence of an upward trend in use among
young people.  Murphy, O'Mahony & O'Shea's (1998) comparative research on
Irish and European drug policies relating to the use of ecstasy included a small-
scale qualitative study of ecstasy use by adults aged between 17 and 27 years.
The findings of this research suggest that ecstasy was a component of poly-drug-
using careers initiated during the mid- to late-teenage years.  Ecstasy use was
synonymous with the rave/dance scene and was usually consumed in
conjunction with alcohol and other drugs, including amphetamine and/or
cannabis.  More recently, a larger qualitative study of patterns and levels of
ecstasy use in Northern Ireland (McElrath & McEvoy, 2000) found a high
proportion of 'heavy users' in their sample of ninety-eight respondents.
However, the dosage (i.e. number of tablets) per episode of use varied across the
sample and typical reports indicated that many users 'staggered' their intake of
ecstasy during individual sessions of use.  In common with the findings of
Murphy et al. (1998), the concurrent use of ecstasy, alcohol and cannabis was
common among users.  Although it is not possible, on the basis of current
knowledge, to provide a reliable estimate of the prevalence of ecstasy use, the
issue has nonetheless been the focus of some research.  Other drug use, including
amphetamine, LSD and cocaine, have received little or no attention in an Irish
context.
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The purpose of the current paper is to examine cocaine use in Ireland.  This
research coincides with renewed attention, in a European context, to suggestions
of a possible increase in the availability and use of cocaine.  Increases in cocaine
use across Europe have been visible since the late 1960s (Erickson, Adlaf, Murray
& Smart, 1987).  For example, studies in the United Kingdom have shown steady
increases in various indicators of cocaine use during the past 10 to 15 years
(Marsden, Griffiths, Farrell, Gossop & Strang, 1998; Ramsay & Partridge, 1999).
A recent British review of law enforcement figures, treatment statistics and other
key prevalence indicators, reveals a steady and significant upsurge in cocaine
use from 1991 to 1998, suggesting that the United Kingdom may be witnessing
the rapid spread of new cocaine use (Corkery, 2000). 
The primary aim of this current research was to investigate levels and patterns
of cocaine use in Ireland. The study was undertaken against a backdrop of
anecdotal and impressionistic evidence suggesting that cocaine is very much
'around', more easily procured than previously and making a conspicuous
breakthrough on the drug scene.  Hence, the research sought to locate and
analyse all available data identified as potentially useful in an assessment of the
extent and nature of cocaine use in Ireland. 
The multiple existing data sources used in the research are described in detail
below.  However, as a starting point, it is helpful to provide a brief overview of
the pharmacological properties of cocaine and the principal routes of cocaine
administration.
3.2 Pharmacological Dimensions of Cocaine and Modes of    
Use
Cocaine is a naturally-occurring substance derived from the leaves of the coca
plant, Erythroxylon coca, a shrub that grows in the Andean area of South America
(Fischman & Foltin, 1991).  It is an odourless, white crystalline powder and is
classified as a central-nervous system stimulant.  Cocaine was first extracted in
1855 and later became a popular stimulant and tonic.  Up until 1904 Coca-Cola,
the popular non-alcoholic beverage, contained small quantities of cocaine (ISDD,
1996).
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The most common form of ingesting cocaine is 'snorting' - sniffing fine cocaine
crystals via the nostrils.  By snorting, cocaine is conveyed into the bloodstream
via the mucous membranes of the nose and throat where it dissolves.  Cocaine
increases feelings of alertness and energy and produces intense euphoria.
Negative effects include anxiety, inappropriate levels of aggressiveness,
sleeplessness, sweating, impotence and heavy feelings in the limbs.  Very heavy
users of cocaine may report strong feelings of paranoia.
The smokeable form of cocaine is known as free-base, rock or crack cocaine. The
cocaine powder is converted into cocaine base and smoked, usually through a
pipe. Crack cocaine is processed with ammonia or sodium bicarbonate (baking
soda) and water, and heated to remove the hydrochloride.  Because crack is
smoked, the user experiences a shorter but more intense high than snorting the
drug (Corrigan, 1997; NIDA, 1999).  Crack cocaine produces effects far more
rapidly than the powder form and this, coupled with the shorter duration of the
euphoria, makes crack smoking a potentially highly-addictive substance.
However, neither tolerance nor heroin-like withdrawal symptoms occur with
repeated use of cocaine (ISDD, 1996).  Users may develop a strong psychological
dependence on the physical and mental well being afforded by the drug.
Finally, cocaine may be used intravenously, although this mode of ingestion is
less common and is viewed as dangerous by most cocaine users (Cohen, 1989).
Intravenous injection results in an almost immediate high within fifteen seconds
of injecting (Pinger, Payne, Hahn & Hahn, 1995).  Some drug users combine
cocaine powder or crack with heroin to produce a drug cocktail known as
'speedballs'.
Prolonged heavy cocaine use is usually followed by a 'crash' if use is
discontinued. This 'crash' is characterised by exhaustion, restless sleep patterns,
insomnia and depression (Erickson et al., 1987).  However, there is considerable
disagreement over what constitutes 'addiction' or 'dependence' in the case of
cocaine.  Furthermore, there is little consensus on who is susceptible to or at
greater 'risk' of cocaine dependence.  Waldorf, Reinarman & Murphy (1991), in a
study of 'heavy' cocaine users (users who the authors claim qualify as the most
serious 1 per cent of the cocaine-using population), found that even among this
group, a large number maintained a stable, although heavy, pattern of use over
several years without increasing their cocaine intake.  They add that 'it is
exceptionally difficult to predict which users will maintain control and which
will become compulsive' (Waldorf et al., 1991: 102).  
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Other research similarly concludes that many heavy cocaine users do not
become dependent (Erickson et al., 1987; Cohen, 1989; Chitwood & Morningstar,
1985).  Hammersley & Ditton (1994), in a study of Scottish cocaine users not
known via their criminality or contact with drug services, conclude that 'cocaine
can lead to protracted bouts of heavy or excessive use, but many users can then
stop or moderate use prior to encountering problems' (Hammersley & Ditton,
1994: 68).  
The accumulated research evidence on cocaine use across several jurisdictions
suggests that, among community samples of cocaine users (that is, users not in
contact with drug treatment services), even heavy users will not necessarily
develop symptoms normally associated with chronic drug dependence.
Reinarman, Murphy & Waldorf (1994), summarising three studies of cocaine
users (Warldof, Murphy, Reinarman & Joyce, 1977; Murphy, Reinarman &
Waldorf, 1989; Waldorf et al., 1991), concluded that addiction is not an inevitable
consequence of cocaine's pharmacological action on human physiology.  Rather,
both cocaine dependence and controlled use of the drug are contingent upon the
social circumstances of the user and on the conditions under which cocaine is
taken.  
On the other hand, Parker & Bottomley's (1996) study of crack cocaine users,
many of whom were known to drug services, revealed only a minority of
controlled users.  Among this group, there appeared to be a complex pattern of
dependency on both cocaine and heroin, whereby users were 'psychologically
hooked into rock cocaine but physically dependent on heroin' (Parker &
Bottomley, 1996: 36).  Other research indicates significant differences between
treatment and non-treatment cocaine users.  Chitwood & Morningstar (1985)
found that users in treatment were more likely than community samples to be
heavy rather than light users of cocaine, and to be unemployed and lacking in
support networks of close friends.
3.3  Research Methodology
There are three research components in this analysis of cocaine use in Ireland.
The first (see Section 3.4) examines existing, predominantly statistical, data
sources in order to identify emerging patterns and trends in cocaine and
base/crack cocaine use.  Relevant data from several sources, all considered to be
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Year Cocaine Heroin CannabisResin Ecstasy LSD
TABLE 3.1
Ireland 1990-1999.
Qu ntities (kg) of Cocaine and Other Drugs Seized by An Garda Síochána.
1990 1.009 0.578 114.76 N/A 90 u
1991 .031 0.161 1,101.62 429t 3,169 u
1992 9.850 0.794 498.47 271t 13,431u
1993 .348 1.285 4,200.31 744t 5,522 u
1994 .046 4.649 1,460.72 28,671t 16,634 
1995 21.800 6.400 15,529.00 123,699t 819 u
1996 642.000 10.800 1,933.00 19,244t 5,901 u
1997 11.020 8.211 1,247.88 17,516t 1,851 u
1998 333.167 38.340 2,157.24 604,827t 798 u
1999** 85.554 16.957 2,511.30 229,091t 577 u
Source: Annual Reports of An Garda Síochána, 1990-1999.
Qu ntities of ecstasy in tabs (t); LSD in units  (u).
** 1999 figures are subject to revision as all statistics were not analysed at the time of going to press. 
N/A = data not available.
key indicators of drug misuse, are presented.  The combined information from
the data sources listed below, covering a range of population segments, are
presented and analysed.
3.4.1 Law Enforcement and Supply Statistics
3.4.2 Drug Treatment Figures
3.4.3 School-Going, College-Going and General Population Surveys
3.4.4 Morbidity and Mortality
3.4.5 Qualitative and Ethnographic Research
Since no detailed empirical investigations of cocaine use have been undertaken
in Ireland to date, two additional components were incorporated into the
research in order to generate a more comprehensive picture of current patterns
of use and to assess dominant perceptions of the scale of the 'problem'.  The
emphasis in the first (see Section 3.5) was on accessing 'front-line' indicators, that
is, individuals working in the community and at street level who are well-
positioned to detect recent or 'new' local developments.  This is important since
available figures may not accurately reflect current drug trends owing to the
time-lag between the collection and the processing and publication of relevant
data.
Individual face-to-face and telephone interviews were conducted with a range of
informants including drug-service providers, An Garda Síochána, youth
workers, drug counsellors, general medical practitioners, hospital personnel,
night-club owners and a small number of key informants considered to have
experience of and insight into common and preferred drug-taking practices.  The
primary objective was to access the views, perspectives and concerns of
individuals who have direct knowledge and/or experience of cocaine users and
of the drug scene generally.  In this context, there was a specific focus on
uncovering information pertaining to the availability of cocaine, local drug
markets, trafficking/dealing/ distribution patterns, health consequences and the
negative repercussions of use.  In addition, interviews with drug-service staff
addressed the issue of service provision, including the needs of cocaine users
and implications for treatment intervention and other drug services.
Finally, in view of the widespread recognition of recreational or non-problematic
forms of cocaine use in other jurisdictions (Erickson et al., 1987; Cohen 1989;
Green et al., 1994; Hammersley & Ditton, 1994), a small-scale qualitative study of
adult cocaine users not in contact with drug-treatment agencies was undertaken
TABLE 3.2
Ir land 1990-1999.
Number of Drug Offences by Type of Drug. 
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Year Cocaine Heroin CannabisResin Ecstasy
1990 11 71 1,413 --
1991 7 45 2,354 45
1992 11 91 2,643 31
1993 15 81 2,895 66
1994 15 230 2,848 261
1995 30 296 2,209 645
1996 42 432 1,441 340
1997 97 564 2,096 475
1998 88 789 1,749 439
1999 169 887 3,281 1,023
Source: Annual Reports of An Garda Síochána, 1990-1999.
(see Section 3.6).  The primary aim of this exploratory research was to examine
respondents' use of cocaine and other drugs.  The research also sought to
examine attitudes to cocaine and other drug use, to investigate perceptions of the
risks associated with cocaine compared to other drugs, and to examine dominant
or preferred circumstances associated with the use of cocaine.  The selection
criteria and recruitment process are discussed in Section 3.6.
In summary, multiple sources were used in order to build a fuller picture from
partial data.  The orientation of the research is largely investigative, with each
segment of data feeding into a 'detective' approach (Douglas, 1976).  General
principles of analytic induction were applied to the examination of pre-existing
data and to data collected through face-to-face and telephone interviews.  This
approach involved establishing an initial description of the phenomenon and the
continued refinement of that analysis in light of further evidence collected in the
course of fieldwork.  The strength of this method lies in its capacity to consider
many alternatives and progress dynamically as opposing or corroborating
evidence appears (Adler, 1990).  Analytic induction was formulated by
Znaniecki (1934), and later refined as a procedure for verifying propositions on
qualitative data by Lindensmith (1947) in a study of opiate addiction.  It was
used by Becker (1963) in his classic study of marijuana users.  This research
orientation is particularly suited to gathering information in sensitive and
'hidden' areas of human behaviour (Stimson, Fitch, Rhodes & Ball, 1999).
3.4 Existing Data Sources and Other Relevant Empirical 
Research on Cocaine Use
In this section, the data pertaining to the use of cocaine (and other drugs) from
several key data categories are presented.  These include law enforcement and
supply statistics, purity levels, drug treatment figures, general population
surveys, school surveys, cocaine-related deaths, hospital morbidity and other
relevant research findings arising from ethnographic and qualitative studies.
3.4.1  Law Enforcement and Supply Statistics
The accuracy of police statistics are a subject of considerable debate (Bottomley
& Pease, 1986).  One of the main difficulties with law enforcement figures is that
they are not contextualised by reference, for example, to specific overt and covert
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operations or 'luck strikes'.  Differences in drug seizures might also reflect
variations in drug control strategies across time (Korf, 1992; South, 1995).
However, at a local level, drug seizure figures provide a useful broad indicator
or sensor of drugs supply and demand (Parker, Bury & Egginton, 1998).
Available statistics pertaining to seizure and offender data are provided in the
annual reports of the Garda Síochána (An Garda Síochána, 1990-1998).  Table 3.1
presents the figures for seizures of cocaine made by the Gardaí between 1990 and
1999.  Seizure figures for heroin, cannabis, MDMA (ecstasy) and LSD are
presented for comparative purposes.
Internationally, it is often estimated that approximately 10 per cent of all drugs
in circulation are intercepted (Boekhoutvan Solinge, 1998; Stimson, 1987).  Table
3.1 illustrates considerable variation in the quantity of cocaine seized by the
Gardaí  between 1991 and 1999.  A quite dramatic rise in the amounts seized is
apparent from 1995.  It should be noted, however, that the exceptionally large
amounts seized in both 1996 and 1998 make the data susceptible to being skewed
(Sutton & Maynard, 1993).  
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TABLE 3.3
Ireland, 1995-1998. Drug Treatment Contacts. Cocaine as Primary and
Secondary  Drug of Misuse. 
Numbers.
Year Cocaine as Main DrugAll Contacts First Contacts
Cocaine as Secondary Drug
All Contacts First Contacts
1995 24 10 67 21
1996 25 17 121 50
1997 42 22 195 48
1998 88 32 291 60
Source: National Drug Treatment Reporting System, Health Research Board.
The number of cocaine offences where proceedings commenced between 1990
and 1999 are presented in Table 3.2.  The figures for heroin, cannabis and ecstasy
are again included for comparative purposes.
The number of individuals charged with, or prosecuted on, a cocaine-related
drug offence is small compared to those relating to heroin, cannabis and ecstasy.
However, the figures do point to an increase in the number of offences where
proceedings commenced between 1990 and 1999.  Figures doubled between 1994
and 1995 and increased three-fold again by 1997, with 1999 producing the record
figure for cocaine-related drug offences.  'Offender' data do, therefore, suggest
that an increase in cocaine possession and supplying is occurring on the ground.
However, this same upward trend is evident in relation to heroin, cannabis and
ecstasy.  Law enforcement strategies need to be considered, therefore, when
assessing the quite dramatic increase in the numbers charged or prosecuted on
all drug-related offences during the latter half of the 1990s.  For example, it may
be related to measures taken during this period to extend and strengthen the
existing statutory framework for the control of drugs (see Loughran (1999: 328)
for a summary of drug-related legislation between 1996 and 1998).
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TABLE 3.4
Ireland 1997-1998. Residents of Health Board Areas Presenting with Cocaine
as Primary and Secondary Drug of Misuse within each
Health Board Region. 
Numbers and Valid Percentages.
Area
All Contacts, 1997
number %
Cocaine as
Primary Drug
number %
Cocaine as
Secondary Drug
All Contacts, 1998
number %
Cocaine as
Primary Drug
number %
Cocaine as
Secondary Drug
EHB 30 (.7%) 173 (4.2%) 58 (1.1%) 263 (5.2%)
SHB 3 (1.2%) 7 (2.7%) 12 (4%) 7 (2.3%)
NWHB __ __ __ __ __ __ 1 (2.1%)
MHB __ __ __ __ __ __ 1 (1%)
WHB __ __ __ __ __ __ 1 (7.1%)
MWHB 4 (4.0%) 2 (2.0%) 3 (3.1%) 2 (2.1%)
NEHB 2 (2.2%) 4 (4.3%) 2 (1.6%) 1 (0.8%)
SEHB 3 (1.9%) 5 (3.2%) 9 (4.5%) 5 (2.5%)
Source: O'Brien et al., (2000).
Finally, drug-product data is determined from analyses carried out by the
Forensic Science Laboratory of the Department of Justice, Equality and Law
Reform.  These analyses are conducted on drugs seized by the Gardaí.
Information from this source indicates that the purity of cocaine has dropped
over the past three years, from 62 per cent in 1996 to 38 per cent in 1998.  It
should be noted, however, that these figures may not accurately reflect the
purity level of cocaine at street level, as no empirical evidence on such a link is
available.
3.4.2  Drug Treatment Figures
Unlike heroin, no specific drug is used for the treatment of cocaine dependence
and there are no prescription figures that can be used as a proxy measure of
cocaine dependence.  Hence, data pertaining to individuals receiving treatment
for drug-related problems are an important indicator of the level and extent of
cocaine use among this group.
The National Drug Treatment Reporting System (NDTRS), operated by the Drug
Misuse Research Division (DMRD) of the Health Research Board (HRB), reports
data on treatment provided by statutory and voluntary agencies countrywide.  It
is the primary national source of epidemiological information about drug
misuse, providing annual figures on the uptake of services as well as socio-
demographic data on clients receiving treatment.  The regularity of data
collection makes it possible to identify changing patterns and trends in the use
of particular drugs across time.  Between 1990 and 1994, data were collected in
the Greater Dublin area only, but coverage was extended to the whole country
in 1995 (O'Brien &  Moran, 1997).  One of the main advantages of more recent
figures pertaining to individuals receiving treatment is that they are regionally
sensitive.  It should be remembered, however, that the figures relate to those
problem drug users who present to services, and not to all those who have a
drug problem, or indeed all those who use drugs.   The number of cocaine users,
even heavy users, outside treatment is likely to be far greater than those who
seek treatment (Waldorf et al., 1991).
HRB figures consistently indicate that opiates are the primary drugs of misuse.
Four out of five individuals presenting for treatment in Dublin during the period
1990 to1996 reported opiates as their main drug of misuse (O'Brien & Moran,
1997).  In 1998, 55.7 per cent of first treatment contacts reported heroin as their
primary drug of misuse (O'Brien et al., 2000).
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In this section the number of clients reporting cocaine as a drug of misuse in
treatment services is examined.  It should be pointed out, however, that because
the development of drug services in Ireland has been orientated towards
problem opiate use, cocaine users may not be attracted to these settings. Table
3,3 illustrates the number of individuals presenting with cocaine as a primary
and secondary drug of misuse during the period 1995 to 1998.
Here we find a clear and consistent increase in the number of all and first-contact
clients presenting with cocaine as a drug of misuse during the period 1995-1998.
This increase is most dramatic among individuals reporting cocaine as a
secondary drug of misuse.  The figure for all persons who made contact with
drug-treatment services reporting cocaine as a secondary drug of use, shows an
increase of over 400 per cent during the period 1995-1998.  Individuals
presenting with cocaine-related problems were more likely to be male than
female.  Of the forty-two who reported cocaine as a primary drug of misuse in
1997, thirty-seven were male and five female.  The gender breakdown for 1998 is
somewhat similar, with seventy-three males and thirteen females reporting
cocaine as a main drug.  For the year 1998, 72.5 per cent of clients presenting with
cocaine as either a primary or secondary drug of misuse were male (O'Brien et
al., 2000).
It is important to consider the figures for cocaine misuse in the context of overall
drug treatment figures.  Taking the 1998 figures as an example, out of a total of
1,625 first contacts nationally, the majority (904 individuals, or 55.7 per cent of
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the total client group) reported heroin as their primary drug of misuse.  This
figure was followed by 24.8 per cent reporting cannabis, 7.4 per cent ecstasy, 2.5
per cent methadone, 2.3 per cent amphetamine and 2 per cent reporting cocaine
as their main drug of misuse (O'Brien et al., 2000).  Hence, individuals reporting
cocaine-related drug problems constitute a relatively small proportion of the
total number presenting for the first time with drug-related difficulties.
Looking then at the regional breakdown of reported cocaine-related problems
among all contacts within each of the health board areas during 1997 and 1998
(see Table 3.4), we find that individuals reporting cocaine as either a primary or
secondary drug of misuse are concentrated within particular health board
regions.   
The largest number of contacts stating cocaine as a drug of misuse were resident
in the Eastern Health Board region.  This is hardly surprising given that the
majority of treated contacts countrywide occur within this same region.  The
Southern Health Board and South Eastern Health Board areas had the next
highest proportion of treated cocaine contacts in 1997 and 1998.
TABLE 3.5
Ireland, 1990-1998.
Numbers of Drug-Related Deaths.
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Year All Ages Age 15-49Years
1990 7 7
1991 8 7
1992 14 14
1993 18 16
1994 19 19
1995 43 39
1996 53 50
1997 55 52
1998 99 90
Source: Central Statistics Office.
It is clear from the available figures that greater numbers of individuals than
previously are presenting with cocaine-related difficulties.  However, cocaine is
clearly more likely to be a secondary than a primary drug of misuse.  Individuals
are less likely to present with cocaine-related difficulties, compared to other
drug problems, most notably those related to the use of heroin, benzodiazepines,
cannabis and ecstasy.  
3.4.3  School-Going, College-Going and General Population Surveys
In Ireland, there is an absence of data, collected at regular intervals, on drug use
among the general population and concerning specific groups, including young
adults and adolescents. Furthermore, because differing methodologies have
been utilised across available surveys, it is difficult to compare drug prevalence
rates and establish accurate trends. This section will report on all available data
pertaining to cocaine use in school-going, college-going and general
populations.
Survey research in Ireland has concentrated primarily on studies of secondary-
school students.  Grube & Morgan's (1986) study of drug use by 13-16-year-olds
in twenty-four randomly-selected schools in the greater Dublin area found a
lifetime prevalence rate of 1.5 per cent for cocaine, with 0.7 per cent having used
the drug during the month prior to completing the questionnaire.  This figure is
low compared to 13.2 per cent who had ever used cannabis and 12.9 per cent
who reported the use of glue/solvents at some stage in their lifetime.  Grube &
Morgan's (1990) follow-up study revealed an increase of 0.2 per cent in the
numbers reporting past month use of cocaine.  Brinkley et al.'s (1999) more
recent survey of rates and patterns of substance use among Dublin post-primary
pupils did not report on cocaine use.
The most recently-published national study of drug use by adolescents, carried
out in 1999 as part of the European Schools Project on Alcohol and Drugs
(ESPAD), found that 2 per cent of students aged 15 and 16 years reported
lifetime experience of cocaine (Hibell et al., 2000).  This figure is identical to that
recorded in the 1995 national survey (Hibell et al., 1997). The figures for lifetime
use of crack -  3 per cent in 1995 and 2 per cent in 1997 - are surprisingly high,
given that reported use of crack is generally considerably lower than that for
cocaine among adolescents. For example, the 1998 British Crime Survey revealed
that while 3 per cent of 16-19-year-olds reported lifetime use of cocaine, only 1
per cent reported the use of crack (Ramsay & Partridge, 1999). 
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TABLE 3.6
Ireland 1994-1998. Psychiatric Hospital Admissions
with Diagnosis of Cocaine Use (ICD 10/F14).
Year All Ages
1994 18
1995 7
1996 8
1997 5
1998 9
Source: National Psychiatric 
In-Patient Reporting System,
Health Research Board.
As with other drugs, including cannabis, ecstasy and amphetamine, regional
surveys outside Dublin suggest somewhat lower cocaine prevalence rates than
those reported in Dublin samples.  A survey of post-primary school students in
the Mid-Western Health Board region found that 1.3 per cent reported lifetime
use of cocaine and 0.4 per cent were current users of the drug (Gleeson, Kelleher,
Houghton, Feeney & Dempsey, 1998).  Jackson's (1997) survey of drug use in
Cork and Kerry revealed a lifetime prevalence rate of 1 per cent for cocaine.  A
much smaller proportion (0.1%) reported current use of the drug.
The figures above concur with findings related to school-going populations in
the United Kingdom (Barnard, Forsyth & McKeganey, 1996; Balding, 1998) and
suggest that cocaine use is relatively rare among adolescents, certainly compared
to other drug use.  Available figures indicate only a slight increase in the number
of Irish adolescents reporting lifetime experience and use of cocaine during the
past two decades.
Rather less is known about drug use among college students.  A recent survey of
drug exposure and alcohol consumption among 366 health service attendees at
a Dublin university, revealed cocaine lifetime prevalence rates of 7.1 per cent for
males and 4.9 per cent for females.  This compared to a lifetime prevalence rate
of 50 per cent for cannabis, 16.5 per cent for ecstasy and 10.5 per cent for LSD
(Denehan, Clarke & Liossis, submitted).
Few national surveys of drug use prevalence have been undertaken in Ireland.
A survey carried out in 1998 by the Health Promotion Unit of the Department of
Health and Children and the Centre for Health Promotion Studies, National
University of Ireland (NUI), Galway, examined the lifestyle, attitudes and
nutritional status of people in Ireland.  Cocaine use during the twelve months
prior to the completion of the questionnaire was reported by 1 per cent of
respondents (Friel, NicGabhainn & Kelleher, personal communication).  This is
consistent with findings in the United Kingdom, where cocaine use remains at
low levels of around 1 per cent or less of adult populations (Baker & Marsden,
1994).
In summary, although surveys suggest that drug use is increasingly a feature of
youth culture (Hibell et al., 1997; Brinkley et al., 1999; Hibell et al., 2000), cocaine
use remains rare among school-going adolescents and has shown little sign of an
increase during the past two decades.  Lifetime prevalence among the general
population is currently running at approximately 1 per cent.
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TABLE 3.7
Ireland 1994-1998.  HIPE Figures for Hospital Disc arges with Principal
and Seco dary Cocaine-Related Diagnoses. 
Numbers.
1994 1995 1996 1997 1998
Cocaine Dependence (ICD 304.2) 2 9 11 11 13
Non-Dependent Drug Abuse (Cocaine) 5 20 9 11 19
(ICD 305.6)
Accidental Poisoning (Cocaine) (E855.2) 0 5 4 10 4
Source: Hospital In-Patient Enquiry System, Economic and Social Research Institute.
3.4.4  Morbidity and Mortality
Both morbidity and mortality statistics are of limited value in the estimation of
drug use and drug problems in general (Garretsen & Toet, 1992).  However,
available data relating to morbidity and mortality are presented as an indicator
of the extent to which cocaine is implicated in death or illness.  
Mortality statistics are based on death certificates, which usually contain
information on socio-demographic variables and on the cause(s) of death.
Throughout the 1990s there has been a marked increase in the number of drug-
related deaths throughout Europe. This upward trend appears to be more
pronounced in Ireland than in other European countries (EMCDDA, 1999). The
numbers of deaths where drugs were the direct cause of death, during the period
1990-1998, are presented in Table 3.5 and reveal a dramatic increase in drug-
related deaths during the 1990s.
A recent analysis of drug-related deaths investigated by the Dublin City and
County Coroners in 1998 and 1999 (Byrne, 2000) reveals that cocaine was
implicated in six out of a total of eighty-six opiate-related deaths in 1998 and six
cases out of seventy-seven in 1999.  Only in one of the 1998 cases, however, was
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death attributed directly to cocaine overdose, with five of the six cases having
two or more drugs implicated in addition to cocaine.  Heroin was implicated in
all six of the cocaine-related deaths in 1999 and the quantity of heroin revealed
in toxicology tests was higher than that for cocaine (Byrne, 2000).
Hospital psychiatric data are available from the National Psychiatric In-Patient
Reporting System (NPIRS), which collects data on admissions and discharges
from public and private psychiatric hospitals and units countrywide.  It provides
information on gender, age, marital status, socio-economic status, legal status,
diagnosis and length of stay (O'Brien & Moran, 1997).  Despite considerable
debate about the potential of some illicit substances to cause psychiatric
problems, as well as the role of pre-existing psychiatric conditions in the
development of drug problems, co-morbidity remains a major concern as
elevated levels of drug consumption are found among those with mental health
problems (Commission on Narcotic Drugs, 2000). The figures for admissions to
psychiatric hospitals with a diagnosis of cocaine use (ICD-10/F14)1 during the
period 1994-1998 are presented in Table 3.6. 
1 As defined by The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and
diagnostic guidelines, of the World Health Organisation (1992).
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The Hospital In-Patient Enquiry (HIPE) Scheme, operated by the Economic and
Social Research Institute, is a system designed to collect medical and
administrative data regarding discharges from acute hospitals.  Information
from private hospitals is not included in this database.  One difficulty with these
data is that each HIPE discharge represents one episode of care.  As a result,
double-counting may occur where patients have been admitted to hospital on
more than one occasion with the same or different diagnoses.  Consequently,
these records provide a better indicator of hospital activity than of the incidence
of disease.  Data relating to principal and secondary diagnoses of cocaine-related
discharges are provided in Table 3.7 below.
The figures recorded for the diagnosis of cocaine dependence (ICD 304.2) have
remained relatively stable during the period 1995-1998.  Those for non-
dependent drug abuse (cocaine), on the other hand, have tended to rise slightly
in recent years, albeit from a low base.
Accepting that mortality and morbidity data are not reliable tools for estimating
drug use or drug problems, they can, in association with other data sources, help
to improve the interpretation of available information.  Cocaine is implicated in
relatively few deaths, certainly when compared to heroin. Admissions to
psychiatric hospitals with a diagnosis of cocaine use indicate no clear upward
trend since 1994.
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TABLE 3.8
Face-to-Face Interviews 
Individual Interviews Number ofInterviews
Drug Service Staff 5
Youth Worker 1
Youth Work Co-Ordinator 1
Key Informants 2
Garda 1
Night-Club Owner 1
Hosp tal Personnel 1
Drug Cou sellors 2
General Practitioner 1
Total 15
TABLE 3.9
Telephone Interviews 
Telephone Interviews Number ofInterviews
Student Welfare Service 2
Youth Workers 2
Project Worker s (Young People) 2
Drug Service Staff 2
Liaison Midwife 1
General Practition rs 3
Garda 1
Hospital Personnel 1
Prison Staff 1
Total 15
3.4.5  Qualitative and Ethnographic Research
Qualitative methodologies are particularly suited to accessing 'hidden' drug
scenes (Wiebel, 1990).  An additional advantage of qualitative research in the
drugs research field is that it provides detailed knowledge about types and
levels of drug involvement as well as important details pertaining to the
lifestyles, attitudes and motives of drug users.  However, only a small number
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TABLE 3.10.
Issues Addressed During Face-to-Face and Telephone Interviews.
Interviewees Issues Addressed
Drug Service Staff Numbers presenting with cocaine-related difficulties (stable,
increase, decrease) / Evidence of crack cocaine? / Cocaine as a
primary drug of misuse? / Treatment needs of cocaine users /
Implications for treatment and service provision.
Key Informants* Who is using cocaine (age group/background/SES)? / Availability,
cost and purity? / Is cocaine more accessible than previously? / In
what kinds of settings is use taking place? / Patterns of use
(regular/recreational/occasional etc.)?
Gardaí Drug seizures and arrests: have the figures for cocaine changed
dramatically in recent years? / Any indicators of increased
availability of cocaine at street-level? / If yes, how have the Gardaí
responded to this 'new' development?
Youth Workers Is there evidence of increased use of cocaine among young 
(within ‘high risk’ localities) people? / Any evidence to suggest that cocaine is easier to access
and/or more affordable than previously? / What are the dominant
perceptions of the 'risks' associated with cocaine use? / Are youth
workers adequately equipped to respond to current drug use
trends?
Night-Club Owners Which drugs are most visible/available on the club/dance scene? /
Any evidence of cocaine use? / If so, when did this come to your
attention? / Is cocaine more easily available than previously? / Cost
and accessibility?
General Practitioners Numbers presenting with cocaine-related difficulties (stable,
increase, decrease) / Evidence of crack cocaine/ cocaine as a
primary drug of misuse / Treatment needs of cocaine users /
Implications for treatment and service provision.
Hospital Personnel Any evidence of cocaine emerging as a drug of choice? /  Accident
and emergency admissions?  
* Key informants are individuals who have experience of and contact with the drug scene and are considered
to have knowledge and insights that may contribute significantly to the data collected from other sources.
of such studies have been conducted in an Irish context.  Mayock (2000)
investigated drug use and non-use among a sample of fifty-seven young people,
aged between 15 and 19 years, including abstainers, drugtakers and problem
drugtakers, in an inner-city Dublin community.  In this study, very few of the
young people described as drugtakers (drug users who did not consider their
drug use to be problematic) reported the use of cocaine at any time, and of those
who did (n=2), it was generally a one-time experience.  Cocaine use was far more
prevalent among problem drugtakers (young people who considered their drug
use to be problematic).  All of the young people in this 'problem drugtaker'
category (n=18) reported heroin as their primary drug of misuse.  The vast
majority (n=14) also reported lifetime use of cocaine and nearly 20 per cent
reported cocaine use during the week prior to interview.  In general, cocaine use
occurred subsequent to heroin initiation and was frequently used in conjunction
with heroin and other drugs (mainly benzodiazepines).  Most users of the drug
reported the intravenous use of heroin and cocaine, a drug cocktail known as
'speedballs'.  The reports below provide some insight into the nature of this
group's cocaine involvement.
Interviewer: When did you start using cocaine?
Respondent: Am, there was a big drought on and everyone was just, there was no 
heroin, so everyone was taking coke.  I was taking tablets like for me 
sickness, I was going round stupefied on tablets, d'ya know what I 
mean, and then the coke just ... everyone just got strung out on coke.
(Female, 18.1 years)
Interviewer: Did you use coke when you were on gear?
Respondent: Yeah, used to mix it.  Used to wash up the coke into the drugs, like cook 
the gear into the works, bung the two of them into me together.  Then 
I would be gettin' a buzz like off the coke and then when I'm coming 
down off the coke the gear would bring me down nice.
(Male, 19.1 years)
Finally, McElrath & McEvoy's (2000) qualitative study of ecstasy users in
Northern Ireland revealed that 43 per cent of respondents had tried cocaine
powder.  The mean age of the sample (n=106) was 25 years (range 17 to 45 years).
Cocaine use appeared to be sporadic, not regular, and only one respondent
reported snorting cocaine on a monthly basis during the six months prior to the
Cocaine Use In Ireland: An Exploratory Study
101
interview.  This finding suggests that cocaine was one of numerous drugs tried
or used by this group of young recreational poly-drug users.
3.4.6  Conclusion
The question of how many people are using illicit drugs is notoriously difficult
to answer.  The dearth of regular prevalence studies at both national and local
levels, using uniform or comparable methodologies, compounds this problem.
However, the difficulties associated with establishing accurate and reliable drug-
use prevalence estimates is not just about the absence or paucity of relevant
survey data.  The illegality of drug use ensures that the activity is undertaken
inconspicuously and that many drug users remain hidden.  The best way, in the
present situation, to assess the extent of particular forms of drug use is to utilise
all available data from a wide range of sources (Choquet & Ledoux, 1990; Hay,
1998).
Accepting that available sources such as survey and other empirical data can
produce, at best, imperfect approximations, there are a number of conclusions
that can be drawn from the data presented above. First, there is some evidence
to suggest an increase in the supply of and demand for cocaine.  Extensive use
of the drug, however, is not apparent among the general population.   While
there is a general upward trend in drug experimentation among school-going
teenagers, cocaine is far less likely to be used than cannabis, ecstasy, LSD and
amphetamine.  Among adult population samples, use appears to be restricted to
a minority.  The difficulty with these findings, however, is that they fail to
uncover substantial knowledge about individuals who do use cocaine. 
At the other end of the drugs spectrum are individuals who develop drug
problems.  Many, though not all, are known to drug treatment services. While
heroin remains the primary drug of misuse among drug users who seek
treatment, available figures suggest that cocaine is currently more likely to be
cited as a secondary drug of misuse.  Irish drug treatment data indicate that
cocaine is rarely clients' primary problem.  Yet, there is evidence to suggest that
the drug repertoires of long-term 'problem' drug users have extended to include
a larger and more diverse range of substances including, among others,
benzodiazepines and cocaine (Farrell, Gerada & Marsden, 2000; Rooney, Kelly,
Bamford, Sloan & O'Connor, 1999).  However, while cocaine is clearly available
and increasingly likely to be used, it is clearly less endemic, certainly compared
to heroin, benzodiazepines, cannabis and ecstasy.
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3.5 Views of Service Providers 
and Key Informants on the Cocaine 'Problem'
As stated earlier, this component of the research was concerned with accessing
current perceptions of the extent and nature of the cocaine 'problem', from the
perspectives of individuals working, or in regular contact, with drug users.  The
value of this data relates to its potential to report on current and 'new'
developments on the ground.  Tables 3.8 and 3.9 provide a breakdown of the
number and range of individuals interviewed face-to-face and by telephone.
Efforts were made to incorporate a cross-section of respondents, in terms of the
nature of their experience of drug users and the drug scene.  Table 3.10
summarises the issues addressed in the case of each 'subgroup' of interviewee.
Separate interview schedules were designed for the respective 'subgroups' of
study respondents where appropriate.
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Interviewing took place during May 2000. Face-to-face interviews were tape-
recorded and partial transcripts of this material prepared.  Detailed notes were
taken both during and after telephone interviews.  The major issues and themes
arising from these data are documented in this section.  The presentation of
findings concentrates on the key questions outlined in Table 3.10 and on other
issues raised by informants in the interviews.  For the purpose of clarity and
structure, the findings are presented under three broad headings: cocaine
availability, the extent and nature of cocaine use and implications for drug
treatment and service provision.
3.5.1  Cocaine Availability
The majority of respondents believed that cocaine was more easily available than
previously.  Across the range of individuals interviewed, there was a definite
consensus on increased accessibility and use of the drug.  A spokesperson from
the Garda National Drug Unit described the current situation vis-à-vis cocaine
availability in the following terms.
We are quite aware that cocaine is being used and offered for sale, particularly in certain
areas.  If we look at the statistics in relation to cocaine for say 1998, that shows quite an
amount of cocaine being seized.  We have 333 kilos and 167 grams.  This is a huge
amount.  Now some of that of course, came from major seizures.  But, coke has become
more popular.  I would have no hesitation saying yes, it is more prevalent.
(Garda)
Several respondents involved in the delivery of drug treatment stated that they
had become aware of an increase in the supply of cocaine within the areas where
they worked, particularly during the past year.  
You hear about it more and it's almost becoming a substitute drug for heroin.  With the
availability of methadone now people's need for heroin isn't so great.     
(Drug Counsellor)
Similarly, many professionals working with young people in communities
where drug use is concentrated drew attention to a shift in the local drugs
market towards increased cocaine availability.
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There is a strong sense that it's out there alright.  I've no concrete evidence from the
group we work with but a very strong sense that it's out there and available.
(Youth Work Co-Ordinator)
My impression is that during the past year or year-and-a-half there has been a lot of
selling going on and a good bit of use.  Yeah, it's definitely amongst problem drug users
and I think that you'd probably find a good number of urines testing positive for
cocaine.
(Youth Worker)
Other respondents highlighted the apparent decrease in the street price of
cocaine and felt that this served as a further indicator of the changed nature of
availability and use of the drug.
It would seem now at the moment that a half a gram can be as low as £25.  A number
of years ago it was £300 a gram.  Now it is down to between £60 and £80 a gram.  One
thing that is noticeable is that the price varies depending on where you buy.
(Drugs Worker)
It is also significant that a number of individuals involved in the provision of
methadone treatment reported a conspicuous upsurge in the proportion of urine
samples revealing quantities of cocaine during the latter months of 1999 and the
early months of 2000.  Although this trend appears to have since abated, doubt
was expressed, in some cases, about the validity of the assumption that a
decrease in the percentage of urines revealing cocaine can be reliably viewed as
an indicator of a downward trend in cocaine use among clients receiving
treatment.
The prevalence rate (of cocaine in urines) would appear to be running at around 3 per
cent of the known drug users, the ones in treatment.  Again, I think that's probably
coloured by the fact that cocaine is short-lived in the system.  Drug users can very easily
get around the system and continue to use cocaine.  If say, somebody is clear of every
other drug and they're on weekly take-outs it's not a big deal for them to make sure that
they don't use two days before they come in to pick up their methadone.  So how much
of an indicator it is I don't know.  There certainly was a peak in the three months of
December, January and February but that seems to have gone down again.  Now
whether it is that it's been challenged and drug users are altering their behaviour or
whether they've just managed to work the system, I don't know.
(Drugs Worker)
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It is important to state that the perceived increase in cocaine availability and use
was associated with particular geographical locations in the Dublin area, which,
in the absence of more definitive evidence, will remain unidentified in this
paper.  However, the most likely localities to be mentioned included two specific
areas associated with concentrations of known drug users.  A range of
respondents, including drug service providers, general practitioners and the
Gardaí, drew attention to particular 'pockets' of high cocaine availability.
From the point of view of gaining insight into individuals in the community who
do not identify themselves as drug users per se, interviews were conducted with
a number of key informants with knowledge of, and/or contact with, the
recreational drug scene.  These respondents indicated that cocaine was currently
more visible on the club/dance/drug scene than previously.  It was also
suggested that this trend was accompanied by increased acceptance of cocaine as
a drug of choice.
I'm not into cocaine myself and I don't really hang out with people who are, ya know,
but I know of people who are.  I know it's become a usual thing for lots of people. It's
just a natural normal thing that they do.  There's definitely some people who get more
into it and prefer to do coke and there's also that thing where it's seen as a slightly, you
know, more prestigious.  Coke has always been seen as a middle class drug; for people
who have money essentially.  You can link it directly in this country to the economic
situation.  People have more money, they're more affluent and cocaine is a more affluent
drug.                                                            
(Key Informant # 1)
The majority of respondents stated that there was little evidence to suggest that
crack cocaine was making a breakthrough on the drug scene.  However, one
interview with an ex-cocaine dealer and former crack cocaine addict suggested
some use of 'home-made' crack cocaine among particular networks of drug
users.  This respondent described himself as 'in recovery' at the time of
interview, having previously had a chronic cocaine and heroin problem.  He
stated that he had been involved in the distribution of cocaine, both within and
outside of the Dublin area, for several years.  
I went as far as South Dublin and out of Dublin to deal.  I would travel, yeah.  And
people would travel from everywhere ta me or else, if they couldn't make it I'd make me
way out ta them.  Inner-city, apartments as well, ya know, well-ta-do people ...
everywhere ... this would be sellin' cocaine.  On most occasions I would have ta wash it
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up for them, turn it into crack for them like.  Very few would actually just, very few
people I actually dealt with were buying it ta snort, they were buying crack.
[But people say that there's no crack around?]
I hear this, and I've said it to [name of friend], and it actually makes me blood boil 'cos
there's a big problem out there like and it's like, look at heroin in the 80s.  It was actually
around before then but no, it's nothing, it's only a handful of people, that's what they
said.  And look at it now!  And there's as much coke out there now as heroin.  It's so
easy to get, ya know.
(Key Informant # 2)
Overall, the data points to increased awareness of the presence of cocaine, its
availability on the street, and its potential to become a drug of choice for both
recreational and problematic drug users.  
3.5.2  Nature and Extent of Cocaine Use
The identification of drug use patterns at local level is difficult to quantify and
requires specialist research (Parker et al., 1998).  Hence, the aim here is not to
advance evidence on the extent of cocaine use generally or among particular
sub-groups of the population.  Rather, the emphasis is on documenting
perceptions of what is occurring on the ground, based on the reports of
individuals who have regular contact with drug users.
A conspicuous feature of informants' reports was that despite the general belief
concerning increased cocaine availability, many simultaneously felt that they
had no concrete evidence of cocaine's emergence as a major issue, certainly
compared to heroin and other drug use.  In particular, respondents felt unable to
estimate the extent of cocaine use in the communities where they worked.  There
appeared to be a number of important factors associated with this absence of
clear evidence or knowledge of cocaine's 'position' or status as a drug of use.
First, respondents felt that cocaine use was extremely hidden and consequently,
unlikely to come to their attention.  Secondly, according to a large number of
interviewees, cocaine users are unlikely to perceive their drug use as problematic
and accordingly, are unlikely to seek treatment or advice of any kind in relation
to their cocaine consumption.
I'm not sure that this area is awash with cocaine but what I would have a sense of is that
the ones who are using cocaine are not in touch with services because they don't really
see themselves as having a problem.
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(Drugs Worker)
You see, young people wouldn't seek treatment around that.  Young people do come
forward for treatment but it's mostly for heroin.  They wouldn't see their use of cocaine
as something they can get help for, or that they need help for.
(Youth Worker) 
The picture that I'm getting is that the young people who start using coke don't see
themselves as having a drug problem because they're not on heroin.  So, heroin is still
the biggie in people's perceptions and by taking coke you're avoiding having a drug
problem.
(Drug Counsellor)
However, a number of professionals working in the delivery of drug treatment
at community-level did report direct experience and evidence of cocaine use and
considered this development to be a recent one.  All stated that users were far
more likely to be smoking or injecting cocaine than using the drug intranasally.
Although most of the people who access this service have an opiate problem, I have had
contact with cocaine users.  One person I'm thinking of now started using on holidays
overseas and later developed a dependency.
(Drug Counsellor)
I think it (cocaine) is a serious problem, it's been a serious problem for quite a while.
There's a lot of it going around in the flats.  And we have an ongoing struggle with
people on treatment who might be doing fairly okay as regards the heroin but dabbling
or more than dabbling with cocaine. 
(Drug Service Coordinator)
Two respondents made specific reference to cocaine use among women.  This is
particularly noteworthy in view of the findings of a recent study of drug-using
women working in prostitution in Dublin city (O'Neill & O'Connor, 1999).  Of
the seventy-seven women interviewed for the purpose of the research, forty
reported use of cocaine in the previous month.  Following heroin and
benzodiazepines, cocaine emerged as the next likely drug to be used.  
Most of the clients who report cocaine use to me are women.  And all of them say that
it's very difficult to get off the drug, more difficult than heroin.  These women would
also be working on the street and there seems to be a link between the two.
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(Drug Counsellor)
Despite several examples of reports of cocaine use by clients, the dominant
concern among respondents involved in the delivery of drug treatment remains
firmly on problems related to heroin use.  There was general agreement,
however, that cocaine was far more likely than previously to be a secondary
drug of misuse.  Many respondents made reference to the practice of
'speedballing', which involves the simultaneous intravenous use of cocaine and
heroin.  This practice was described by one of the study's key informants (a
former heroin addict) in the following terms:
What I did then was I made speedballs.  Ya know what a speedball is?  Ya put your
heroin on the spoon and cook it up, have your coke in the works, ya suck it up.  The
effects ya get from that!  You're straight up in the air, like your head feels like it's goin'
to go 'bump'.  It's a great feelin'!  And then ya sorta come down then nice and easy.
It's the sorta feelin' (pause), it's unbelievable.  It'd frighten ya at first 'cos ya think
you'll die but this feelin' ya get from it it's, ya know, it takes all the pain away and all
this shit, that's what it's there for at the end of the day.
(Key Informant # 2)
Several respondents acknowledged that 'speedballing' was a common practice
and a number drew attention to the health implications of injecting risk
behaviour.
What we would find here is that most people are speedballing, they're using a
combination of heroin and cocaine together.  So, in terms of harm reduction and looking
at issues around health, the same difficulties will arise if people are using needles and
injecting cocaine.
(Drugs Worker)
Furthermore, respondents consistently drew attention to dominant risk
perceptions and felt that drug users were unlikely to perceive cocaine use as
posing serious health risks, certainly compared to those associated with heroin.
There is an implicit danger here, if, as perceived, cocaine is increasingly gaining
acceptance and is more commonly in use.
I think the preference here [at the service] among drug users has been for the type of
effects that heroin gives.  Cocaine would not be seen by most of them as abuse.  It would
be seen as recreational.  They don't see it as such a problem.
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(Drugs Worker)
Heroin, as I said before, has that dirty, filthy, low-life thing and all of that, even though
it hits all walks of life.  Cocaine is looked at, 'ah, it's alright, it's only a line a coke'
(Key Informant)
I think that the dominant perception is that cocaine is primarily a recreational drug, just
as hash is understood as a recreational drug.  The effects aren't as dramatic or rapid.
And this is a problem too because I would certainly meet people who have serious
problems with cocaine. 
(Drug Counsellor)
It is important to point out that not all of the respondents reported concern about
cocaine use among their client group.  This is important since it suggests that
particular settings and services may be more likely than others to attract cocaine
users.  A number of respondents stressed that opiates and benzodiazepines
remained their overwhelming concern.
We have heroin problems and all sorts of other problems, tablets and all that.  But from
my point of view, and this is just an overview, we don't get cocaine coming up as a
major issue.  And it seems to me that there's a couple of angles on that, if we generally
accept that heroin is the drug of choice.  People will dabble with cocaine, but that's it,
they'll dabble but they'll revert to heroin.  So, cocaine might be cheap on the streets, they
might go for that for a while, it may become problematic with them but they quickly get
out of it and back almost to the safety of heroin, the known substance, the known area
like. 
(Drugs Worker)
Finally, while concern was expressed by the majority of respondents about an
apparent increase in the availability and use of cocaine, the problem was not
considered to have reached epidemic proportions, as yet, or to merit being
perceived as 'out of control'.  One informant, who previously worked with
cocaine and crack cocaine users in London, drew a clear line of distinction
between the situation in Dublin and that which prevailed in London a number
of years ago, particularly in terms of service needs and responses.
A serious crack problem developed and all of a sudden agencies were inundated with
these people and nobody could relate to them.  And we had to do a lot of training to
adjust to dealing with these people because it was totally different.  The way you'd
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approach a heroin user, you wouldn't approach a crack user like that.  But we're not
getting that here. (Drugs Worker)
To summarise, cocaine use was judged to be far more widespread than
previously.  However, respondents found it difficult to estimate the scale or
extent of use among their client groups, or in the community at large.  While the
majority felt that the cocaine 'problem' was not comparable to that relating to
heroin, they identified cocaine use as an issue requiring attention also.
3.5.3  Implications for Drug Treatment and Service Provision
Interviewees engaged in the provision of services to drug users were asked
whether the needs of cocaine users can be adequately met within the context of
existing treatment interventions.  Considerable variation emerged among this
group on the appropriate way to address cocaine use in the context of existing
services.  While some respondents felt that specific tailor-made interventions
were required to deal with the needs of cocaine users, others believed that
current services needed to develop the knowledge and expertise required to
deliver appropriate intervention and counselling.  Some respondents stated that
their agencies had already attempted to address the issue informally.
I would say that there is a need for separate interventions.  It's a separate drug, a
separate addiction, one which can't be treated like heroin.  If the two drugs are lumped
in together, then it follows that they're going to be used together.  If cocaine users are
in a methadone clinic they're bound to pick up the habits that are all around them. 
(Drugs Worker)
I do think it's a different kind of problem and one of the reasons it's different is that there
doesn't seem to be the same physical withdrawal difficulties but there is an enormous
psychological withdrawal and psychological cravings.  So what we've done here is
supported the person as best we could, get them into counselling and we would also have
treated them with acupuncture.
(Project Worker)
I think that as an agency we've already started to change our approach, even in thinking
what services can offer somebody who might have a dependency on cocaine.  There's no
medical treatment so we have been looking at some level, looking at ways that we can
provide appropriately as a service.
(Drug Counsellor)
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More critical perhaps than the lack of agreement on appropriate interventions
was the fact that several interviewees involved in drug treatment delivery felt ill-
informed and ill-equipped to deal with the presenting behaviours and problems
of cocaine users. In addition, a number of respondents drew attention to the
absence of information on cocaine use and related risk behaviours at community
level.
They've [drug users] had more information, more education on heroin so maybe they
haven't had enough information about cocaine.  Initially, they don't have a fear of
cocaine because they would believe that it isn't addictive.
(Drug Service Co-ordinator)
Prevailing perceptions of the risks associated with cocaine use were considered
to be a compounding factor.  One informant stressed the importance of
contextualising current perceptions of drug-related risk when attempting to alter
behaviour and beliefs about cocaine.
It's largely a methadone culture and that's the context I'm speaking in.  And methadone
is perceived as the solution to the problem.  And for people who are seriously dependent
on cocaine and want help, the belief is that methadone is the solution for them as well
and therefore, they want methadone treatment.  That's the perception in the
community.  So we would have had to be quite strong in helping people to understand
that it's a totally different drug and that there's absolutely no point putting the person
on methadone, that you're actually introducing them to opiates.  But this is all
understandable in the context of a strong heroin and methadone culture.
(Drugs Worker)
Most respondents agreed that there was a need for more information and
training on the effects of cocaine, the presenting behaviours of cocaine users and
appropriate treatment and intervention options.
3.5.4  Conclusion
Using existing data systems, including available data on drug users, Section 3.4
found that opiates remain the primary drugs of misuse among drug users who
access treatment.  Despite this, subtle indicators of a shift in the drugs landscape
were apparent, suggesting increased likelihood of cocaine use among
individuals whose main drug of misuse was heroin.  The reports of drugs
workers confirm this trend.  A large number stated that clients are now more
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likely to present with cocaine-related problems and the majority felt strongly
that cocaine was more readily available and accessible than previously.  The risk
of 'microdiffusion', that is, the dispersal of drugs knowledge, practices and
techniques through established user networks (Parker et al., 1998), may be
substantial if, as indicated, cocaine is making a breakthrough on the drug scene.
Further research is required to qualify and quantify a possible spread of cocaine
use among problem drug users. In particular, the nature of the relationship
between heroin and cocaine, one known to be complex (Bottomley, Carnwath,
Jeacock, Wibberley & Smith, 1997), requires investigation.  Qualitative research
is likely to be the most feasible means of accessing these 'heavy-end' and hidden
drug scenes (Brian, Parker & Bottomley, 1998a).  Preferred routes of cocaine
administration and related risk behaviours need particular attention in this
context.  Blanken & Barendregt (1997) note that the Dutch cocaine smoking
epidemic was restricted mainly to heroin-dependent persons. Furthermore,
Grund, Adriaans & Kaplan's (1991) investigation of cocaine use in a sample of
heroin addicts in Rotterdam found that the mode of ingestion paralleled that of
heroin: injecting drug users injected cocaine-hydrochloride and heroin smokers
smoked cocaine base.  The authors documented the distribution of 'gekookte
coke', otherwise known as 'cooked', 'base' or 'rock' cocaine, by a particular sub-
population of drug users.  The preparatory process is identical to that described
by one of the current study's key informants, a former user and supplier of
'homemade' crack cocaine.
Well, basically all ya do is (pause) ya can add ammonia.  That's a lazy way ta do it.  I
call it the lazy man's way a doin' it.  Ya put your coke on the spoon, your gram a coke
or whatever ya have on the spoon, ya pour a dribble of ammonia over it, light a flame
underneath it.  It's like cookin' heroin.  It bubbles like fuck and it goes inta sort of an oil
and ya leave it cool or else ya can drain it off.  Ya rinse it with cold water then, ya don't
heat it up again, ya just rinse it with water 'cos if ya do that it'll just dissolve inta ...
And then ya take it off.  And ya know a hash pipe?  Like a seven-up bottle or something.
Instead of using tobacco ya use the ash off the cigarette.  It has ta be fresh ash.  So like
you'd have one ashtray for cigarettes, for puttin' out your cigarette.  You'd have
cigarettes burning everywhere but ya wouldn't put the cork out on it 'cos ya want the
ash.  Ya just break bits a lump off it and whatever and (inhales) ya smoke it and ya get
your couple a seconds hit.
(Key Informant # 2)
At present, there is no way of establishing either how widespread the practice of
'cooking' (or 'rocking') cocaine is, or how prevalent this technique is among drug
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users.  However, problem opiate users are far more likely to be injecting or
smoking than to be snorting cocaine (Grund, Adriaans & Kaplan, 1991).
Research is required to explore dominant and preferred patterns of cocaine use
among both treatment and community samples of heroin users.  Brian et al.'s
(1998a) follow-up investigation of continuity and change in crack cocaine users'
drug careers in north-west England found that, owing to crack's negative image,
dealers sold it as 'rock' or 'stone', particularly to new, younger users.  Knowledge
about the marketing of cocaine, including users' accounts of initial points of
contact with the drug, and acquired (or recommended) techniques of use, would
greatly assist targeted strategies, including advice on harm minimisation,
particularly to 'high-risk' young drug users.
Finally, the treatment needs of individuals who co-abuse opiates and other
substances require attention.  Rooney et al. (1999), comparing Irish drug users
who are dependent on opiates and benzodiazepines with drug users who are not
dependent on benzodiazepines, found that the former group tended to take
more drugs in general.  Thirty-five per cent of those dependent on opiates and
benzodiazepines used cocaine, compared to 13.8 per cent of the opiate users not
dependent on benzodiazepines.  More recently, Farrell et al. (2000) analysed the
results of urine tests for opiates, benzodiazepines and tricyclics carried out in
five addiction clinics across the Eastern Health Board area and found that 65 per
cent tested positive for benzodiazepines.  The authors conclude that this high
rate of positivity indicates 'a major problem of poly drug misuse which requires
urgent and concerted attention' (Farrell et al., 2000: 8).  Further confirmation of
extensive poly-drug use among heroin users can be found in Byrne's (2001)
analysis of 254 opiate-related deaths investigated by the Dublin City and County
Coroners in 1998, 1999 and 2000.  This research identified poly-drug use as a
major risk factor associated with fatal drug overdose.  A single drug was
implicated in only a minority (6.7%) of fatalities, with heroin implicated in 61.8
per cent, benzodiazepines in 70.5 per cent, methadone in 56.7 per cent and
cocaine in 6 per cent of cases.
Despite considerable evidence indicating poly-drug use, including cocaine use,
among individuals who seek treatment for heroin-related problems, relatively
little is known about the nature of combination or poly-drug-using careers. This
represents a significant gap in knowledge, given the likely range of treatment
challenges arising from the current tendency, across Europe, for heroin users to
become poly-drug users (Brian, Parker & Bottomley, 1998b).  Bottomley et al.
(1997) note that, in general, research has provided little guidance as to how drug
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services can help problematic cocaine users, or, for that matter, how this group
of users might be attracted to services.  Reporting on the findings of a
community survey of cocaine users, the majority of whom reported an opiate-
using history, the authors recommend a service response combining the medical
treatments offered by community drug teams with an accessible drop-in service
and an outreach initiative of peer education, as an appropriate intervention for
crack cocaine users.  
Drugs workers and service providers in the current study expressed concern
about increased availability and use of cocaine among their client groups.
However, it also seems clear that some services are currently more likely than
others to be treating clients who report the use of cocaine.  Consequently, the
lack of consensus on appropriate treatment and intervention responses to
cocaine use is not altogether surprising.  More critical perhaps, is the fact that
drug workers felt that they lacked adequate knowledge and understanding of
cocaine use among their client groups, including information on dominant user
practices and the effects, risks and health consequences associated with the co-
abuse of heroin and cocaine.
3.6 Exploratory Study of Social/Recreational Cocaine Use
Population surveys in Ireland identify few cocaine users.  However, anecdotal
evidence suggests that cocaine is easily available and its use more widespread
than previously was the case.  In this exploratory study of social/recreational
cocaine use, the research challenge was to locate and gain the co-operation of a
small number of adult cocaine users in the community, who are not currently
attending, and who have at no stage contacted, a drug treatment centre.  In other
words, the emphasis was on accessing individuals who do not identify
themselves as having a drug problem.  The principal aim was to 'capture' users
not normally accessible through treatment or other institutional settings and to
examine patterns of use and attitudes to cocaine. 
3.6.1  Study Parameters, Research Instruments and the Recruitment Process
The study's selection criteria, in terms of past and current cocaine use, was
deliberately broad.  No strict or binding guidelines pertaining to precise levels of
drug intake were applied at the outset of the selection procedure, owing to the
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absence of prior empirical research on cocaine use in an Irish context.  However,
to qualify for participation in the study, respondents had to have used cocaine at
least five times during their lifetime, preferably at least once during the past
year.  Other criteria for entry to the study, in addition to some experience with
cocaine, were that participants must be 21 years of age or older and must have
been employed for at least six of the twelve months prior to interview.  
The purpose of the research was not to ascertain how many people use cocaine,
but rather to gain some insight into reported patterns of cocaine use among a
small group of social users.  Hence, the central concern was not one of
generalisability but one of access.  In this context, the guiding principle was 'less
is more' (McCracken, 1988:17).  McCracken (1988), who describes the key
characteristics of the long interview, recommends working longer and with
greater care with a small number of people, and suggests that eight respondents
are sufficient for many research projects.  
The research aimed to generate knowledge and insight into cocaine use by adults
not associated in problematic drug consumption, a phenomenon not previously
researched in an Irish context.  Ten adult cocaine users were interviewed in-
depth during May/June 2000.  The questions addressed in the context of
individual interviews included how users first came into contact with cocaine,
how their use progressed from the time of initial use, past and current cocaine
use, how they regulated their intake of the drug, typical cocaine-using contexts,
availability, cost and quality of cocaine, the benefits of cocaine, perceptions of
risks associated with use, and the appeal of cocaine. Importantly, the research
examined respondents' use of a range of mood-altering substances, so that
cocaine was not examined in isolation from other drug use.
Study respondents were accessed initially via the researcher's personal contacts
with potential participants. This gradually facilitated access to other individuals
through 'snowballing', whereby, additional respondents were recruited through
the recommendations of individuals previously interviewed.  This technique is
well-known in the drugs research field and is particularly suited to
investigations of illicit and hidden activities (Biernacki & Waldorf, 1981; Power,
1989).  
In an effort to access a range of cocaine-related experiences, attempts were made
to contact a variety of user networks.  The recruitment task proved more difficult
than originally anticipated, particularly during the early stages of establishing
A Collection of Papers on Drug Issues in Ireland
116
contact with cocaine users.  Prospective participants were sceptical about the
intentions of the research and understandably reluctant to divulge details about
their drug use.  They invariably asked questions about the purpose of the study
and about the publication of study findings.  The challenges to recruitment were
overcome by gradually extending access routes and by providing assurances of
anonymity and confidentiality.  The recommendations of key informants
(individuals who had contact with cocaine users) greatly facilitated this process.
The time invested in the selection of participants resulted in six user networks
across the sample.  All interviews were tape-recorded.  Choice as to the time and
place of the interview rested with the participant.  Interviews took place in a
variety of settings including the researcher's office (n=1) or home (n=1), a public
venue (n=3) or at the home of the respondent (n=5).  
Biographical details and drug history were recorded for each respondent using
a pre-coded, structured questionnaire.  This included details of each
respondent's age, gender, education, employment, household situation and
current income.  Lifetime, past month and past week drug use, as well as future
drug intentions,  were recorded for each individual participant. All respondents
resided in Dublin city.  The study does not claim to be representative of
social/recreational cocaine users generally.  Rather, it is illustrative of a 'mode'
of cocaine involvement among adults who do not consider their drug use to be
problematic.  
The protection of informants' identities was a priority throughout the research.
No names, addresses or contact numbers were recorded on the pre-coded
questionnaires.  In addition, all identifiers (place names, birth place, current area
of residence and so on) were removed from transcript material and fictitious
names substituted in all cases for the purpose of reporting the study findings. 
3.6.2  Data Analysis
Full transcripts of nine of the ten individual in-depth interviews were prepared.
A partial transcript was prepared for one interview owing to poor conditions at
the interview site, resulting in a high level of background noise.  This partial
transcript was reinforced by note-taking both during and after the interview.
The findings presented here are based on a thematic analysis of all transcript
material.  Boyatzis (1998) describes thematic analysis as a 'process for encoding
qualitative information' (Boyatzis, 1998: 4) and clarifies the meaning and use of
themes for analytic purposes.
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TABLE 3.11.
Lifetime, Recent and Future Use of Cocaine and Other Drugs (n=10).
Drug LifetimeUse
Past Month
Use
Past Week
Use
Future Drug
Use*
Cannabis 10 10 8 10
Ecstasy 10 7 4 7
LSD 10 1 1 2
Amphetamine 10 0 0 1
Cocaine 10 8 4 9
Heroin 3 0 0 0
Methadone 2 0 0 0
Magic Mushrooms/ Psilocybin 9 0 0 3
Glue/Solvent 2 0 0 0
Tranquillisers 3 0 0 0
Other 6 0 0 0
* Respondents were asked to state which drugs they intended to use in the future.
A theme is a pattern found in the information that at a minimum describes and
organises the possible observations and at a maximum interprets aspects of the
phenomenon.
(Boyatzis, 1998: 4)
In other words, a theme is not merely a 'fact' or set of facts extracted from the
data but a pattern that presents itself throughout a data set.  Themes provide a
useful interpretative structure for understanding the phenomenon of interest.
The data were coded manually in accordance with the research aims, and
ancillary codes were added as the fieldwork process advanced.  In this way, the
analysis incorporated both predefined categories and those that emerged
directly from respondents' accounts of their cocaine use.
Interpretation of the results has to be qualified by a number of study limitations.
First, the research is based solely on self-reports of frequency and quantity of
drug consumption of a small number of informants, all of whom were resident
in Dublin city at the time of interview.  Second, the sample was opportunistic or
one of convenience. Accordingly, it would be inappropriate to generalise the
findings to cocaine-using adults generally. 
A number of techniques were employed throughout the data collection and
analysis phases of the research to ensure valid and reliable findings.  The
safeguards concerning confidentiality and anonymity help to validate the
responses.  Moreover, the questioning and data collection techniques employed
meant that the consistency of cocaine and other drug use reported by
respondents could be checked.  All respondents were asked about their drug use
(lifetime, past month and past week use) on two separate occasions during the
interview.  This data were also recorded on a questionnaire.  One hundred per
cent consistency was found in respondents' reports in nearly all cases.
The presentation of research findings focuses, first, on the socio-demographic
characteristics of study respondents.  Baseline data on cocaine and other drug
use are then presented.  The analysis moves then to present a more detailed
description of respondents' use of cocaine, including the circumstances
surrounding use, the appeal of cocaine, the negative effects and perceived
benefits of cocaine use and risk perceptions.  The issues of availability, price and
purity are also examined.
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3.6.3  Socio-Demographic Characteristics
Eight males and two females were interviewed individually. The average age of
the research respondents was 27.3 years (range 25-29 years).  Nine of the ten
interviewees were born in Ireland.  One was born in the United Kingdom but
had been residing in Ireland for several years.  
The educational attainment for the sample was high.  All had completed their
Leaving Certificate or equivalent and all attended a third-level educational
institution.  Eight of the ten respondents graduated with a third-level degree or
diploma.  At the time of the interview, eight were employed full-time and two
part-time.  All had experienced periods of unemployment ranging from two
months to six years. It is significant, however, that in most cases, stated periods
of unemployment coincided with time spent travelling abroad and extended for
between one and two years.  Two respondents declined to state their current
gross annual income.  Of the eight who did, annual incomes ranged from £10,000
to £30,000.  Seven of the ten respondents were earning in excess of £20,000 per
annum and five had a gross annual income of between £25,000 and £30,000.
Finally, all respondents resided in Dublin city.  All were single and over half
(n=6) lived with a partner.  Three respondents lived with friends and one with
her child.  All respondents resided in a rented private-sector house or apartment.
3.6.4  Patterns of Cocaine Use and Routes of Administration
This section provides baseline data on the respondents' reported cocaine use.
The average age of initiation into cocaine use was 21.2 years and half (n=5)
reported first use between the ages of 20 and 23 years.  On average, respondents
had a cocaine 'career' of 6.5 years since initiation.  Eight of the ten respondents
had used cocaine at least once during the month preceding the interview.  The
most popular mode of cocaine ingestion was 'snorting', or intranasal use of the
drug.  Two respondents reported having ingested the drug orally on a number
of occasions and a third stated that he had smoked cocaine in a 'joint'.  This was
the only reported method of smoking cocaine.  In fact, the majority were not
familiar with the practice of 'freebasing' and did not regard this mode of
administration as a future drug option.  
Cocaine typologies have been devised by several researchers, based on
participants' reported frequency and intensity of use (Hammersley & Ditton,
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1994; Waldorf et al., 1991; Ditton, Hammersley, Philips, Forsyth & Khan, 1996).
This technique was not utilised in the current study owing to the small sample
size.  However, it is helpful to summarise general patterns of cocaine use for the
sample.  Following initiation, the majority did engage in subsequent use for
some time (in some cases, for two to three years).  Overall patterns of cocaine use
varied considerably across the sample.  Although a number (n=4) reported
bingeing on cocaine, the duration of such 'bouts' of use were short, and most
(n=6) had not used cocaine for more than two consecutive days.  Monthly use
emerged as the most frequently-reported current pattern of use; daily cocaine
use was not the norm for this group of users.  Nine of the ten respondents
intended to use cocaine in the future.  The remaining participant stated that she
may well use cocaine at some time but had no definite plans to do so in the
immediate future.
3.6.5  Other Drug Use
Practically all respondents were experienced users of a range of illegal drugs.
Table 3.11 presents the figures for lifetime, past month and past week use of
cocaine and other drugs.  Drug intentions are also included on this table.
Alcohol and tobacco, being licit drugs, are referred to independently.  Six of the
ten respondents were current smokers and all consumed alcohol on a regular
(two to three times weekly) basis.
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The average age of drug initiation for the sample was 15.8 years (range 13 to 19
years).  Five respondents were 17 years or over at the time of first drug use. Table
3.11 indicates that respondents had tried or used a range of substances.  All
reported lifetime use of cannabis, ecstasy, LSD and amphetamine.  Nine had
used magic mushrooms (psilocybin).  Three respondents reported lifetime use of
heroin; two had used methadone; two tranquillisers; and two solvents or
inhalants at some stage.  Lifetime use of other substances not listed included
opium (n=2), mescaline (n=2) and 'crystal meths' (methamphetamine) (n=2).
Cannabis was by far the most commonly-stated drug of initiation, and LSD and
psilocybin (magic mushrooms) were frequently-stated second drugs used (n=7).
Seven of the ten respondents were regular cannabis users (weekly or fortnightly
users) and a significant number (n=6) reported past month use of ecstasy.  A
large number reported concurrent drug use, that is, the use of two or more
substances in close succession for the attainment of specific or heightened drug
experiences.  The most popular drug cocktails were alcohol and cocaine; alcohol
and cannabis; ecstasy and cannabis; cocaine, ecstasy and cannabis; and ecstasy
and cocaine.  Cannabis was considered to be compatible with most drugs and
was frequently smoked subsequent to the ingestion of another substance.
Nearly half the respondents (n=4) reported daily or near-daily use of cannabis.  
Nine respondents intended to use cannabis and cocaine at some stage in the
future and a large number expected to use ecstasy (n=7).  Considerably fewer
intended to use LSD (n=2), psilocybin (n=2) or amphetamine (n=1).
3.6.6  First Use of Cocaine
Respondents were asked to describe the circumstances surrounding their initial
use of cocaine.  In practically all cases, use was initiated in the company of
friends in a social setting where alcohol and/or other drugs were being
consumed.  The majority stated that they had contemplated cocaine use in
advance of first experimentation.  However, while most stated that they
intended to try cocaine at some stage, first use usually occurred incidentally.  For
this reason, first cocaine experiences were often free.
With friends at a party under the influence of another drug which was Ecstasy.  I hadn't
planned it as such but I had expressed an interest in taking it before that night anyway.
I was up and ready for it but I hadn't planned it.
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I was with some other musicians and they had it.  It's a social drug and they were
sharing it. At that time I was only starting to dabble with that kind of stuff.  Someone
asked me did I want some so I tried it.
For a smaller number of respondents (n=3), first cocaine use involved some
advance planning.  
I got it through friends.  I asked to get it.  I got it for a party.  And I was in my early
20s at the time, about twenty-two.
At the time of initiation, most shared approximately one gram of cocaine with
two or three friends, the typical intake being 'two or three lines' or 'a few lines'.
Informants frequently reported drinking alcohol and/or using one other drug
(either cannabis or ecstasy) at the time of initial cocaine use.  The majority
reported first cocaine experiences in positive terms.
It was amazing.  Down there (abroad) anytime I got it, it was absolutely amazing.  I
could really see the attraction in it ... it was weird being so high but so clear.  I suppose
it was a very confident buzz I got out of it.
I thoroughly enjoyed it, yes it was good.  It has similarities to other stimulants as such
but I would certainly differentiate between that and ecstasy or speed.
Only one respondent stated that he was not impressed with the drug at the time
of first use and asserted that he 'didn't really see what the attraction was'.  Most
agreed that subsequent cocaine experiences were superior to first or early use
episodes.  A process of learning to recognise and appreciate cocaine effects
clearly accompanied the initial stages of use.
I remember being able to deal with it and just kind of recognise the buzz and again it
was probably just a learning thing going on.
There is not a huge kick off it [cocaine] which is why I think you don't know what to
expect at first and maybe after the second time you probably ... you can tell people 'that
was crap' and they say 'well, did you not feel this' ... and then you say, 'well maybe I
did'.  And then the next time you have probably talked yourself into the buzz, what you
are supposed to feel.
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At the time of first use, practically all respondents had previously experimented
with and used a range of stimulant and hallucinogenic drugs.  In fact, cocaine
was commonly listed as fifth or sixth drug ever used.  On average, there was a
five-and-a-half-year time lapse between first drug use and first cocaine use.
Hence, the majority were 'experienced' drug-takers at the time they first tried
cocaine.  None expressed any doubt, scepticism or anxiety about the prospect of
using cocaine when describing the circumstances surrounding first use of the
drug.  Hence, although cocaine initiation occurred later in respondents' drug
'careers', it was not an unexpected or unanticipated event.  
3.6.7  Frequency and Contexts of Cocaine Use
All respondents were asked explicit questions about the frequency and quantity
of their cocaine use generally.  However, during questioning, there was a
particular focus on two specific periods - use during the two-to-three-year
period subsequent to initiation, and cocaine consumption during the two years
preceding the interview.  Hence, early and current use of the drug were
examined in detail, in order to construct typical patterns of cocaine use across
time. Given the substantial drug history of respondents prior to first cocaine use,
coupled with frequent reports of using cocaine in association with alcohol and
other substances, cocaine use is examined here with reference to respondents'
use of a range of substances. This section will describe respondents' cocaine use,
in terms of the frequency, intensity, intake and duration of use.  The
circumstances and locations associated with use are important components of
this analysis.
As stated earlier, there was a considerable time-lapse between first and more
regular use of cocaine.  Hence, while cocaine initiation took place, on average, at
the age of 21, more consistent use of the drug did not emerge for quite some
time.  Use of the drug was sporadic initially, and appeared to be dictated largely
by economic factors: cocaine was expensive and most respondents had not yet
secured their first job.  Availability was an additional factor that appeared to
deter regular use at this stage.
In those days I was a student and I had fuck all money anyway, you know.  And a lot
of the time when you're in that scenario, you probably get in with somebody and get to
know somebody who has a contact somewhere else.  Or, they might be dealing
themselves or be able to get it irregularly or cheaply.  And coke wasn't one of those kinds
of drugs that you could get easily.  And when you got it, it was never cheap.
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When I was 21, £80 or £70 for a wrap of coke plus your drinking, plus getting into a
club … I just couldn't do it.  £150 out of your pocket for a night, I just couldn't do it
... and I wouldn't have had it myself because I wouldn't really have known the people
that you would get it from, so it would have been a real hit and miss thing which will
change as you go along because you will find people who sell it.
Consequently, early use of cocaine was intermittent and viewed largely as a
'treat', or an extravagant drug for special occasions.  At this stage, other drugs
were more likely than cocaine to be in use, largely because they were more
economical and easier to procure.
I'd say it was more sporadic [for several years after first use], you know.  If it was
available and if I had the money in my pocket I'd get it.  But if there was other stuff
available I wouldn't bother.  I'd go the cheap route because number one it's [other
drugs] cheaper and number two, it'll go further.
There were huge gaps between when I would take it, so it would be months between
taking it.  It could be two or three months before a similar party or circumstance would
come up.  But it was always party generated, you know, because of the nature of it.
It is significant that among this group of informants, in their mid- to late-
twenties, most had only started to use cocaine more regularly during the past
three years or less.  Current frequency of use varied across the group.  The
largest number (n=7) reported monthly use of cocaine.  One stated that he had
used cocaine approximately eight times during the past year.  For two others,
use was less regular and less deliberate: some respondents did not secure a
regular personal supply of the drug and described their current use as
occasional.
It is very rarely an arranged thing.  It would be a case of somebody saying 'I have two
grams of coke, does anyone want to go in on it?'  That is probably the extent of my
cocaine use at the moment.  I wouldn't be a huge fan, I don't really see the value in it,
shall we say.
One respondent reported having reduced her cocaine intake from former, more
regular and intense consumption levels, including two 'bouts' of use when she
used cocaine several times weekly.  
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Given that regular cocaine use was quite a recent development for the majority
of respondents, it is important to examine how they described this drug
transition.  As stated previously, all respondents reported a sizeable repertoire
of drugs prior to cocaine initiation.  A large number were current, regular
cannabis users. In addition, practically all had gone through a short phase of
LSD use and a sustained phase of ecstasy use, ranging from several months to
two years.  While ecstasy was described in positive terms, the majority drew
attention to the negative effects of regular, heavy use and indicated a definite
shift from this particular 'style' of ecstasy use.  Most stated that while they
currently used ecstasy on occasions, they had quit regular weekend use of the
drug.
I don't do E that often any more.  I used to alright but, ah, just too much hassle now
with the come down an' all.  But yeah, I used to love it and would still do it but not in
the way I used to.  Takes too long to recover.  
I haven't done any [E] for a long time.  It is so physically draining for me to take, you
know, you take an E and for a couple of days you are just not really as sharp as you
normally should be.  You are not really on the ball.  It takes an awful lot out of you.  I
haven't taken acid in a couple of years either and that's the same, it knocks you for six.
Many perceived cocaine to be a lighter, more manageable drug.  First, cocaine
did not induce powerful physical effects during use, certainly compared to
ecstasy.  Second, it did not produce profound negative side-effects during the
days following use. Both factors emerged as primary motives for a reduction of
ecstasy (and LSD) intake on the one hand, and increased cocaine use on the
other.
I know if it is a line or two of coke I still find I can go about my daily routine.  If I take
ecstasy I know I won't feel the best the next day but Es are a funny thing.  Sometimes
you take one and you find that you can be in a pub atmosphere, enjoy a pint or two and
its not too heavy.  And then sometimes you take another and whatever is in it, you're
just gone.
In comparison to ecstasy, physically with ecstasy it is hard to get up the next day and
get through it, you know, you have black rings under your eyes.  Usually on ecstasy
you're higher than you are on cocaine, even if it is really good cocaine.  And then
mentally with ecstasy, you know sometimes you have to have a couple of days to recover
from the night out as such.  Coke does not have that effect, not on me anyway.  It is far
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easier to just go out and have a good time with some coke and get up the next day and
either go to work or just get through the day and not be in a hassle.
Respondents' preferred circumstances of cocaine use varied but most favoured a
relaxed setting in the company of friends.  Respondents regularly drew attention
to the circumstances of use and considered the setting to be a strong determinant
of positive drug experiences.  
Sometimes the buzz with coke is a bit better than others because of purity I suppose.  But
it is 90 per cent circumstances.  I am not saying that circumstances completely override
the quality of coke at the end of the day, you know, if you are a relatively seasoned user.
But at the end of the day when I look back at nights when I have taken coke or taken some
other drug it is usually the circumstances and the company that I keep and whether I
am enjoying myself, and my current state of mind.  They are usually the predominant
factors in how good the night was, you know.
A majority preferred to use cocaine in private, rather than public, social settings.
Situations in which people wished to communicate and enjoy the company of
friends were most frequently mentioned as those where cocaine use occurred.
Less frequent, but visible also, were situations in which people wanted to dance.
I prefer to use coke in a house.  Yes, with a few friends in the house.  I have used it in
clubs before but you wouldn't be using there often because you can't use it openly, you
know.
It would be mostly at home or in the pub you might slip into the jacks and have a quickie
in the coke sense.  But generally it would be in a house situation.  It is not really
conducive to doing in a public place in that there is a little bit of preparation and that
involved.  You have to get it out into a line and it is not the ready-made package that
our friend ecstasy is.
I'd be inclined to use cocaine in quieter more laid back circumstances ... say there was a
weekend of music somewhere, a festival or something like that.  I'd make up my mind,
like I'd go for coke or for a few tablets as well, you know.
Taken on its own [cocaine] you are elated and you are aware of yourself but you are
aware of yourself as being full of confidence and you feel really sexy and especially say,
if you are dancing or you are in a club.
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Most respondents reported using cocaine in a social setting at night-time (either
at home or out).  However, a small number had also used cocaine during the day
on occasions, although this was by no means a preferred or usual practice.
The last time I took coke was two weeks ago.  It was in the middle of the day and I was
sitting in.  I was away for a week and I was sitting in the house drinking cups of coffee
and smoking joints.  And we decided it was time to hit the town so it was about mid-
afternoon, something like that.  And I had a line, went out, spent the whole day buzzing
around and would have had maybe two or three more lines that night.
From the reports of respondents it could be inferred that cocaine use is strongly
related to lifestyles where going out, social gatherings and socialising are
dominant.  For the most part, cocaine use was confined to weekends and holiday
times, when there was sufficient time to 'recover' and fewer potential negative
repercussions from use or over-indulgence.  In addition, cocaine use was
strongly linked with alcohol consumption.  A number of respondents
commented on the compatibility of alcohol and cocaine.  In fact, cocaine was
rarely, if ever, consumed alone.  Although descriptions of use varied, cocaine-
using scenarios invariably incorporated the use of other mood-altering
substances, including cannabis, alcohol and, less frequently, ecstasy.
It is a drug you tend to mix as well, primarily with alcohol now, the two, for whatever
reason seem to combine.  Now medically they could be the worst thing for you, I don't
know, but from a results or effects point of view they mix well and you tend to drink
more and you tend to sit around and you would be in considerably better form, not
really sure why, considerably better form.
Coke and alcohol are a very crucial mix for a night.  If you are doing coke you have to
have some booze so I would say that that goes hand in hand with the amount of booze
you are going to go through.
Hash may or may not come into it as well.  If we're out drinking and are back in
someone's house we might have a smoke or not.  I actually like mixing ecstasy with a
bit of coke too, you know it's good fun.  You get a good energy and physical [pause], an
energetic rush from the ecstasy both mentally and physically and taking it with a bit of
coke also maintains the same kind of rush that you would have got from ecstasy.  So it
is almost prolonging the effect that you get from ecstasy.  They are both stimulants so
they are both doing the same kind of thing but ecstasy makes you more amorous and
friendly to others and you would be less likely to talk about yourself.
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Current frequency of use was strongly linked with economic factors.
Individuals with more disposable income were far more likely to use monthly or
weekly.  One respondent stated that cocaine was simply not economical and that
he could not afford to buy the drug regularly.  Compared to other drugs,
cocaine's short-lived effects relative to its high cost rendered other drug choices
more cost-effective.
For the same money, if you want to compare them as regards what the user gets out of
it, you get a much better night or a much better hit of six Es which is the equivalent [cost
wise] as a gram of coke.  It think it [cocaine] is very expensive and prohibitively
expensive which is probably a good thing because if it got any cheaper, it would become
a lot more popular very quickly because I have noticed an increase in its popularity in
the last year, year and a half.
On a scale of drugs that I'd take, it would probably be the least common drug that I'd
use.  Um, because for value for money, it's the worst.  Because you could actually buy
a gram and consume the whole gram in one night.  So that's eighty quid, gone, whack.
Whereas you could get a good quality ecstasy tablet for a tenner that would last you the
whole night.  So, it's down the list for me anyway.
Other respondents, by contrast, stated that their current income permitted more
regular use of cocaine than in the past.
Well, at first it was never really something that I went out of my way to go off and take
and then when I had a bit more disposable income and I was growing tired of other
drugs that I had taken, ecstasy really, then I started doing it a bit more.
As a young adult I couldn't really afford it whereas now I can afford it so there is that
sort of thing.
One respondent attributed his increased cocaine consumption during the past
year to a heavy workload, resulting in more stress and fatigue.
It [cocaine intake] has probably increased a little this year.  I don't know why really?
Probably work because I am working a hell of a lot more and so, I would have two nights
off.  And I kind of go for it big, kind of a more intense night out.  And that is probably
one of the reasons for it.  Plus, in the last few months ... it gives you that sort of a pick
up.  Because at the moment I have changed job so I am working more hours and am more
tired.
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The study's regular users of cocaine generally restricted use to weekends, when
their intake of the drug ranged between one and two grams per session.  Most
reported periods of abstinence ranging from one to several months.  While a
number of informants stated that there were times when they had exceeded their
usual intake, bingeing on cocaine was not a common practice.  Cocaine was
rarely used on more than two consecutive days.
I suppose in the past I may have taken a load of coke and not slept, had a meal or
something like that and then started a session again if there was a particular reason to
be on a party buzz.  And then I may have done it two nights in a row, sometimes I
suppose three but I have never gone on a complete weekender without any sleep.
I've never actually taken coke for more than like two days or something like that.  I've
never gone on a binge of coke.
One respondent did report two separate phases of intense and regular cocaine
use.  On both occasions, the individual had easy access to the drug and did not
have to pay a high price for a 'good' supply.
I have gone on coke sprees.  I remember one in particular and it was really, really good.
About three years ago it was with my boyfriend's friend.  He had loads of it and it was
pure and when I think about that, it is interesting because now that I remember it, it
was great because there wasn't any comedown.  I think I have particularly bad
comedowns because of what it is mixed with.  But he was giving us the good stuff.
To summarise, while frequency of cocaine use varied across the ten respondents,
it was possible to identify a number of distinct patterns of use.  The largest group
of cocaine users (n=5) had previously used a range of other stimulants (ecstasy
and amphetamine) and hallucinogenic drugs (LSD and magic mushrooms) and
had significantly curbed their intake of these substances.  Respondents regularly
drew attention to the cumulative negative effects of sustained ecstasy use and to
the lengthy recovery period following use. In this context, cocaine had
increasingly emerged as a drug of choice.  This shift also appeared to coincide
with significant lifestyle changes.  In particular, respondents reported increased
career commitments.  Importantly, this group of mid- to relatively high-earners
had more disposable income than previously.  Cocaine was considered to be a
'cleaner' drug, and use did not impinge on routine responsibilities, which
centred largely on professional and career considerations.  This sub-group
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engaged predominantly in weekend cocaine use, with frequency of use varying
between one and four times monthly. 
Four additional respondents described a pattern of less regular cocaine use.  This
group's drug preferences did not focus as strongly on cocaine and they reported
more regular use of other drugs.  While cocaine-using occasions were sometimes
planned, most occurred by chance.  For this group, cocaine was not a primary
drug of use and was more likely to be used intermittently and incorporated into
a wider poly-drug repertoire.  Finally, one participant, a former regular cocaine
user, had not used cocaine for several months.  
In general terms, the broad picture emerging of the study respondents is one of
eclectic poly-drug use.  It appears that cocaine has become a more regular and
valued feature of this group's poly-drug 'careers'.  Regularity of cocaine use
varied across the sample and use frequency appeared to be determined by a
number of interacting factors including past drug experiences, current income
and user's drug preferences.
3.6.8  Availability, Purity and Price of Cocaine
Respondents were asked to comment on current availability and ease of cocaine
accessibility.  Across the sample, there was general consensus that cocaine was
more easily available and more commonly used than previously.
It is far more freely available now, you would see more and more types of people doing
it and there are bars and clubs in town where a lot of people would use it ... it would
have had that tag of being a more exclusive drug years ago because it wasn't freely
available and used more for an occasion.  But now a lot more people I know do it every
weekend.
It's a lot easier to get it now really, but that's probably down to my own circle of
acquaintances as well.  Yeah, if I want it I can get it.
Coupled with increased availability, there was a strong belief in cocaine's
acceptance as a drug of choice.
There is a large acceptance, people that I know and people's parents do it the odd time,
do a line, and it is fine by them.
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There is a big difference now, sure even if you look at toilets in a club, it is nothing to
see two males go in and out of a cubicle together and the likelihood is that they are both
going in to do a line but nobody bats an eyelid.  I think years ago whereby we were told
how bad drugs were, people would readily stand up and go 'listen'.  That is not on
nowadays.  There just doesn't seem to be that anymore.  Nobody is going to turn around
and be disgusted that you are doing something like that.
Strong differences emerged, however, in the perceived reliability of personal
access routes to cocaine. Expectations regarding the quality and purity of
available supplies also varied.  Regular cocaine users had sought out and located
one or more reliable supplier of the drug and felt assured about the quality of
cocaine they purchased.  
I find availability okay.  I wouldn't buy it off somebody I didn't know, and you are still
taking a bit of a gamble with somebody you know with what you are getting, you are
still not getting extremely good quality but I would have no problems, if I got muck in
cocaine, giving it back to the person [supplier] as well.  I wouldn't pay that amount for
something that's not acceptable at all.
Others, who did not have a regular dealer, relied on friends to secure a supply
of cocaine.  It appeared that those who socialised in user circuits were able to
access cocaine easily.
If I wanted it [cocaine] I would have to talk to a particular friend ... and he would talk
to the guy who deals it for him.  I don't have a dealer so if I heard there was something
going on at the weekend and people getting stuff I could ring up and just say put me
down for a wrap [a single quantity, usually 1 gram] or whatever.
Less committed and regular users of the drug, on the other hand, had to go to
greater lengths to procure 'good' cocaine and a number did not have a reliable
dealer.
I have a regular supplier for years and I wouldn't be a heavy coke user.  So anytime I go
to get coke, it's more of a hassle for me to go and get it because I have to go out of my
way to get it because he doesn't supply it.
The quality varies from very poor to very good.  Again, there is no trend to that either,
it's totally pot luck.  I am sure there are people, and again this is my experience because
I don't know many people or one person, to be honest, who sells the stuff.  If you knew
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more people that sold it, the chances are you would probably be able to get it more
regularly and get good stuff.
Respondents' reports indicate that the current street price of cocaine varies
between £50 and £80 per gram.  The majority stated that the quality and purity
of supplies vary enormously depending on the source and availability of the
drug.  Most respondents had used cocaine while in countries other than Ireland
at some stage and frequently mentioned the inferior quality of cocaine here,
certainly compared to that which they had sampled abroad.
The way you kind of socially create sources for obtaining coke, well after a while you do
notice that one person gives you coke and it may not be as good as the next person.  And
sometimes after a few years or after a while of taking it you can actually take some lines
of coke and you can actually see what it is cut with, you can taste it or you can see it.
It is just something that you develop over the course of time and the purity in Dublin
anyway is not always the best.
It is pricey, but as well as that you see it is hard to tell because in Ireland it is hard to
get good cocaine.  You can get it but it is few and far between, it is a bit of a gamble
when you go to buy because you don't know if it's going to be good.  But if you have a
regular source and you know what is good then you are fine.  And you will find that
there are times when you will get really good stuff all the time and then other times you
are getting crap, you know.
In general, the evidence suggests that cocaine is readily accessible to individuals
who are motivated to use the drug and have established contact with a reliable
supplier.  Less frequent users, while having easy access to cannabis and ecstasy
via their regular dealers, had less well established access routes to illicit cocaine
supply systems.  They were not motivated to seek out a more reliable cocaine
supply route and allowed situational factors to determine the quality of the
cocaine they consumed.  At the buyer level then, it would appear that cocaine,
albeit of variable quality, is relatively easily available to individuals who opt to
use the drug.
3.6.9  Perceived Attractive and Unattractive Aspects of Cocaine
All psychoactive substances have appealing and unattractive attributes and
cocaine is no exception in this regard.  All of the respondents were well versed
on the drug-induced outcomes of a variety of substances; they distinguished
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clearly between the effects of individual drugs and had preferences for specific
drugs or drug combinations, depending on the circumstances or settings of use.
In this section, the perceived appealing and negative aspects of cocaine are
examined.  Reference is made to the perceived advantages of other drugs in
instances where this has a bearing on respondents' attitude to cocaine.
The data revealed three dominant cocaine attractions.  They are not discussed
here in hierarchical order, as it was difficult to determine individual advantages
which prevailed over others in terms of their importance for individual users.
Rather, all three merged as components of a psychoactive 'hit' which was
perceived to be gratifying, beneficial and enjoyable.  Cocaine's appeal focused on
three major themes - pleasure, control and lifestyle.
Cocaine simply made partying better, according to the majority of respondents.
The psychoactive 'hit' produced feelings of exhilaration, confidence and
psychological pleasure, thus enhancing social occasions in which the drug was
in use.
Taken on its own you are elated and you are really aware of everything and you are
aware of yourself but you are aware of yourself as being full of confidence.
It boosts the night by about five-fold.  If you are out and you are having a great laugh
it seems to add that little bit extra to the night.  The banter is a bit quicker as it goes on
... It is just like a mood enhancer.
With coke you can have a little stash of it and you can stay up all night.  It is just that
it breaks down all those barriers and you are just babbling away having a good time,
socialising with people.
Closely linked to the social and psychological pleasures described by
respondents was that cocaine provided an immediate injection of energy and
enthusiasm and made the night last longer.  
If I was taking uppers - speed, cocaine, something like that - it would be to promote my
energy levels for the evening or elongate it so you can go with the craic for longer. 
Two respondents drew attention to the enhancement of sexual experiences
following cocaine use.
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Coke is more of an indoor drug and if you are with someone that you are quite into a
relationship with it is good as well.  You can lock yourself in and have a gram of coke
and have a really good night sexually as well as mentally.
As with other drugs, the pleasure factor was high on respondents' list of
priorities when rating cocaine as a drug experience.  The physical and
psychological pleasures cited by respondents in the current study are very
similar to those documented by Ditton et al. (1996) in their sample of cocaine
users in Scotland.
A second key advantage of cocaine over other drugs, according to many
informants, was that unlike other drugs, cocaine permitted the user to retain a
high level of 'control' during times of use.  Discretion was closely associated with
control: cocaine did not demand much preparation and users felt able to conceal
the fact that they had taken the drug.  In addition, cocaine consumption
facilitated and enhanced communication with others, rather than hampering it.
At the same time, the rapid onset of cocaine-induced effects following
consumption, coupled with the short duration of these effects, allowed the user
to maintain charge over his/her disposition and behaviour.
It's immediately effective and it's convenient to carry around and it's convenient to
take, relatively.  Like, there's no work, you don't have to prepare anything, you know.
And you get an immediate kick out of it.
You can control it insofar as it only lasts ten minutes and then you can take some more
of it if you want it.  Whereas ecstasy, you take it and you are out of it for at least two
hours.
It is the most social because you can sit there and you can converse with everyone and
you don't look like you are out of it.  It's a good drug like that.
It doesn't stop me thinking and I don't do anything stupid, you know what I mean.  You
can get into a taxi and talk to the taxi man and you know what you're doing.
Critically, cocaine use, according to several respondents, did not result in the
negative after-effects associated with ecstasy and other drugs. These included
physical and/or psychological exhaustion and feelings of being 'wrecked'
during the days following use. Half the respondents (n=5) reported several
undesirable side-effects following a sustained period of regular ecstasy use.
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and assuming behaviour.  Others drew attention to mood swings and depression
among regular users.
I am talking about people I know and people who would use it as their drug of choice
and not just on weekends, but on a regular basis.  And it has changed them hugely.
Like, you know, mood swings, vicious mood swings, and basically just depressed when
they are not high on coke.  And it makes for a sad life.
To summarise, cocaine was regarded as superior to other drugs for a variety of
reasons.  Users' subjective experiences suggest that cocaine was viewed
positively by the majority of respondents.  From the vantage point of the user,
attractive features of cocaine included its energising effects, the ability to
maintain control while intoxicated and the sociability of the drug.  Cocaine was
perceived to be a 'clean' drug, one that did not carry the negative image or
undesirable after-effects of other stimulant drugs.  Perhaps surprisingly, in view
of cocaine's apparent allure, only two respondents described cocaine as their
'favourite' drug.  Cannabis was by far the most popular drug across the sample
(n=6).  Two respondents stated that their preferred drug was ecstasy, in tablet or
powder form.  
3.6.10  Risk Perceptions and Self-Regulation of Cocaine Intake
Respondents were asked to express their views on the risks associated with
cocaine and other drug use.  In general, respondents had no reservations about
using cocaine, provided they felt relatively self-assured about the source of the
drug.  Most stated that they would avoid buying cocaine from a stranger in
social settings such as nightclubs.  However, concerns about getting bad value
for money tended to be higher on respondents' risk agenda, than anxieties about
the presence of contaminants.  Hence, one of the biggest 'risks' with cocaine was
the unpredictability of available supplies and the gamble taken in this regard.
Other drugs were considered to be far more reliable in this respect.
Cocaine isn't dodgy.  You would probably be more likely to get a bad E that makes you
ill for whatever reason.  You will get bad coke but it is poor quality as opposed to
anything else.  When it's cut sometimes you can taste the glucose.  E is probably more
dangerous in that sense.
One respondent compared cocaine to legal substances when expressing his view
on the risk of getting substandard cocaine.
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I don't wonder what's in a cocktail at a bar because it's so readily available and
acceptable.  With cocaine it doesn't come into my head either, to be honest.
The overwhelming view was that cocaine was a 'safe' drug.
I think it's probably one of the safest drugs.  You can't, of all the drugs that you can
take, if you take acid there is a small chance that you will have a bad trip.  But I think
that cocaine is the safest drug.  The effects are short-lived.  There will only be ill-effects
if you are doing it all the time but that won't happen easily because of the price of it.
When asked about the addictive potential of cocaine and other drugs, several
respondents placed a great deal of emphasis on the individual's relationship
with any given substance (including alcohol) as a major determinant of later
difficulties.  The general belief was that the pharmacological properties of the
substance played a secondary role in the development of drug-related problems,
certainly compared to other factors.  This group of cocaine users did not consider
that their own behaviour around drugs was comparable to the behaviour,
personal or social conditions of individuals who experience drug problems.  
I'd say it depends on your personality or your state of mind.  But I could easily imagine
if you're in a scenario whereby you have an altered state of being, by being on a drug,
and your life is a piece of shit, well, you'll obviously going to get back to where you were
last night as soon as possible.  Now that depends on probably, your state of mind, your
education, your ignorance of drugs.  All of that, all those levels - your social
circumstances, the amount of friends you have around you.  If you feel lonely and you
feel down, you know, you just more than likely want to get off your head.  I could easily
see somebody getting addicted to any drug.  But specifically to cocaine?  I don't know?
I think if it was me I'd want to be seriously fucked in the head to get addicted to cocaine.
I can see why people can get addicted and having said that I could never see myself
becoming an addict to coke.  About a year and a half ago I kicked cigarettes and I think
that is about as addictive as anything you can get.
Many pointed out that their use of cocaine and other drugs took place in social
settings where friendships and other social relationships took precedence over
the use, per se, of any drug.  Respondents distinguished clearly between drug
use and drug abuse, and did not equate their own cocaine use with dangerous
or addictive patterns of drug consumption.  Again, 'control' emerged as an
organising construct in the discourse and respondents invariably pointed out
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that they, and not the drug, maintained 'charge' in the context of drug-taking
scenarios.  
I enjoy the fact that I have a fairly stable and happy atmosphere in my head and I am
confident that I can do it [cocaine].  And if I ever felt that being threatened then there'd
be no argument there.  If it retarded my sense of drive or whatever, that'd be it.
I like to have control and I know how much I can handle.  Yeah, I've overdone it at times
but at the end of the day, drugs aren't important enough to me to let things get out of
hand.
Several respondents recognised situations and emotional states that were not apt
for cocaine use.  For example, most respondents restricted use to when they were
in the company of friends and stated that they did not use the drug when
socialising with their parents and/or other family members.  While a number
admitted that there were times when they went 'overboard', cocaine use was
generally confined to occasions when it was least likely to impact on work and
other responsibilities.  Respondents' also made reference to the importance of the
individual's emotional and/or psychological state at the time of use.
If I had to work the following day I wouldn't take it.  If I was hungry I wouldn't want
to suppress my appetite for a while because I would want to have a meal.  I would say
that if I had a lot on my mind, if I was stressed or if there was an awful lot going on at
work and in my life in general and I didn't want to deal with a hangover ... because at
the end of the day if I go off and do some coke I am going to have a pretty bad alcohol
hangover too because I tend to do the two together.  And you think you're superman
regarding alcohol intake so if my head doesn't feel right at the time then I wouldn't be
taking it.  Usually for me, if I had a lot going on in general I would avoid it for that
reason.  And then you are either in the mood or you're not, it's like anything, you know.
The quotes above illustrate the range of informal social controls that are
practised when people consume drugs.  Other respondents drew attention to
how they regulate their intake of cocaine during the course of a night out.
I would take cocaine more during the early part of an evening and then just let it peter
out.  What I don't like is coming in at three o'clock in the morning and sitting there
wide awake and not being able to sleep.  So, for myself I would have the bulk at the
beginning of the early part of the evening and then later in the evening have one or two
lines just for a perk.  And then when I get home, I am home to actually sleep.
Cocaine Use In Ireland: An Exploratory Study
137
While the level and range of 'control' measures practised by respondents varied
across the sample, all mentioned conditions that were more or less apt for
cocaine use.  Overall, it would appear that respondents perceived the risks
associated with cocaine use to be minimal, in terms of the drug's potential to
cause physical and/or psychological harm.  Interestingly, two respondents
expressed concern about the legal risks associated with the possession and use
of controlled substances.  
The illegality of it is a huge worry because other than the fact that I use drugs for
recreation, I am a 100 per cent law-abiding citizen.  I pay my taxes etc.  So, it is very
hard to keep reminding yourself that you are actually a criminal.  But you do, you
actually have to remind yourself on occasion.  Even though you are a really nice bloke,
you are actually a criminal and if you get caught you could well end up inside ... and
the repercussions could be huge from a legal, family, work point of view.  Huge
repercussions.
The majority, however, felt that it was relatively easy to conceal their use of
cocaine and that the chances of getting 'caught' were small or negligible.  
I would never worry about being stopped because I can't really see what provocation
there would be for the police to stop me.
I know it's a class A drug but I usually wouldn't worry.  I wouldn't want to get caught
but I usually wouldn't worry much so long as I am not carrying too much.
To summarise, cocaine was viewed as a relatively innocuous substance and
users did not consider cocaine use to have negative repercussions on their health
or well-being. None expressed concern about any short- or long-term health
implications associated with their personal use of the drug and many felt that
cocaine was 'safer' than other drugs.
3.6.11  Summary and Conclusion
Respondents in the current study described themselves as social/recreational
drug users.  Across the ten individuals interviewed, use was relatively modest
and none of the respondents could be described as heavy users of cocaine.  All
respondents funded their cocaine and other drug use through legitimate income.
Cocaine use was clearly integrated into social events; it was shared in social
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settings, sometimes in small intimate groups and, at other times, in the context
of larger social gatherings.  Cocaine was thought to facilitate communication and
to induce feelings of self-confidence. The stimulating properties of cocaine, in
conjunction with a 'controlled' high, were particularly attractive characteristics
of the drug experience.  This dynamic was important, particularly to more
regular users, who did not wish cocaine to encroach on their normal activities
and/or their physical and psychological well-being. 
While the frequency of use varied across the group, most could be classified as
'monthly', 'weekend' or 'intermittent' cocaine users.  Variation in frequency of
use  among recreational cocaine users has been documented previously by
Green, Pickering, Fosster, Power & Stimson (1994) in their UK sample.
Practically all respondents in this study reported the concurrent use of alcohol
and other drugs during cocaine-using events.  In fact, the vast majority had
extensive drug repertoires. The combined use of licit and illicit drugs is far from
atypical in the current European context.  Nabben (2000), for example, found that
among clubbers and ravers in Amsterdam, half used illicit drugs in combination
with alcohol.  A considerable number of the current study's respondents had
gone through a phase of regular weekend use. While ecstasy was rated highly,
all former regular users had reduced their intake of the drug owing to the
significant negative repercussions following sustained use.  For this group,
cocaine was perceived to be 'lighter' and 'cleaner' and did not interfere with the
user's desired level of functioning and well-being.  Henderson (2000) similarly
found that club-goers in Liverpool explained their cocaine use in terms of the
drug being perceived as a 'healthy' alternative to ecstasy.
The majority of respondents expected to find themselves in social settings where
cocaine was available and practically all intended to use cocaine at some time in
the future.  Reports indicated that the street price of cocaine varied between £50
and £80 per gram.  However, conspicuous differences emerged in respondents'
level of contact and association with local cocaine distribution networks.  Those
who socialised regularly in users' circuits had superior and more reliable access
routes to cocaine.
Relatively few disadvantages associated with cocaine emerged from
respondents' reports but most drew attention to the high cost of cocaine and to
the poor quality of available supplies.  Others commented on their observations
of friends and acquaintances during sessions of use and felt that cocaine
consumption sometimes produced undesirable, self-indulgent behaviour,
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including arrogance and greed.  Few respondents reported that they themselves
had experienced negative physical or psychological side-effects following
cocaine use.
Social settings have been shown to influence a range of drug-taking behaviours
(Becker, 1963; Young, 1971; Zinberg, 1984).  Cohen (1989) claims that settings and
individual responses largely determine not only the effects of use but also the
choice of drug in particular contexts. Respondents in this study used a range of
informal control mechanisms in an effort to regulate their cocaine intake and to
minimise potential negative consequences of use.  They also recognised settings
not suited to cocaine use and avoided the drug in these contexts.  Decorte (1999)
has documented similar control strategies among a sample of cocaine and crack
cocaine users in Belgium.  In the current study, respondents prioritised work,
friendships and their partners, and did not wish to jeopardise these
relationships.  Specifically, they did not allow cocaine or other drug use to
impinge on their performance in the workplace. Reference was made to a range
of circumstances under which the drug was not used, including during working
hours and in the company of parents and/or other family members.
Respondents also considered their own emotional and physical well-being prior
to using cocaine.  
None of the study's respondents reported 'problems' as a result of their cocaine
use and none considered their current intake to be worrying or damaging,
certainly in the short term.  Claims that they, the users, and not the drug,
maintained 'control', emerged strongly from their reports.  This is interesting
since the concept of 'loss of control' seems to be better adapted to current
perspectives on illicit drug use (Cohen & Sas, 1992), with rather less attention to,
and understanding of, controlled drug use.  The majority of respondents
considered the addictive potential of cocaine to be low, certainly from a personal
viewpoint.  Indeed, it is claimed that in many circumstances, cocaine is enticing
rather than addictive (Hammersley & Ditton, 1994).  Drug dependence is, of
course, strongly mediated by the circumstances, disposition and views of the
user (Zinberg, 1984).  The cocaine users in this study did not fear addiction;
neither did they believe that they were susceptible to developing a dependent
relationship with cocaine, owing largely to a belief in their ability to control and
regulate their intake of the drug.
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3.7  Cocaine Use in Ireland: Discussion and Conclusion
The drug scene in Ireland has undergone dramatic change during the past
decade and has become increasingly diverse according to age, drugs of choice,
availability and price.  National and local surveys of youthful populations
indicate a clear upward trend in the range of drugs used, suggesting that
recreational drug use has become a more obvious feature of adolescent lifestyles.
At the other end of the drugs spectrum, long-term opiate users, many of whom
are known to drug treatment services, appear to have extended their repertoire
from heroin and methadone to poly-drug patterns.  Benzodiazepines have been
identified as a primary supplement to opiate users' drug intake (Farrell et al.,
2000; Rooney et al., 1999).  The propensity of cocaine, particularly in its injectable
and smokeable forms, to appeal to this endemic group of heavy users is an issue
of critical concern.  
This research has attempted to build up a picture of cocaine use nationally, using
available indicators of drug use/misuse and the perceptions of key informants
and drugs workers.  The research did not set out to estimate the prevalence of
cocaine use; rather, it aimed to provide information on the nature of cocaine use,
with specific reference to particular sub-groups, namely, recreational and
problem drug users.  In the absence of previous research on the topic, a multi-
method approach, using several indicators, was judged to be the most effective
means of analysing the current cocaine situation.
The findings strongly suggest increased availability and use of cocaine.  Law
enforcement statistics point to an upward trend in the availability of cocaine.  In
addition, the study has repeatedly noted the ease with which users can obtain
cocaine.  Although population and school surveys indicate that only small
numbers use cocaine experimentally or intermittently, this current research
provides evidence of individuals who use cocaine regularly for recreational
purposes. Reference was made by most study respondents to the visibility of
cocaine on the club and pub scenes, a development which was regarded as
recent.  While there is no systematic evidence of widespread cocaine use, the
broad picture uncovered is one of increased likelihood of cocaine use among
certain groups of recreational poly-drug users.  The extent, nature and frequency
of cocaine use among such groups, however, remain unclear.  
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Coupled with a possible expansion of cocaine use within the recreational drug
scene, are signs of increased cocaine use among opiate users who come from
more deprived urban areas, particularly within Dublin City.  While cocaine has
clearly been 'around' for some time, supply and availability appear to be
stronger than previously.  The reports of a diverse range of drugs workers and
service providers confirm that this development is recent, certainly no more than
three years old.  Impressionistic accounts also strongly suggest that cocaine use
has become a more conspicuous and accepted drug option.  
It is important to state that the nature of cocaine use is likely to be diverse and
that the role and function of cocaine within the drug repertoires of
social/recreational cocaine users is likely to differ substantially from that of
'seasoned', heavy and problematic opiate drug users (Chitwood & Morningstar,
1985; Hammersley & Ditton, 1994).  In addition, routes of administration are
likely to vary between the two groups. Social users interviewed for the purpose
of this research ingested cocaine intranasally or orally, and did not consider their
drug consumption as damaging or problematic.  None had been exposed to
crack cocaine and did not consider using cocaine in this form.  On the other
hand, available statistical indicators, coupled with the reports of drugs workers,
suggest that cocaine use has become more apparent among clients in treatment
for heroin misuse. As stated earlier, there is currently little knowledge or
understanding of preferred patterns of cocaine use, or of dominant routes of
cocaine administration among problem drug users.  This information is essential
if cocaine's role in the drug repertoires of opiate users is to be fully understood.
Furthermore, an understanding of smoking versus injecting cocaine rituals
would greatly enhance knowledge and awareness of the possible range of health
risks associated with cocaine use.
It would be premature to conclude, on the basis of the current study, that cocaine
is a major 'drugs issue', or that the spread of cocaine use to neighbourhoods
where heroin use is concentrated, is imminent or inevitable.  Further research
and monitoring of drug trends at local level is required to confirm or,
alternatively, discount the proposition that cocaine is an expanding 'problem'.
Despite this, heroin epidemics, both here and in the United Kingdom, have
taught us that particular communities are susceptible to drug outbreaks (Dean,
Bradshaw & Lavelle, 1983; O'Kelly, Bury, Cullen & Dean, 1988; O'Brien & Moran,
1997; Comiskey, 1998; Parker, Bakx & Newcombe, 1988; Pearson, 1989; Parker et
al., 1998; Egginton & Parker, 2000).  If cocaine continues to be easily available
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and gains acceptance among drug users, it may have the potential to find its way
into communities that traditionally attract drug problems.  In this sense, the
current research might be appropriately viewed as an 'early warning sign'
(Parker et al.,  1998) of cocaine's emergence, thus, signifying the opportunity to
monitor the situation and 'get ahead'.  In this context, a cautious response to
possible signs of increased cocaine use is more appropriate than either outright
rejection of the possibility, or hysteria and over-reaction.
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Chapter 4
Women, Children and Drug Use 
Eimear Farrell
4.1 Introduction
This paper provides an overview of the issues relevant to women and children
affected by drug misuse in Ireland. It attempts to bring together very disparate
sources of information in order to gain an understanding of the main issues
facing women drug users and their children.  The main areas covered are:
4.2 Historical and Cultural Background 
4.3 Epidemiology of Female Drug Use 
4.4 HIV/AIDS, Women, Children and Drug Use
4.5 Drug Use among Female Prisoners
4.6 Pregnancy and Drug Use
4.7 Children and Drug Use
4.8 Demand Reduction (Prevention, Treatment and Care) and Female 
Drug Users 
4.9 Barriers to Service Access
4.10 Conclusion
4.11 References
One of the most striking features of the available Irish research is the emphasis
on pregnancy and drug use, and the scarcity of studies focusing on children of
drug users. 
1 This chapter was written in 1999 as a 'Key Issues' chapter for inclusion in Moran, R., O'Brien, M., Farrell,
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1
E. & Dillon, L. (1999). National Report on Drug Issues Ireland 1999.  Internal document. Dublin: Drug
Misuse Research Division, The Health Research Board. Only National Drug Treatment Reporting System
figures have been updated in the current chapter.
4.2  Historical and Cultural Background
According to the United Nations Drug Control programme (UNDCP), female
involvement in drug use may be divided into three categories:
1. female non-drug users with drug-abusing families or partners;
2. females who consume drugs illicitly; and
3. females who are involved in the production and/or distribution of 
drugs.
In Ireland, very little is known about both non-drug-using women who have a
drug-using partner or family, and women who are involved in the production
and/or distribution of drugs.  
No estimate is available of the number of women affected by familial drug use.
However, a number of support groups have been set up for parents and partners
of drug users.  These support groups include the Coolmine Family Association
and a group established for parents of drug users, entitled 'Le Chéile' (Together),
which was established in 1993 but has since been discontinued. 
The only Irish data available on women and drug production and distribution
are police statistics on drug offences.  These statistics indicate that between 1990
and 1994, approximately 14 per cent of people charged with drug offences were
female (An Garda Síochána, 1991, 1992, 1993, 1994). In the following two years
(1995 and 1996), this figure decreased, with about 10 per cent of drug-related
offences being committed by women  (An Garda Síochána, 1995, 1996). In 1997
this figure almost doubled, increasing to 22 per cent (An Garda Síochána, 1997).
There is some anecdotal evidence that women in general, and pregnant women
in particular, are increasingly being used in drug trafficking, which may explain
the sudden increase in the percentage of women being charged with drug-
related offences in 1997.
Although more information is available on women drug users in Ireland relative
to the other two categories, it is not possible to examine long-term trends, as the
collection of epidemiological data on drug use is a relatively recent
phenomenon. 
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4.3  Epidemiology of Female Drug Use
An important issue when considering women and drug use is the extent to
which male and female drug users differ in terms of drug-using history, patterns
of risk behaviour and health issues.
The main source of information on gender differences and drug use in Ireland is
the National Drug Treatment Reporting System (NDTRS), which provides
statistics on treated drug misuse. An analysis of the NDTRS data for 1998
indicates that almost a third (30%) of drug users presenting for treatment were
female.  Male and female clients were similar in age, the mean age of female
clients being 24 and the mean age of male clients being 25 (NDTRS)2. As with the
general population, women seeking treatment were more likely to be classified
as lone parents (9%) than were men (0.3%).  Women were also more likely to be
living with a drug-using partner: 36 per cent of women lived with a drug user
compared to 22 per cent of men. This finding may relate to the fact that women
are generally more likely to be introduced to drugs by a male partner (Ettore,
1992).  The majority of both male (70%) and female drug users (75%) seeking
treatment were unemployed. Interestingly, more women (88%) than men (78%)
reported that opiates were their primary drug of misuse.  However, a lower
proportion of male (35%) than female (39%) users reported that they were
currently injecting.  In terms of risk behaviour, of those who were currently
injecting, women (28%) were slightly more likely to be sharing injecting
equipment than were men (25%).
Gender differences in drug usage, risk behaviour and health have also been
studied among drug users attending an inner-city Dublin needle exchange
programme (Cox, O'Shea & Geoghegan, submitted for publication).  Over a year
and a half, 934 consecutive new attendees at the needle exchange were
interviewed. The study found that female clients were significantly younger
than male clients and were more likely to inject their primary drug daily.
Women were also more likely to suffer from injecting-related problems such as
difficulty finding injecting sites.  Men were less likely to have a partner who was
injecting and less likely to be living with an injecting drug user. In terms of risk
behaviour, women were more likely to share injecting equipment with their
sexual partner and to report recent sharing of injecting paraphernalia.  However,
women had a shorter interval between injecting and attending a needle
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exchange than did men. In terms of health and general well being, women were
more likely to
2 National Drug Treatment Reporting System.
report weight loss and abscesses and were less likely to have had a hepatitis B
vaccination than men. Women were also more likely to report mental health
problems such as depression, suicidal tendencies, isolation and anxiety.
However, women were more likely to have visited a general practitioner in the
last three months and to have a medical card.  Thus, the findings suggest that
women were more likely than their male counterparts to engage in risk
behaviour, but were more likely to acknowledge these difficulties and to seek
help. 
Summary
Consistent with the European situation, about a quarter of drug users who
present for treatment in Ireland are female (EMCDDA, 1998). Although fewer
women than men are captured in the treatment figures, research suggests that
women in Ireland are more likely to suffer negative consequences from drug use
than men.  It also suggests that women in Ireland are more likely than men to
engage in risk behaviour, to be living with a drug-using partner and to suffer
from drug-related health problems.
4.4   HIV/AIDS, Women, Children and Drug Use 2
Drug use can have serious health-related consequences, particularly in relation
to HIV and hepatitis B and hepatitis C.  While no national information is
available on hepatitis B and C, statistics on the incidence of HIV in the
population are routinely published by the Department of Health and Children.
These statistics contain information on the percentage of HIV-positive cases that
are related to intravenous drug use (IDU).
As Table 4.1 indicates, from January 1986 to December 1998, 42 per cent of all
those who tested positive for HIV (n=1,986) were IDUs. Of these, almost a
quarter (24%) were female.  During the same period, a total of 149 children were
deemed 'at risk' of becoming HIV positive, representing 7.5 per cent of all HIV-
positive cases. The HIV statistics for children do not indicate the route of
infection and, therefore, it is not known to what extent HIV among children is
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attributable to maternal drug use or other sources, e.g. transfusions or
heterosexual or sexual transmission. 
2 See Chapter 2 for a discussion of the HIV/AIDS figures up to the end of 1999. 
The available statistics for AIDS present a similar picture.  Two-fifths (41%) of
the 650 AIDS cases diagnosed between January 1986 and 31 December 1998 were
IDU related, of which, again, a quarter were female (see Table 4.2).  An age
breakdown is also available for AIDS cases, which indicates that twenty-six
cases of AIDS (representing 4% of all AIDS cases) occurred among children
under the age of 15.  Unlike the HIV figures, the AIDS figures for children
provide information on the route of infection.  These figures indicate that from
1982 to 1998, thirteen children born to IDUs developed AIDS, representing 2 per
cent of all AIDS cases over this time period.  
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TABLE 4.1
T tal Number of Known HIV Cases in Ireland: IDU Related, by Gender;
and Children at Risk.  Numbers and Percentages.
Cumulative figures January 1986 - December 1998.
Total HIV
Cases IDU Cases Female IDUs Male IDUs
Children
at Risk
1,986 844  (42%) 202  (23.93%) 628* 149  (7.5%)
Source: Department of Health and Children.
* In 14 of the 844 IDU-related cases of HIV, the gender was not known.
650 266 (41%) 200 (75.2%) 66 (24.8%) 26 (4%) 13 (2%)
TABLE 4.2
Total Number of AIDS Cases in Ireland: IDU-Related, by Gender;
among Children < 15; and among Children born to IDUs.
Numbers and Percentages. Cumulative Figures January 1986 - December 1998.
Source: Department of Health and Children.
IDU-Related AIDS Cases
Gender Breakdown
Male
Total
Female
Total
AIDS
Cases
AIDS
Cases
among
Children
Aged < 15
AIDS
Cases
among
Children
born to IDUs
332 148 (44.6%) 109 (73.6%) 39 (26.4%) 11 (3.3%) 8 (2.4%)
IDU-Related AIDS Deaths
Gender Breakdown
Male
Total
Female
Total
AIDS
Deaths
AIDS-Related
Deaths
among
Children
Aged < 15
AIDS-Related
Deaths
among
Children
born to IDUs
A Collection of Papers on Drug Issues in Ireland
158
TABLE 4.3
Total Number of AIDS Related Deaths in Ireland: IDU-Related, and Gender;
among Children < 15; and among Children born to IDUs.
Numbers and Percentages. Cumulative Figures January 1986 - December 1998.
Source: Department of Health and Children.
Figures are also available for AIDS-related deaths (see Table 4.3). These figures
indicate that between 1982 and 1998, 44.6 per cent of AIDS-related deaths were
IDU related, and of these, 26.4 per cent were female. An age breakdown of
known AIDS deaths shows that eleven (3.3%) occurred among children under
the age of 15.  The figures also reveal that eight children (representing 2.4% of all
AIDS-related deaths) born to IDUs are reported to have died from AIDS. 
It is also possible to identify trends in known cases of IDU-related HIV among
women and known cases of HIV among children (see Table 4.4). An analysis of
these figures over a three-year period (1996-1998) indicates that the proportion
of IDU-related cases of HIV among females more than doubled in 1998,
compared with 1997 and 1996.   Similarly, the number of new cases among
children doubled between 1997 and 1998.  This may be a reflection of increased
testing for HIV among pregnant women. Routine antenatal testing for HIV was
introduced in 1999, in order to allow a mother infected with HIV to receive
special treatment that could reduce the likelihood of her baby becoming infected
by up to 66 per cent (Department of Health and Children, 1999b).  The testing
was introduced following a five-year study (1992-1997), which estimated the
incidence of HIV among new-borns, using unlinked, anonymous antenatal HIV
screening.  The screening was carried out on blood specimens routinely collected
for rubella serology from pregnant women attending antenatal clinics.  A total of
287,099 tests were carried out over the five years, of which 64 were positive for
HIV, giving an incidence rate of 0.02 per cent.  However, the extent to which
HIV-positive results were drug related is unknown.
A study of HIV infection among women attending thirteen genitourinary
medicine/HIV clinics in England, and one clinic in both Dublin and Edinburgh,
found that women in Dublin and Edinburgh were more likely to have contracted
the disease through IDU rather than sexual intercourse (MRC Study Group,
1996).  For over two-thirds of the seventy-three women interviewed in Dublin
and for four-fifths of the forty-two women interviewed in Edinburgh, the most
probable route of transmission was drug use; whereas in London (n=266) and in
the rest of England (n=19), only one-fifth (21%) of women were thought to have
been infected through drug use. Although not directly comparable, an analysis
of Irish statistics on the route of infection among women with AIDS (collected by
the Department of Health and Children) indicates that, across all cases, a smaller
percentage of women contracted AIDS as a result of drug use than is suggested
by the MRC study. The Department of Health and Children statistics indicate
that 54 per cent of registered female AIDS cases were IDU related (Department
of Health and Children, 1999a).
Although basic epidemiological data are available for the incidence of HIV, very
little is known about the needs of female drug users with HIV.  However, one
Dublin study has investigated the needs of HIV-positive women by consulting
with HIV-positive women and healthcare workers involved in their care (Butler
& Woods, 1992).  The results indicate that Dublin women who were HIV-
positive were primarily concerned with taking care of their families and saw
their own health problems as being of secondary importance. The healthcare
workers interviewed stated that HIV-positive women in Dublin tended to be
Women, Children and Drug Use 
159
TABLE 4.4
Ireland 1996 - 1998. Numbe  of IDU-Related HIV Cases among Women,
and Number of New Childhood Cases. Numbers and Percentages.
1996 1997 1998
Women Children Women Children Women Children
3 (15%)* 8 3 (14%)* 10 10 (38.4%)* 20
Source: Department of Health and Children.
* Percentages are calculated based on the total number of new, IDU-related HIV cases.
young, working-class and to have contracted HIV through IDU and/or sexual
relationships with drug-using men. When asked about the services available to
HIV-positive women, respondents acknowledged that, while a broad range of
services was available, many of these were poorly co-ordinated.  They also felt
that there was a lack of practical support for those who were ill and that the drug
services could not yet be described as 'user friendly'.  It was also suggested that
HIV-positive women did not take up health and social services to the same
extent as men for two reasons.  Firstly, women were often too busy with child-
minding and other chores to avail of services and, secondly, they feared being
labelled as 'unfit' mothers.  However, since this study was conducted, there has
been a major expansion of drugs services.
Summary
The proportion of female IDU-related HIV and AIDS cases is similar to the ratio
of male to female drug users in treatment.  Approximately one-quarter of IDU-
related AIDS and HIV cases occur among women.  The number of IDU-related
HIV cases appears to have increased in recent years.  Very little information is
available about the needs of female IDUs with HIV/AIDS.  One study suggests
that HIV-positive drug-using women with children may be inhibited from
seeking treatment owing to concerns about being seen as an 'unfit mother'
(Butler & Woods, 1992).
4.5  Drug Use among Female Prisoners
Drug use among women in prison has received some attention in Ireland. A
study of 100 consecutive women prisoners entering the main prison in Dublin
suggests that drug misuse is a significant problem among the female prison
population. The study, conducted over a six-week period in February and March
1994, found that sixty of the women interviewed had used drugs (Carmody &
McEvoy, 1996).   Among the sixty women who used drugs, heroin was the most
frequently-used drug (95%), followed by methadone (83%) and benzodiazepines
(83%).  Cocaine had been used by almost two-thirds (63%) of the women, and
amphetamines by over a third (35%).  All except one of the sixty women were
using drugs on imprisonment, as indicated by a positive urine test for opiates.
The vast majority of the drug-using women (92%) were daily users, and 86 per
cent stated that injecting was the primary route of administration. Almost half of
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those who had injected had shared a needle in the last month. Interestingly, 43
per cent of the women described methadone as one of their drugs of first choice.
When asked about their history of drug treatment, four-fifths of the drug-using
women stated they had been detoxified at least once, and over half (57.1%) had
been detoxified three or more times.  Over half (53%) had been detoxified in
prison. About half the drug-using women had been on methadone maintenance
at some stage in the past, and 43.3 per cent were on methadone maintenance at
the time of imprisonment. The results of the study also indicate a possible link
between drug use and psychiatric problems among this population, as 61 per
cent of the forty-nine women who had received psychiatric treatment were drug
users. 
A more recent survey of male (n=1,148) and female prisoners (n=57) found that
women prisoners were more likely than their male counterparts to smoke heroin
and/or inject drugs (Allwright, Barry, Bradley, Long & Thornton, 1999).  Almost
three-fifths (59.6%) of the women surveyed, reported smoking heroin, compared
to 45.2 per cent of male respondents. Three-fifths (59.6%) of women also reported
ever injecting, compared to just over two-fifths (42.4%) of men. 
Summary
The results of two surveys of the prison population suggest that opiate use is a
serious problem among women in the Irish prison system.  Furthermore, women
in prison appear more likely than their male counterparts to smoke or inject
heroin (Allwright et al., 1999).
4.6 Pregnancy and Drug Use
Maternal drug addiction was first recognised as a problem in Ireland in 1981,
when nine babies were born to heroin-addicted mothers attending one of the
main maternity hospitals in Dublin (Ryan, Arthurs, Kelly & Fielding, 1982).  This
represented a marked increase, as the previous eight years (1973-1980) had seen
only a total of six babies born to heroin-addicted mothers. A socio-demographic
profile of thirteen of the fifteen opiate-addicted mothers indicated that the
majority (69%) were under 20 years of age, half were unemployed and only one
had completed post-primary education. All the women were heavy cigarette
smokers. One third of the women had a parent with a nervous or psychiatric
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history and less than a quarter described their relationship with their parents as
good. Furthermore, nine of the thirteen women had received treatment for
emotional or psychiatric disorders.  In terms of physical health, seven had
hepatitis and two had venereal diseases.  The profile of the partners of these
women indicates that twelve of the thirteen partners were drug addicts and only
two gave the mother any support or assistance when she was pregnant.
Although none of the infants were small for gestational age, anxiety about the
social conditions of mothers led to longer hospitalisation and separation of the
infants from their mothers. This study also investigated the short-term outcome
for the infants and their mothers.  The results indicated that two mothers were
drug free, two had developed serious neurotic illnesses following withdrawal,
one was hospitalised for a drug-related psychiatric illness, and the remainder
were still addicted. Furthermore, three of the babies had been taken into care.
A similar profile of the pregnant drug user emerges from a study of the
characteristics of thirty pregnant women who attended the National Drug
Advisory and Treatment Centre, Jervis Street, Dublin, between 1969 and 1983
(Kelly, Roche, Stafford-Johnson & Honeyman, 1983).  Interestingly, the age of
first contact for pregnant drug users was, on average, a year and a half younger
than non-pregnant women attending the same service.  The study found that the
majority (87%) of pregnant opiate users had left school before the age of 16.  A
third of the women were married and living with their husbands. The majority
(83%) of the women's partners misused drugs or alcohol and over a third (37%)
had a record of crime or violence. Only three of the women had partners who
gave them consistent support and assistance during their pregnancies. Almost
three-quarters (73.3%) of the women had a behavioural disorder or received
psychiatric treatment prior to drug taking. An investigation of the family
background of these women revealed that a quarter of the women had mothers
who had a psychiatric problem or were excessive drinkers. A third of the
women's fathers were excessive drinkers and a quarter were reported as being
violent or criminal.  On a more positive note, over half the women received on-
going support from their mothers, and almost half were described as having a
good relationship with their own family. Similar to the earlier study, babies born
to drug-addicted mothers were hospitalised for longer and therefore separated
from their mothers at an early age. The women appeared reluctant to avail of
healthcare services both prenatally and postnatally. Only half the women
attended for antenatal care at an early stage. Many of the mothers were resistant
to any health board involvement postnatally and many refused to attend for the
normal developmental checks and vaccinations.
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In terms of outcome, at least 65 per cent of the mothers were known to have
returned to serious drug misuse (21.5% lost contact with the Centre and their
outcome is unknown), and three (11%) remained drug free.  In the majority of
cases (70.3%), babies were in the care of their mother; in the remainder of cases,
babies were either in the care of a grandmother or jointly cared for by the
grandmother and the mother (11%), or had been adopted (11%).  In two cases,
the outcome was unknown. 
Another retrospective study, of twenty-nine narcotic-addicted mothers and their
forty-two babies born between 1982 and 1985, found that the average maternal
age was 23 and, in all cases where information was available (29 of 38
pregnancies), all fathers were drug users (Thornton, Clune, Maguire, Griffin &
O'Connor, 1990).  Twenty-three of the twenty-nine mothers (79%) were on a
methadone maintenance programme during pregnancy, but they all continued
to use heroin intermittently. All the women were from socially-deprived areas
and all, except one, smoked cigarettes.  In terms of physical health, four of the
mothers had a hepatitis B infection and thirteen had a previous history of
hepatitis B infection. In comparison to a matched control group, babies born to
heroin-using mothers had significantly lower birth weights and mean
gestational periods and were more likely to develop jaundice. In addition,
heroin-using mothers made fewer antenatal visits and were admitted to hospital
more often and for longer stays than were the control group.  A high incidence
of withdrawal symptoms was recorded, with 84 per cent of babies suffering
some symptoms of withdrawal.  The incidence of multiple births (i.e. twins) was
also much higher among drug-using mothers (10.5%) compared to the control
group (1.2%).  
Another similar study, conducted in 1988, examined the characteristics and
treatment progress of forty-five opiate addicts referred to a treatment centre
between 1984 and 1986 (O'Connor, Stafford-Johnson & Kelly, 1988).  The psycho-
social profile of this group indicates that all were unemployed, were regular
smokers and had left school on average at the age of 14.  The average age of first
use of heroin was 16.5 years and the average age at the time of the study was 23.3
years.  Almost half (46.6%) of the women had used heroin intravenously as their
first illicit drug. The average length of time on drugs before referral was three
years. Interestingly, the majority of mothers (86.7%) were attending the clinic for
an average of 2.5 years before becoming pregnant.  Four-fifths were single.
Almost all (95.5%) had been convicted of a criminal offence.  In terms of family
profiles, nearly half the women had fathers who suffered from alcoholism and a
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third had mothers who suffered from alcoholism or depression.  Over half
(55.5%) reported severe family disharmony. This study also investigated HIV
status and found that fifteen of the forty-five women were HIV positive. Over
half the women had a history of hepatitis B infection. Almost half (45%) the
women responded positively to treatment during pregnancy, as indicated by
regular attendance, non-abuse of drugs (as detected through the results of
supervised urinalysis), discontinuation of criminal behaviour and improved
awareness of their children's needs (O'Connor et al., 1988). 
A six-year follow-up of these women was conducted, focusing on their drug use
and the outcome for their children (Keenan, Dorman & O'Connor, 1993).  On
follow-up, seven of the forty-five women (15%) could not be contacted.  Of the
remaining thirty-eight, ten were on methadone maintenance, eighteen were
either attending another service or abusing chaotically, three had become drug
free and seven had died from drug-related illnesses. Of the women who had
died, four had died from AIDS and three from drug overdoses, two of which
were accidental and one deliberate. Over the six-year period, all but two of the
women (4.5%) had re-attended at the treatment centre at least once, and twenty-
five women (55.6%) had attended at least four times.   There was an increase in
the number of women with HIV, from one-third of the group to over half the
group (53.4%) during the six years (1986-1992), and a quarter of the fifteen
children born to HIV-positive mothers before 1996 had become HIV positive.
More worrying was the fact that fourteen of the eighteen HIV-positive women,
who were still alive, were not attending any medical service on a regular basis.
This may be, in part at least, related to a fear of being seen as an unfit mother, a
reason cited earlier among HIV-positive women for not accessing services
(Butler & Woods, 1992). The increase in the incidence of HIV among the women
is interpreted by the authors as signifying instability and poor compliance with
advice and treatment. On a more positive note, since 1986 only three of the
women (6.6%) had contracted hepatitis B infections, compared to twenty women
(45%) prior to 1986. Over half the women (55.5%) had no further children and
there was also a decrease in the level of criminal activity among the women.
Before 1986, nearly all the women (97.8%) had a forensic history.  However, since
1986 just over half the women had been in contact with the criminal justice
system.
All the studies discussed so far have specifically focused on opiate-using
mothers. A more recent study has examined the prevalence of drug and alcohol
use in an obstetric population in the Dublin area (Bosio et al., 1997). This
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prospective study involved anonymous urinalysis of 504 'first-visit' antenatal
patients and 515 postnatal patients six weeks after delivery. The study found
that the prevalence rate for drug use in antenatal patients was 2.8 per cent; the
corresponding postnatal figure was 5.6 per cent. Cannabis was found to be the
most commonly-misused substance. Women who tested positive for drugs
antenatally were almost twice as likely to be single, unemployed and on a second
or subsequent pregnancy. The higher postnatal rate of drug use is interpreted as
possibly indicating a more responsible pattern of behaviour during pregnancy,
in an effort to minimise exposure of the foetus to chemical substances. Bosio et
al. (1997) conclude that drug abuse does not appear to be a serious problem
among Dublin's pregnant population. However, they acknowledge that drug
users may present late in pregnancy, as has been found in previous studies of
pregnant opiate users (Kelly et al., 1983; Thornton et al., 1990). 
Summary
The research available on opiate addiction and pregnancy in Ireland suggests
that opiate-dependent pregnant women are a high-risk medical category, with
many psychological and social problems.  Numerous studies have shown that
opiate-using pregnant women tend to be young, poorly educated, regular
tobacco smokers, and from socially-deprived areas.  Research also indicates that
these women tend to be involved with a partner who also misuses drugs and to
have poor family relationships, or come from families with a history of alcohol
misuse, drug abuse and/or psychological problems. The level of psychological
difficulties among the families of these women is consistent with findings
internationally that dysfunctional family life, rather than poverty, seems to be
one of the most significant predisposing factors to drug use (United Nations
Drug Control Programme, 1997).
4.7  Children and Drug Use 
In Ireland, the issue of how children are affected by parental drug dependence is
emerging as a new social and clinical concern (Hogan, 1998). In an exploratory
study, Hogan had noted that little is known about the social and psychological
effects on children of parental drug use: 'the main focus of existing research in
Ireland has been on prenatal chemical exposure of children to drugs rather than
on postnatal social exposure' (Hogan, 1997: 4). 
Women, Children and Drug Use 
165
Although the prevalence of parenthood among drug users is unknown, the fact
that the majority of treated drug abusers in Ireland are of child-bearing years
(Moran et al., 1997), coupled with anecdotal evidence that many drug users are
parents, suggests that a large number of children may be affected by drug abuse.
The statistics for treated drug misuse indicate that, in 1998, 9 per cent of women
presenting for treatment stated, when asked about their living status, that they
were lone parents (NDTRS)3.  However, the NDTRS does not capture parental
status per se and the number of drug-using women who have children is likely
to be much higher. A study of the parental status of clients attending a voluntary
drug agency (Ana Liffey Project) found that over three-quarters of the 186
women attending the service during 1992 were parents (Woods, 1994). Over
three-fifths (62.8%) of the 142 mothers were caring for their own children.   A
possible explanation for the high level of attendance of mothers at the voluntary
agency may be that voluntary services are perceived as less threatening than
statutory services among drug-using women with children (Woods, 1994).   It is
likely that some women with children may be reluctant to approach treatment
services because of concerns about being seen as an 'unfit mother' (Butler &
Woods, 1992). 
One of the earliest references to children and drug misuse, in the Irish context, is
a case study of a boy who had begun misusing drugs before his eleventh
birthday (Ryan et al., 1982).  The boy, who was 12 years old on admission to the
Drug Advisory and Treatment Centre, had been abusing a number of drugs
including diconal, palfium, cocaine and heroin for eighteen months. At this time,
it was discovered the boy had chronic hepatitis B infection with cirrhosis. The
boy was from a large family (he was third eldest in a family of ten), his father
was unemployed and his mother suffered from a neurotic disorder with
agoraphobic symptoms.   He was also on probation, having broken into a car. He
had been attending a special school for two years and had presented with
behavioural problems at 7 years of age. Ryan et al. (1982) comment on the
difficulties encountered in the hospitalisation and placement of very young
offenders with drug problems, as exemplified by this case.
Another study, which is relevant in this context, although it does not focus on
children per se, is a study that looked at the risks associated with methadone
storage. Following a coroner's hearing into the death of a 3-year-old boy, who
died after ingesting methadone stored in a baby's feeding bottle, a study was
conducted to investigate the extent to which babies' bottles were used to
m e a s u r e
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3 National Drug Treatment Reporting System 
and store methadone (Harkin, Quinn & Bradley, 1999).  The study involved nine
general practitioners, who asked 186 patients in receipt of a methadone
prescription whether or not they used a baby's bottle to measure methadone, and
if they had children under the age of 14.  The results indicated that almost a
quarter of patients (n=48) had used a baby's bottle to measure methadone in the
previous month, and twenty-one (43%) of these had a child under the age of 14.
Furthermore, seven patients had used a baby's bottle to store methadone in the
previous month, and four of these had a child under the age of 14. Although it is
difficult to draw conclusions from these findings, they suggest that the use of a
baby’s bottle to measure and/or store methadone may present a threat to the
health of children  
In an attempt to redress the lack of research on children of drug users in Ireland,
Hogan (1997) is conducting a two-stage study on the social and psychological
effects on young children of parental heroin use. The first part of the study,
which involved a qualitative study of ten families, in which one or both parents
were opiate users, has been completed. Interviews were conducted with thirty
informants consisting of parents, teachers, professional workers and non-
parental caregivers. The study found that all the children (n=10) in the sample
had at least one parent who had been incarcerated and that the majority had
experienced separation from their parents owing to parental drug use (Hogan,
1997).  From the interviews with teachers and parents, it emerged that only a few
children showed evidence of social-emotional problems; however, the majority
were experiencing difficulties at school.  Parents expressed three main concerns
about how their drug use might impact adversely on their parenting.  The first
concern related to their pre-occupation with obtaining drugs, which might result
in inadequate attention being paid to their children. The second worry was that
their drug use would affect their social interaction with their children. The third
related to a prevailing atmosphere of secrecy in the home owing to parental drug
use and the possible development of distrustful relationships between the
parents and children. Key workers interviewed were particularly concerned
about the questionable quality and consistency of care-giving by drug-using
parents, the danger of physical neglect, and the possibility that children might
witness drug use. Interestingly, all these concerns were raised in a recent
editorial in the journal Addiction (Barnard, 1999).  Key workers also emphasised
that there were a number of parents about whom no concerns existed and whose
competence they stressed. Thus, as Barnard (1999) points out, it cannot be
assumed that drug dependence automatically results in diminished capacity to
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parent adequately or that the development of children is necessarily adversely
affected by parental drug use.
Hogan (1997) also identifies a number of variables that mediate the effects on
children of parental drug use, including the living arrangements of the child, the
social support available to parents, the extent to which one or both parents are
in treatment, whether or not the drug-using parent is in treatment, the history of
drug use and treatment, the age of the child when parents begin using heroin
and whether or not this drug use is chaotic.  Stage 2 of Hogan's study, which is
currently under way, investigates the extent to which children are exposed to the
drug culture and aims to examine the consistency and adequacy of care
provided to children of drug users.
Summary
Although the extent to which children in Ireland are affected by drug misuse is
unknown, a study of drug-using women attending a voluntary agency suggests
that many drug-using women are also parents (Woods, 1994). Very little is
known about the needs of children of drug users in Ireland; however, a study is
under way that aims to investigate the needs of drug users and their children
(Hogan, 1997). The first phase of this study has been completed and has found
that the majority of children experienced separation from one or both of their
parents owing to drug use.  Parents, key workers and teachers interviewed
expressed concerns about the possible impact of drug use on children. The study
also identifies a number of variables such as the social support available to
children and drug-using parents that can influence the extent to which parental
drug use affects children.
4.8 Demand Reduction (Prevention, Treatment and Care) 
and Female Drug Users
A small number of initiatives have been developed specifically for women in
Ireland.  The focus of these initiatives has been on treatment, rehabilitation and
care rather than prevention. There is at least one harm-reduction programme in
place especially for women.
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Harm Reduction
A harm-reduction programme for women sex workers who are using drugs has
been set up by the Merchant's Quay Project, a voluntary organisation providing
services to drug users and persons with HIV/AIDS in Dublin's city centre
(Merchant's Quay Project, 1998).  The harm-reduction programme is overseen by
a healthcare worker and operates on a weekly basis, offering services such as
needle exchange and condom distribution. The programme has produced some
positive outcomes, with some clients subsequently progressing to the Mobile
Clinic (a low-threshold service) and to detoxification programmes.  
Treatment
Some treatment facilities in Ireland have support groups or drop-in times
designated for women only (e.g. Ana Liffey Project).  One service, the Merchant's
Quay Project, accommodates mothers wishing to access the needle exchange,  by
allocating hours in the morning, found to be more suitable for women with
children.  However, there are very few treatment services dedicated to providing
programmes specifically for women drug users.  The treatment services
available in Ireland specifically for women drug users include a drug-free
residential programme, and services developed for pregnant women.
The Coolmine Therapeutic Community provides a residential drug-free
programme specifically for women at Ashleigh House, Clonee, County Meath.
This programme, based on the Minnesota Model,4 involves an abstinence-
orientated approach. At the time of writing there were twenty-five women
participating in this programme. Ashleigh House is currently being renovated to
accommodate mothers and their children, as part of a project funded through a
Local Drug Task Force.  When completed, the facility will allow five to ten
mothers, with up to two children each, to participate in the programme.
A special programme for pregnant opiate addicts in Ireland was established by
the then National Drug Advisory and Treatment Centre  in 1984, in response to
the growing numbers of pregnant clients attending the clinic (O'Connor et al.,
1988). The programme involved low-dose methadone maintenance, weekly
group therapy and fortnightly attendance at antenatal clinics (Keenan et al.,
1993). Participants in the programme were also encouraged to attend 
4 Associated with the Alcoholics/Narcotics Anonymous programmes, the Minnesota model offers a 12
step programme to long term abstinence based on the idea that addiction is a disease. Devised by the
Hazelden Hospital in Minnesota, the programme offers spiritual as well as practical guidance.
(www.drugscope.org.uk)
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programmes outside the clinic where appropriate.  Postnatally, women were
given advice about contraception and encouraged to address their addiction.
Participation in the programme was conditional on non-consumption of drugs,
as monitored by daily, supervised urinalysis, engagement in weekly group
meetings, and attendance at antenatal care. 
According to Williams & Kinsella (1990), other services available to pregnant
opiate addicts in Ireland include group therapy, occupational therapy,
individual counselling and support groups for family members. In Ireland,
methadone maintenance is generally the preferred treatment option for pregnant
opiate users for a number of reasons.  Firstly, it is hoped that the prescription of
methadone will reduce/eliminate illicit opiate misuse during pregnancy.
Secondly, the administration of regulated methadone doses helps to reduce the
risk of an infant developing withdrawal symptoms in the immediate postnatal
period (Keenan et al., 1993).  Thirdly, methadone maintenance encourages better
antenatal care and a more stable drug environment for mother and child (Kelly
et al., 1983). 
The Eastern Health Board (EHB)  employs three drug liaison midwives to make
contact with substance-misusing pregnant women and to liaise between the
obstetric hospitals and the drug-treatment services. The midwives are
responsible for ensuring that the medical, psychological, obstetrical and social
needs of each woman have been accurately assessed and for drawing up a
detailed clinical/psychological/social care plan for each woman (Eastern Health
Board, 1998). 
A unit, which will provide intensive medical care to stabilise expectant drug-
addicted mothers and improve neonatal outcome, is currently being planned
and will be located in Dublin's Cherry Orchard Hospital (Vize, 1999).  The
twelve-bed facility will offer intensive medical treatment by a psychiatrist with
a team of specially-trained nurses, and access to counselling and screening.
Additionally, the unit will incorporate a facility for female addicts who have
delivered and since destabilised, which will allow mother and baby to remain
together while treatment is being administered.  At present, only three of
seventeen beds in the detoxification unit of the hospital are allocated to pregnant
women requiring stabilisation. According to Dr Keenan, consultant psychiatrist
in the EHB, the new unit should have a significant impact on the prevalence of
neonatal complications and morbidity associated with opiate dependent
pregnancies (Vize, 1999). 
A Collection of Papers on Drug Issues in Ireland
170
Care and Rehabilitation
At the time of writing, the most recent service plan for the largest health board
area in Ireland (Eastern Health Board) has placed an increased emphasis on
after-care and rehabilitation.  Although there is no particular emphasis on
women-only services, SAOL has been established, providing rehabilitation and
support for women who are stable opiate users.  SAOL stands for Seasamhacht,
Abaltacht, Obair, Leann, meaning stability, ability, work and learning - the word
'saol' means life. The project, which began in 1995 in Dublin's north inner city,
offers a two-year programme for sixteen women.  The project aims to help clients
move from addiction and dependency to self-direction and self-reliance. The
programme incorporates a wide variety of activities, including literacy skills,
English, creative writing, aromatherapy, relaxation and massage. It is based on
the principles of social justice, equality and inclusion. A review of the
programme by Weaver (1998) indicates that participants view the programme as
a 'job', which gives them a perceived status in the community.  Participants
reported increased levels of self-esteem, ability to re-establish relationships with
family members and becoming reintegrated into their communities as a result of
the programme.
Summary
Very few services have been developed specifically for women.  Some treatment
centres accommodate women and children by having more flexible opening
hours for this client group. There is one residential drug-free programme for
women only.  Services have also been developed for pregnant opiate users and
a harm-reduction programme is in place in the Dublin area.  A women-only
rehabilitation service has also been established.  
4.9  Barriers to Service Access
In examining the services available to female drug users and their children, it is
also important to examine possible barriers, which would prevent or inhibit
women from accessing services.
A recent Dublin study found that lack of childcare facilities is a barrier to
accessing drug treatment, in particular for women (Moran, 1999).  The research
found that only nine of forty-five drug-treatment centres in Dublin provided
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crèche facilities.  Interviews were conducted with a wide variety of personnel
(including crèche leaders and workers, treatment staff, parents/guardians, and
children attending the crèche) in six of the nine centres offering crèche facilities.
The results indicate that crèches are perceived as playing an important role in the
children's emotional, psychological and educational development. It was also
found that crèche leaders facilitate mothers in their parenting by providing
advice and help in relation to parenting skills. Furthermore, having access to a
crèche influences parents' willingness to attend treatment and their
psychological approach to treatment.
Butler & Woods (1992) found that HIV-positive female drug users were less
likely to seek treatment, owing, in part at least, to fears of being judged an unfit
parent and having their children taken into care by the State. Similarly, Hogan
(1997), in her study of the psychological and social needs of the children of drug
users, found that mothers' fears of having their children taken into care were
quite pronounced. 
Dunne (1994), in a study exploring the service needs of fifty female drug addicts,
found that the vast majority (82.5%) had family support, mainly from their
mothers. Consistent with other studies, the majority (71%) had drug-using
partners. More worrying was the finding that half the women had partners who
were described as violent. When asked what services were important to them,
'women-only support groups' were most frequently mentioned, followed by
welfare, one-to-one counselling, crèche facilities, relaxation and parenting skills.
The study concludes by recommending that female support groups with
professional facilitation be established in each treatment centre and that crèche
facilities be extended and improved in drug-treatment facilities. 
Summary
Lack of crèche facilities and fears of being seen as an 'unfit mother' appear to be
the main barriers facing Irish drug-using women seeking treatment.  An analysis
of the needs of drug-using women also suggests that female support groups are
considered an important aspect of treatment. 
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4.10  Conclusion
It is apparent that research on women, children and drugs in Ireland has focused
almost exclusively on pregnant opiate addicts.  Consequently, there is a lack of
information on how drug use affects women in general and how parental drug
use impacts on children.  
The available research suggests that Irish female drug users engage in more risk
behaviour than their male counterparts, which has significant health
implications, increasing their likelihood of contracting HIV and hepatitis B and
C infections.  The profile of the pregnant opiate user clearly indicates that these
women are in need of a very high level of support. The high rate of drug use
among women prisoners is also an issue of concern. 
Lack of crèche facilities and fears of being seen as an 'unfit mother' appear to be
two of the main barriers preventing women from accessing treatment.
Consequently, an increase in the provision of crèche facilities would help more
women gain access to services.  Similarly, it appears that assurances need to be
given to female drug users seeking treatment, that accessing services will not
jeopardise their custody of their children. 
The available indicators all suggest that female drug users have particular needs
that require to be taken into account in service planning and provision. Much
more research effort is needed into the issues surrounding drug use by women
in Ireland and internationally.
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Introduction
This collection of papers was developed as part of the work undertaken by the
Drug Misuse Research Division (DMRD) in the context of its work as Focal Point
to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).  
The EMCDDA is a European Union (EU) institution providing information
concerning drugs and drug addiction and their consequences.  The EMCDDA
works to improve the comparability of drug-related data in the member states,
and to disseminate information and co-operate with international bodies dealing
with drug-related issues. In fulfilling its role, the EMCDDA co-operates with a
network of 'focal points' or national centres dealing with drug-related issues in
the member states. This network is called the REITOX network (European
Information Network on Drugs and Drug Addiction).  The DMRD of the Health
Research Board (HRB) is the designated Irish Focal Point for the REITOX
network.  Focal Points act as an information resource to the EMCDDA in relation
to the national situation in each member state and disseminate European-level
information nationally. 
Each Focal Point, under contract with the EMCDDA, prepares an annual report
on the state of the drug problem. The EMCDDA provide guidelines for the
content and structure of such documents. The EMCDDA uses information from
these reports from the member states when compiling its annual report on the
state of the drugs problem in Europe (EMCDDA, 1996, 1997,1998,1999,2000). The
Europe-wide reports are available on the EMCDDA and the linked HRB
websites as follows - www.emcdda.org and  www.hrb.ie. The HRB edits and
publishes the contributory Irish national report every three years (O'Brien &
Moran, 1998). The annual report for Ireland 2000 is published elsewhere (Moran,
O'Brien, Dillon & Farrell, with Mayock, 2001).
The EMCDDA guidelines for the 1999 and 2000 annual national reports included
coverage of some 'key issues or topics', which were agreed, by the countries of
the EU and the EMCDDA, to be of particular interest. A selection of these key
issues form the chapters presented in this document. 
Chapter 1 overviews the main institutional mechanisms involved in the
implementation of Irish Government strategy in relation to illegal drugs. Thus,
the Cabinet Committee on Social Inclusion, the National Drugs Strategy Team,
the National Advisory Committee on Drugs (NACD), the Local Drugs Task
Forces (LDTFs) and the Young People's Facilities and Services Fund (YPFSF) are
(xiii)
described in the context of Ireland's National Drugs Strategy 2001-2008 (2001).
This chapter has been updated to take into account the main developments
emerging from the publication of Ireland’s National Drugs Strategy 2001-2008
(2001).
Chapter 2 provides an overview of the current situation in Ireland in relation to
drug-related infectious diseases (HIV, hepatitis B and hepatitis C infection). The
chapter shows that such infectious diseases are of concern in relation to Irish
injecting drug-users. Risk behaviours such as  the sharing of injection equipment
and unsafe sexual practices are discussed. The authors point to the need for more
research on the societal and familial consequences of drug-related infectious
diseases, which have received little attention in the Irish context to date.
Chapter 3 presents findings from a small (n=10) exploratory study of cocaine
users. The study is important as there is considerable anecdotal evidence that
cocaine use is becoming more widespread in Ireland, as in other European
countries, yet there is little research in the area. The increase is occurring in the
context of changing socialising patterns, among young people in particular. In
addition, drug-service-providers have had little training in the treatment of
problematic cocaine use. The ten users interviewed expected to find themselves
in social settings where cocaine was available. They tended to use cocaine in
some chosen social settings and not in others, and most often its use was
combined with the use of alcohol. The need to monitor trends in cocaine use on
an ongoing basis is noted. The chapter includes a review of Irish literature and
official information sources on cocaine use, e.g. the National Drug Treatment
Reporting System (NDTRS), drug seizures/arrests and surveys. 
Chapter 4, prepared for the 1999 national report (Moran, O'Brien, Farrell &
Dillon, 1999), reviews the Irish literature on women, children and drug use.
Although not updated for the present publication, this is an important
contribution to the drugs literature, as the information available in Ireland is
dispersed (in the medical, social, psychological and grey literature) and has not
previously been brought together. The review covers, inter alia, the
epidemiology of female drug use; HIV/AIDS and women, children and drug
use; drug use among female prisoners; children and drug use; demand
reduction; and barriers for women in accessing services.
The term 'drug misuse' as used in this report refers to the taking of a legal and/or
illegal drug that harms the physical, mental or social well being of the
individual, the group or society.
Rosalyn Moran
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